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ABSTRACT OF DISSERTATION 
 
INVESTIGATION OF THE PHYSIOLOGICAL ROLE OF RIN GTPASE IN CELL 
DEATH, AXONAL INJURY, AND INFLAMMATION FOLLOWING TRAUMATIC 
BRAIN INJURY 
 
Traumatic brain injury (TBI) is a progressive disorder, in which the primary 
injury results in the initiation of a complex cascade of secondary biochemical and 
metabolic changes resulting in lasting neurological dysfunction and cognitive 
impairment. The heterogeneous nature of the disease has complicated the 
development of pharmacological agents to improve the outcomes of TBI; to date, 
no therapeutic treatment has been shown to be effective in clinical trials. 
Treatments targeting multiple secondary outcomes (cell death, axonal 
degeneration, and inflammation) may provide enhanced therapeutic efficacy 
following TBI. 
Small Ras family GTP-binding proteins govern diverse cellular processes 
by directing the relay of extracellular stimuli to the activation of select intracellular 
signaling pathways. Rin (RIT2) is a member of the Rit subfamily of Ras-related 
family of GTPases, and is expressed solely within neurons of the CNS. Early cell 
culture models demonstrated that Rin signaled upstream of the stress-activated 
protein kinase, p38, and lacked the transformative abilities displayed by other 
members of the Ras family, suggesting functions for Rin other than cell growth 
and proliferation.  
To begin to define the physiological function of Rin, we generated a RIT2 
knockout mouse and examined the impact of Rin loss in the CNS following brain 
trauma. Our data demonstrates that Rin deficiency is neuroprotective following a 
controlled cortical impact (CCI) injury, reducing both acute hippocampal 
neurodegeneration and promoting sustained neuronal survival, without affecting 
post-CCI neurogenesis. Hippocampal neuroprotection achieved by Rin loss was 
accompanied by improved cognitive function in injured mice. Furthermore, we 
demonstrated that Rin loss led to blunting of axonal degeneration and microglial 
activation in the optic nerve following optic nerve stretch injury. The molecular 
interaction between Rin and dual leucine zipper kinase suggested a potential role 
for Rin in the regulation of a novel stress MAPK-dependent neuronal death 
cascade. Lastly, we demonstrated through diffuse closed head injury, that Rin 
loss mitigates cytokine release as a result of injury without altering glial 
activation. 
Together, these studies establish Rin as a novel regulator of neuronal cell 
death, cognitive decline, axonal degeneration, and cytokine production following 
traumatic brain injury.  
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CHAPTER ONE 
 
Background and Introduction 
 
Traumatic Brain Injury  
Epidemiology and Etiology  
Traumatic brain injury (TBI) is broadly defined as any blow or jolt to the 
head that results in damage to the brain and disruption of normal brain function 
(CDC 2015). TBI is a leading cause of death and permanent disability worldwide; 
there are approximately 57 million people living that have been hospitalized for 
TBI around the globe (Murray 1996). In the United States alone, TBI affects 1.5 
million people annually (Thurman 1999). As a result of these injuries, 1.1 million 
people visit the ER, 235,000 people are hospitalized, and 50,000 will perish 
(Thurman 1999, Langlois, Rutland-Brown et al. 2006). Despite these substantial 
numbers, TBI statistics are underrepresented, as surveys do not include cases 
treated in outpatient settings, physicians’ offices or military facilities in the United 
States or abroad (Langlois, Rutland-Brown et al. 2006, Summers, Ivins et al. 
2009). 
TBI is not constrained to any particular age, gender, or demographic, thus 
has the potential to affect everyone. The overall leading causes of TBI are falls 
(32%), motor vehicle accidents (19%), struck by/against events (18%), and 
assaults (10%) (Rutland-Brown, Langlois et al. 2006). When age is factored into 
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the equation, clear trends are observed throughout the life course. It can be seen 
that the peak incidence rates in young adults are due to motor vehicle accidents, 
whereas in the elderly peak rates are the result of falls (Thurman 1999). Finally, 
although both genders are affected, the rates of TBI among males are 
significantly higher than those observed in females (650.9 per 100,000 compared 
to 429.1 per 100,000). The highest incidence rate of TBI has been reported in 
males between the ages of 20 and 30 years (Langlois, Rutland-Brown et al. 
2006, Rutland-Brown, Langlois et al. 2006). 
TBI is referred to as the invisible epidemic because the long-term effects 
of the disease are not always visually apparent. Long-term disabilities resulting 
from brain injury include alterations in cognition, mood and personality. TBI has 
also been associated with increased risks of other health problems; indeed, 
compared to the general population, those who have suffered from TBI are more 
likely to experience epilepsy or binge drinking behavior, and are 7.5% more likely 
to die within three years of the head injury (Horner, Ferguson et al. 2005, 
Selassie, McCarthy et al. 2005, Langlois, Rutland-Brown et al. 2006). 
Additionally, TBI has also been associated with increased prevalence rates of 
depression and Alzheimer’s disease (Plassman, Havlik et al. 2000, Holsinger, 
Steffens et al. 2002). Furthermore, military soldiers returning from Iraq who had 
suffered a mild head injury displayed a strong comorbidity of depression and/or 
post-traumatic stress disorder (Hoge, McGurk et al. 2008). Overall, it is estimated 
that 5.3 million people (approximately 2% of the population) in the United States 
alone are living with a permanent TBI-related disability (Thurman 1999). The 
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annual cost of care and rehabilitation for TBI sufferers within the United States 
was calculated at over $76 billion in 2000 (Finkelstein 2006, Coronado, Xu et al. 
2011). 
Pathophysiology 
 The clinical manifestations of TBI are heterogeneous, ranging from a mild 
headache or concussion to coma and/or death. Clinically TBI is defined as an 
alteration in brain function that could include any of the following: loss of 
consciousness, memory loss of events before or after the injury, neurological 
defects, sensory loss, loss of balance or coordination, or altered mental state 
such as confusion or disorientation (Menon, Schwab et al. 2010). Alterations in 
cognition is one of the most commonly reported functional impairments following 
TBI (Lundin, de Boussard et al. 2006). Regardless, both cognitive and motor 
deficits have been reported to persist months following the initial insult in 40% of 
patients (Satz, Forney et al. 1998). 
To evaluate the diverse outcomes of a TBI, the Glasgow Coma Score 
(GCS) was introduced in the late 1970s to gage the severity of a head injury. 
GCS scores fall on a scale from 3 to 15 judging by the ability of a patient to 
respond to verbal, auditory, and visual stimuli along with an assessment of motor 
and verbal proficiencies (Teasdale and Jennett 1974). Based on this scale, a 
patient with a GCS score ranging from 13-15 is classified to have a mild TBI, 9-
12 a moderate TBI, and 3-8 a severe head injury. Nevertheless, patients 
presenting with the same GCS score often have vastly different injuries and 
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require distinctive treatment methods. More recently, utilization of neuroimaging 
techniques, such as magnetic resonance imaging and computerized tomography, 
has further advanced characterization of TBI to allow for more appropriate 
treatment intervention (Marshall, Marshall et al. 1992, Maas, Steyerberg et al. 
2007). 
TBI results in the activation of a multitude of pathological outcomes. These 
mechanisms set forth by traumatic injury can be separated into primary and 
secondary injury events. The primary injury results from the initial mechanical 
force to the head. Damage from the mechanical force then triggers the activation 
of secondary injury cascades (Figure 1.1). 
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Figure 1.1 Progression of primary and secondary injury following insult to 
the head. A primary mechanical force to the head results in tissue deformation 
and cell shearing within seconds to minutes of the insult results in the activation 
of secondary cascades that can persist for months. Together, the primary and 
secondary injuries lead to functional deficits. Modified from (Xiong, Mahmood et 
al. 2013). 
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Primary Injury 
 The primary injury results in shearing, compression and/or stretching of 
nervous system cells and vasculature along with a disruption of membrane 
integrity following the application of a mechanical force to the head (Beauchamp, 
Mutlak et al. 2008). This initial mechanical disruption can be caused by a variety 
of injury mechanisms including: contact with a penetrating or non-penetrating 
object, rapid acceleration/deceleration forces, or a blast injury (Menon, Schwab 
et al. 2010).   
Depending on the type of force, primary injury can be classified as either 
focal or diffuse. Focal damage is localized to a discrete area of the brain and 
associated with mass lesion formation often caused by contusion and/or 
hemorrhage, which leads to localized cell death and ischemia (Povlishock and 
Katz 2005).  Contrarily, diffuse injury occurs in non-discrete areas across the 
brain and is often characterized by edema and axonal injury (Povlishock and 
Katz 2005). In either case, the tissue damage and cell death caused by the 
primary insult do not lend themselves for therapeutic intervention, instead they 
initiate a cascade of detrimental consequences (Beauchamp, Mutlak et al. 2008, 
Maas, Roozenbeek et al. 2010). 
Secondary Injury Cascades  
 Secondary injury is defined by the self-propagating pathological alterations 
occurring in cells and tissues that result in cellular dysfunction and death hours to 
weeks following the initial insult (Borgens and Liu-Snyder 2012). Secondary 
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cascades are characterized by a complex set of biochemical and molecular 
alterations giving rise to neuroinflammation, delayed cell apoptosis or necrosis, 
and edema for prolonged periods following injury (Beauchamp, Mutlak et al. 
2008). The nature of secondary injury processes that manifests is dependent 
upon the type and severity of the primary injury. Furthermore, secondary injuries 
are complex, propagating spatially and temporally following trauma. Disruption of 
cellular integrity results in a loss of ion homeostasis as extracellular calcium ions 
flow into damaged neurons. This unregulated flow of calcium into the neuron 
initiates uncontrolled release of neurotransmitters along with the activation of 
intracellular proteases, such as calpain, inducing excitotoxicity and disruption of 
cellular transport (Baker, Moulton et al. 1993, Saatman, Bozyczko-Coyne et al. 
1996, Hall, Sullivan et al. 2005, Krishnamurthy and Laskowitz 2016). High 
intracellular concentration of calcium also contributes to mitochondrial 
dysfunction as the organelle becomes overwhelmed attempting to clear cytosolic 
calcium, which ultimately leads to increases in reactive oxygen species (ROS), 
loss of ATP production, and the commencement of apoptosis (Sullivan, 
Thompson et al. 1999, Singh, Sullivan et al. 2006, Chen, Yang et al. 2007). The 
occurrence of a multitude of detrimental events overwhelms the cell inducing cell 
death which leads to a wave of excess calcium and neurotransmitters, further 
propagating cell death through excitotoxicity in surrounding cells (Conti, 
Raghupathi et al. 1998, Pleasant, Carlson et al. 2011).  Additionally, shearing of 
axons and subsequent degeneration and demyelination interrupt signal 
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transduction following injury (Meaney, Margulies et al. 2001, Povlishock and Katz 
2005, Mac Donald, Dikranian et al. 2007).  
Traumatic Axonal Injury 
 Traumatic axonal injury (TAI) is a common feature of diffuse TBI, 
generally resulting from high-velocity rotational forces that result in stretching and 
shearing of axons (Hill, Coleman et al. 2016). The majority of axonal damage is 
not due to shearing at the time of primary injury	  (Buki and Povlishock 2006); 
rather, demyelination and atrophy along white matter tracts progresses for 
decades in TBI patients (Johnson, Stewart et al. 2013, Green, Colella et al. 
2014). Axonal pathology develops over the course of days following injury. Within 
seconds of stretch injury, the axons become misaligned and take on a wavy 
structure due to temporary loss of elasticity (Smith, Wolf et al. 1999). Although 
axonal structure recovers, axonal swellings become visible within hours of injury. 
Over the course of days to weeks, accumulation disruption of cytoskeletal 
elements and cellular transport exacerbates axonal pathology leading to 
secondary axotomy, pathologically denoted by the presence of a bulb formation 
at the axon terminal (Smith 2000). Traditionally it was believed that all these 
damaged axons would disconnect and undergo Wallerian degeneration, 
characterized by the degeneration of axon segment distal to the site of 
transection (Smith 2000). However, it is now recognized that many of these 
damaged axons will not disconnect and dieback, but instead will undergo axonal 
repair	  (Buki and Povlishock 2006). 
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Axonal damage is a progressive secondary cascade that manifests as a 
interruption of protein transport and breakdown of cytoskeletal elements (Hill, 
Coleman et al. 2016).  Indeed, labeling of transported proteins, such as amyloid 
precursor protein (APP), can be observed localized in axonal swellings within 
hours of traumatic injury (Roberts, Gentleman et al. 1991, Roberts, Gentleman et 
al. 1994, Smith 2000). It has been proposed that disruption of protein transport is 
caused by proteolysis and compaction of the axonal cytoskeleton, which is 
primarily composed of neurofilament proteins (Hall and Lee 1995, Povlishock, 
Marmarou et al. 1997). In addition to proteolysis, dephosphorylation of 
neurofilament proteins may also contribute to compaction of the axonal structure 
(Okonkwo, Pettus et al. 1998).  
Blood Brain Barrier Breakdown 
 Disruption of the blood brain barrier (BBB) is a hallmark of severe TBI 
(Baldwin, Fugaccia et al. 1996, Price, Wilson et al. 2016). The microvessels of 
the BBB are composed of endothelial cells connected by tight junctions; these 
endothelial cells interact with the glial cells of the CNS to form a restrictive barrier 
between the CNS and the rest of the body (Price, Wilson et al. 2016). Following 
primary trauma, vasculature disruption causes a breakdown of the endothelial 
tight junctions of the BBB allowing for atypical transport of molecules from the 
peripheral blood stream into the brain including clotting agents such as thrombin, 
fibrinogen and albumin that decrease blood flow and increase the risk of 
ischemia (Chodobski, Zink et al. 2011, Price, Wilson et al. 2016). Increased BBB 
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permeability also allows for accumulation of plasma proteins and water in the 
brain contributing to post-traumatic edema (Greve and Zink 2009, Chodobski, 
Zink et al. 2011). Lastly, disruption of the BBB allows for immune cells from the 
periphery, such as macrophages and neutrophils, to enter the brain through the 
damaged vasculature. Upon infiltration, these cells become active and secrete 
cytokines such as TNF-α and IL-1β, which activate resident glial cells initiating a 
neuroinflammatory response (Ziebell and Morganti-Kossmann 2010, Chodobski, 
Zink et al. 2011, Kumar and Loane 2012).  
Glial Activation and Inflammation 
 Resident astrocytes are important for maintaining homeostasis by aiding 
in support of the BBB, secretion and absorption of neurotransmitters, and 
maintenance of extracellular ion concentrations (Kolb 2008). Following trauma, 
astrocytes become activated; this process of astrocytosis is characterized by 
cellular proliferation and hypertrophy (increased expression of glial fibrillary acidic 
protein (GFAP), elongation of cellular processes, and cytoplasmic enlargement) 
(Saatman, Feeko et al. 2006, Bardehle, Kruger et al. 2013, Burda, Bernstein et 
al. 2016). Following brain insult, astrocytes form a glial scar that acts as a 
protective barrier between damaged tissue and the intact brain (Villapol, Byrnes 
et al. 2014) Although the scar compartmentalizes cellular debris and biochemical 
byproducts of the damaged tissue, astrocytes in the scar continue to release 
cytokines, that promote inflammation, and chondroitin sulfate, a molecule that 
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has been shown to inhibit regeneration and repair (Smith, Miller et al. 1986, 
Snow, Steindler et al. 1990, McKeon, Schreiber et al. 1991). 
 Mircoglia are the resident immune cells of the CNS. In their resting, or 
inactive, state they survey tissue for biochemical markers of damage and 
infection (Harry 2013). Upon detection of TBI-induced damage, microglia become 
activated and begin to release cytokines to signal other glia cells to respond to 
injury (Chiu, Liao et al. 2016). These cells, along with peripheral macrophages 
and neutrophils (introduced following the breakdown of the BBB), recognize 
foreign antigens and clear cellular debris (Harry 2013). Microglia have been 
demonstrated to switch between two different states of activation: M1 and M2. 
M1 activated microglia release pro-inflammatory cytokines, such as TNF-α and 
IL-1β, along with ROS, which lead to further cell death (Chiu, Liao et al. 2016). In 
an M2 state, however, microglia promote tissue repair and regeneration by 
releasing trophic factors such as insulin-like growth factor-1, anti-inflammatory IL-
10, and the incretin, GLP-1 (Chiu, Liao et al. 2016). The inability of microglia to 
switch between these two states is detrimental to brain health. Sustained 
elevation of IL-1β and TNF-α impair the switch from the M1 to M2 phase leading 
to neuronal dysfunction (Streit, Mrak et al. 2004).  
Treatment of TBI 
The activation of a diverse array of secondary injuries cascades has made 
the treatment of TBI complex. Disappointingly, to date no pharmacological 
treatment for TBI has convincingly shown benefit in a multicenter phase III trial 
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and made it to market. The rationale for trial failures have been attributed to a 
variety of factors including: drugs not reaching their target, not attaining an 
adequate intracranial concentration, or missing the appropriate time for 
intervention (Beauchamp, Mutlak et al. 2008). Due to the lack of pharmacological 
agents, clinically, the symptoms of TBI are mitigated through the use of mannitol 
to decrease brain edema and surgical craniectomy to stabilize intracranial 
pressure (Muizelaar, Wei et al. 1983, Munch, Horn et al. 2000). However, 
increasing focus on the cellular and molecular changes accompanying TBI 
continues to provide new therapeutic targets for drug development (Beauchamp, 
Mutlak et al. 2008). One area of focus is on agents that are able to enhance the 
brain’s endogenous plasticity and regeneration capabilities.  
Recovery following TBI: Neurogenesis 
Following trauma, the brain initiates endogenous repair mechanisms, 
promoting plasticity and regeneration (Scheff, Price et al. 2005, Rola, Mizumatsu 
et al. 2006, Xiong, Mahmood et al. 2010). Although glial cells quickly proliferate 
in response to injury, the developed brain has less capacity to replenish lost 
neurons. Historically, it was believed that all neurons in the brain were derived 
during embryonic development and the adult brain was unable to produce new 
neurons throughout the life course. However, it is now understood that resident 
neural stem cells are able to self-renew their own pool through proliferation and 
also have the ability to differentiate into astrocytes, oligodendrocytes, and 
neurons through the process of neurogenesis (Gage 2000). New neurons are 
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generated in two discrete niches within the adult brain: in the subventricular zone 
of the lateral ventricles and the subgranular zone of the hippocampal dentate 
gyrus (Gage 2000). Neurogenesis is a dynamic process and rates of proliferation 
are responsive to environmental stimuli (Kempermann, Kuhn et al. 1997, van 
Praag, Christie et al. 1999, van Praag, Shubert et al. 2005). Indeed, increased 
levels of neurogenesis have been observed following various brain insult 
including ischemia (Jin, Minami et al. 2001, Osman, Porritt et al. 2011), seizures 
(Parent and Lowenstein 2002, Smith, McLean et al. 2005), and TBI (Dash, Mach 
et al. 2001). Although neurogenic activation indicates an attempt at self-repair 
following injury, the number of neurons generated, and subsequently integrated 
into the circuitry, is too few to generate complete functional recovery	  (Quadrato, 
Elnaggar et al. 2014). 
A better understanding of the molecular components that drive neuronal 
plasticity and recovery following TBI is needed, for treatments that reduce 
neurodegeneration while promoting enhanced plasticity may prove to be 
efficacious for the treatment of TBI. Although the molecular mechanisms 
contributing to the regulation of neurogenesis are poorly understood, it is 
suspected that neurotrophins, such as BDNF, NGF and NT-3, and growth factors 
such as IGF-1, bFGF and VEGF, play important roles in the regulation of 
neurogenesis (Maisonpierre, Belluscio et al. 1990, Aberg, Aberg et al. 2000, 
Carro, Trejo et al. 2001, Lee and Son 2009, Mudo, Bonomo et al. 2009). The Ras 
superfamily of GTPases regulate cellular responses downstream of growth factor 
stimulation (Katz, Amit et al. 2007) and have been implicated in the control of 
	   14	  
processes involved in neuronal plasticity (Darcy, Trouche et al. 2014, Mir, Cai et 
al. 2017, Mir, Cai et al. 2017), suggesting that they function critically to regulate 
recovery following injury. 
Ras superfamily  
The Ras superfamily of GTPases encompasses a large family of 
structurally related hydrolysis enzymes that function to regulate a variety of 
cellular processes by acting as molecular switches relaying extracellular stimuli 
to the activation of appropriate intracellular responses (Reuther and Der 2000, 
Colicelli 2004, Wennerberg, Rossman et al. 2005). The Ras superfamily can be 
separated into five subfamilies: Ras (Rat sarcoma), Rho (Ras homolog gene 
family), Rab (Ras-related GTP-binding protein), Ran (Ras-related nuclear 
protein), and Arf (ADP-ribosylation factor) (Colicelli 2004). Ras family protein 
signal transduction cascades commonly activate cell proliferation and survival 
responses (Satoh, Nakafuku et al. 1992, Downward 1998, Wennerberg, 
Rossman et al. 2005). Rho proteins are associated with the regulation of 
cytoskeletal dynamics and cell morphology (Jaffe and Hall 2005, Wennerberg, 
Rossman et al. 2005). The Rab family is critical in modulating membrane 
trafficking (Stenmark and Olkkonen 2001, Wennerberg, Rossman et al. 2005), 
while Arf proteins function in vesicular transport (Wennerberg, Rossman et al. 
2005, Gillingham and Munro 2007), and the Ran family in nuclear transport 
(Pemberton and Paschal 2005, Wennerberg, Rossman et al. 2005). Although the 
functions of many GTPases have been well characterized, there remains a 
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subset whose physiological roles have not been defined. The focus of this 
dissertation is one such protein of the Ras subfamily, Rin (Ras-like protein in 
neurons). 
GTPase cycle 
 Despite the broad array of functions controlled by different small GTPase 
families, a majority of the Ras superfamily shares a conserved protein core that 
is responsible for nucleotide binding and hydrolysis (Colicelli 2004). This core 
region drives a conformational switch between an inactive, GDP-bound, and 
active, GTP-bound, structural state. In their GTP-bound structural state Ras 
GTPases are capable of associating with, and activating, a diverse array of 
cellular effector proteins (Wennerberg, Rossman et al. 2005). It is the capability 
of GTPases to function as GTP/GDP driven molecular switches that permits 
them to serve as critical regulators of diverse cell signaling cascades (Figure 
1.2).  
 The activation of the small GTPases is dependent on nucleotide 
exchange. When GDP is bound, the protein is found in an “inactive” 
conformational state, with the G2 effector loop buried within the protein. This 
conformational state inhibits the interaction of Ras G-proteins with their 
downstream effectors, thereby preventing signaling. The binding affinity for 
guanine nucleotides is high, with a Kd value in the 10-11M range; therefore, 
spontaneous activation of Ras proteins does not occur under physiological 
conditions	  (Lowy and Willumsen 1993). Furthermore, the intrinsic hydrolysis 
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activity of these enzymes is low and, without assistance, inactivation of the GTP-
bound active state would not occur on a biologically effective time scale (Lowy 
and Willumsen 1993). Rather, two families of regulatory factors control rapid 
activation and inactivation of the GTPase: guanine nucleotide exchange factors 
(GEFs) and GTPase-activating proteins (GAPs) (Figure 1.2). GEF proteins bind 
to the small GTPase inducing the release of bound nucleotide (Quilliam, 
Khosravi-Far et al. 1995, Bernards and Settleman 2007). Upon GEF-mediated 
nucleotide release, the nucleotide free GTPase rapidly binds GTP given its 
intracellular concentration is approximately 10-fold higher than GDP. To 
overcome the slow rate of intrinsic hydrolysis, binding of GAP proteins stimulate 
the enzymes’ intrinsic hydrolysis rate (Bernards and Settleman 2005). Members 
of the Rho and Rab family have an additional level of regulation through binding 
to guanine nucleotide dissociation inhibitor (GDIs) (Geyer and Wittinghofer 1997) 
(Figure 1.2). GDIs bind to GDP-bound enzymes to prevent GEF binding and 
membrane targeting, retaining an inactivated state (Geyer and Wittinghofer 
1997). 
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Figure 1.2. The GTPase cycle. Ras family protein cycle between an inactive 
GDP-bound state and an active GTP-bound conformation. Guanine nucleotide 
exchange factors (GEF) trigger the release of GDP, which is promptly replaced 
by GTP. Binding of GTP elicits a conformational change allowing for binding to 
downstream effector proteins. GTPase-activating proteins bind to Ras proteins to 
increase their intrinsic GTP hydrolysis, releasing inorganic phosphate and 
returning Ras to its inactive state. Rab and Rho proteins interact with guanine 
nucleotide dissociation inhibitors (GDIs) to prevent GEF binding and maintain an 
inactive conformation.  
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Ras Biochemical Characteristics and Structure 
 The Ras superfamily shares five highly conserved core regions, or G box 
sequences, that confer their biochemical activity of guanine nucleotide binding 
and hydrolysis (Figure 1.3) (Barbacid 1987, Lowy and Willumsen 1993, Colicelli 
2004). The G1 sequence is necessary for binding to the α and β-phosphates of 
purine nucleotides and is also referred to as the P-loop or Walker A motif 
(Colicelli 2004). The G3 domain binds the γ-phosphate group of GTP and the 
nucleotide associated magnesium ion (Lowy and Willumsen 1993). G4 and G5 
regions are responsible for nucleotide specificity, conferring selective GTP 
binding instead of ATP, as they specifically bind the guanine ring (Colicelli 2004). 
Of all the G box domains, G2 is the least conserved among Ras family members. 
The G2 domain is also referred to as the “effector domain” because it serves as 
the primary site of interaction for downstream effectors following activation by 
GTP binding (Colicelli 2004). Therefore, the diversity of the G2 sequence allows 
for small GTPases to recognize distinct collections of effector proteins, which 
regulate diverse physiological functions. Furthermore, the G2 and G3 domains 
undergo nucleotide-dependent conformational alterations (Cherfils and Zeghouf 
2011). When in contact with the γ-phosphate of GTP, the two loops are exposed 
to the surface of the GTPase core allowing for recruitment of effectors and the 
initiation of downstream signaling (Cherfils and Zeghouf 2011). Upon GTP 
hydrolysis, the loops change position and are buried within the protein and 
effector recruitment is terminated, thus ceasing downstream signaling cascades 
(Cherfils and Zeghouf 2011).  
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A majority of Ras-related small G-proteins rely on membrane localization 
for their biological activity, although they do not encode transmembrane spanning 
domains. Instead localization is most often achieved by post-translational 
prenylation, palmitoylation, and/or myristoylation. The carboxy terminus of Ras 
proteins contains two signal sequences that promote their association with lipid 
membranes (Reuther and Der 2000). The C-terminal CAAX motif (where the C is 
cysteine, the A is an aliphatic amino acid and the X is variable) is the recognition 
site for protein prenyltransferases. Following prenylation, the AAX tripeptide is 
proteolytically cleaved and the C-terminal cysteine is methylated leading to a 
more hydrophobic protein that displays greater membrane association (Lowy and 
Willumsen 1993). Specific targeting often requires additional post-translational 
modifications. For H-Ras and N-Ras there are additional cysteine residues 
upstream of the prenylation signal that becomes reversibly palmitylated to further 
increase membrane affinity (Lowy and Willumsen 1993). Arf family proteins lack 
a C-terminal prenylation site and are instead myristoylated at the N-terminus to 
promote membrane association (Casey 1994). Lastly, there are several members 
of the Ras family that lack lipid modification motifs, specifically the Rad/Gem/Kir 
(RGK) and Rit subfamily of GTPases (Colicelli 2004). Instead, these subfamilies 
contain extended poly-basic C-terminal regions which promote membrane 
association through charged interactions with phosphatidylinositol 3,4,5-
triphosphate [PI(3,4,5)P3] and phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] 
on the plasma membrane (Heo, Inoue et al. 2006). Interestingly, these proteins 
lacking canonical membrane targeting sequences have also been demonstrated 
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to migrate in and out of the nucleus (Heo, Inoue et al. 2006). However, it is 
currently unclear how C-terminal membrane targeting and nuclear localization 
impact the biological activity of this set of enzymes.  
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Figure 1.3. Alignment of the Rit subfamily of small GTPases. Rin and RIt 
define the Rit subfamily of small GTPases. Consensus G box motifs are 
highlighted in yellow. NCBI reference sequences are as follows: dRic 
NM_057863, hRin NM_002930.3, hRit NM_001256821.1, hHRas NM_005343.3 
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Rit subfamily of GTPases 
 The Rit subfamily of Ras-related GTPases is comprised of Rit (Ras-like in 
tissues), Rin (Ras-like in neurons) in vertebrates and the Drosophlia ortholog, Ric 
(Ras-related protein which interacted with calmodulin) (Lee, Della et al. 1996, 
Wes, Yu et al. 1996, Shao, Kadono-Okuda et al. 1999). Although Rit and Rin 
share 64% of their amino acid sequence identity, they display variability in their 
patterns of developmental and tissue expression	  (Lee, Della et al. 1996). Rit is 
expressed ubiquitously and throughout development, while Rin is expressed 
solely in central nervous system neurons and its expression suppressed until 
embryonic day 13 (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999, 
Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015). Both Rit and Rin have 
unique biochemical and structural properties that distinguish them from other 
members of the Ras subfamily (Shi, Cai et al. 2013). 
Biochemical Characterization of the Rit subfamily 
The Rit subfamily members act as canonical GTPases having high 
preferential binding affinity for guanine nucleotides and low intrinsic hydrolysis 
activity (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999). Despite their 
functional similarity, the Rit subfamily is structurally unique. Although the G box 
domains of the Rit subfamily are highly conserved, both Rit and Rin have 
extended N- and C-termini accounting for the proteins’ higher molecular weights 
of approximately 25kDa, compared to roughly 21kDa for other Ras family 
members (Figure 1.3). Membrane localization is achieved in both Rit and Rin 
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through a stretch of polybasic amino acids at the C-terminus (Shao, Kadono-
Okuda et al. 1999, Heo, Inoue et al. 2006). 
Rit and Rin also share a unique G2 effector domain (HDPTIEDAY) that is 
distinctive of the Rit subfamily and unique among other GTPases, although most 
similar to the Ras subfamily with only two amino acid substitutions (YDTIEDSY) 
(Figure 1.3). To test the hypothesis that these amino acids substitutions would 
lead to differences in effector binding between the Rit and Ras family, a yeast–
two hybrid experiment was performed using either constitutively active or 
dominant negative Rit and Rin as bait and known Ras effectors as prey (Shao, 
Kadono-Okuda et al. 1999). In these experiments H-Ras was able to interact with 
the Ras binding domain of Raf1 (Raf1-RBD), the Ras interaction domain of 
RalGDS (RalGDS-RID), the Ras interaction domain of Rlf (Rlf-RID), AF6, RIN1, 
and the p110 catalytic subunit of PIK3	  (Shao, Kadono-Okuda et al. 1999).  It was 
demonstrated that Rit and Rin were able to interact with only a subset of the 
effectors tested (Raf1-RBD, RalGDS-RID, Rlf-RID and AF6)	  (Shao, Kadono-
Okuda et al. 1999). The Drosophila ortholog, Ric, contains an intermediate G2 
effector domain containing only one amino acid substitution (HDTIEDSY); 
however, studies have not been conducted to determine how this may impact 
effector binding.  
Initial biochemical characterization found that both Rit and Rin displayed 
guanine nucleotide dissociation rates of 5 to 10-times higher than Ras GTPases 
(Shao, Kadono-Okuda et al. 1999). Given the high concentration of intracellular 
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GTP compared to GDP, this in vitro study suggested a high basal rate of 
activation for these proteins. However, subsequent affinity isolation of activated 
(GTP-bound) Rit and Rin from cell culture studies demonstrated only modest 
levels of GTP bound protein in unstimulated cells, measured through GTP-
selective pull-down assays (Shao and Andres 2000, Hoshino and Nakamura 
2002). This suggests that the high basal rates of activation seen in vitro may 
result from the C-terminal deletion necessary for bacterial expression. 
Furthermore, a series of oncogenic Rit mutations that drive transformation have 
been discovered (Berger, Imielinski et al. 2014, Xu, Sun et al. 2015, Cave, Caye 
et al. 2016), further supporting the hypothesis that Rit subfamily activity is 
controlled through the conical GTP/GDP cycle. 
Activation of the Rit subfamily has been found to be stimuli dependent.  
Previous work has indicated that Rit becomes activated following exposure to 
epidermal growth factor (EGF), nerve growth factor (NGF), neurotropic peptide 
pituitary adenylate cyclase activated polypeptide 38 (PACAP38), and various cell 
stressors (TNF-α, DNA damage and oxidative stress) (Spencer, Shao et al. 
2002, Shi and Andres 2005, Shi, Rehmann et al. 2006, Lein, Guo et al. 2007, 
Shi, Jin et al. 2010, Shi, Jin et al. 2011). Using a similar experimental approach, 
Rin has also been shown to be activated following NGF, EGF, PACAP38, and 
12-myristate stimulation (Spencer, Shao et al. 2002, Hoshino and Nakamura 
2003, Shi, Han et al. 2005).  
Function of the Rit subfamily in TBI 
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 A previous graduate student in the laboratory, Dr. Weikang Cai, 
demonstrated that Rit mediates an evolutionarily conserved p38 MAPK-
dependent pro-survival pathway in response to reactive oxygen species (ROS) 
(Cai, Rudolph et al. 2011, Shi, Jin et al. 2011).  Elevated concentrations of ROS 
is thought to be one of the key mediators of neuronal loss in the setting of TBI 
(Zink, Szmydynger-Chodobska et al. 2010), leading him to speculate that Rit may 
function in oxidative stress resistance within neurons. Through his studies, it was 
found that Rit deficiency sensitized immature neurons and delayed neurogenic 
recovery within the dentate gyrus of the hippocampus to cell death following TBI, 
suggesting that Rit functions to promote immature neuronal survival and trauma-
mediated hippocampal neurogenesis (Cai, Carlson et al. 2012). 
 To date, there is no literature accessing the role of Rin in TBI. However, 
because of the overlap in biochemical properties and activating stimuli between 
Rin and Rit, along with its neuron specific pattern of expression, we hypothesize 
that Rin signaling will play an important role following brain injury. Indeed, in vitro 
studies have demonstrated potential roles for Rin upstream of signaling 
pathways activated following trauma. These pathways and their regulation by Rin 
are described below. 
Rin-mediated Signal Transduction Pathways and their Implications in TBI 
 The mitogen activated protein kinase (MAPK) signaling cascade is a well-
characterized effector pathway known to be regulated by many Ras subfamily 
proteins. Generically, the pathway consists of a three tiered protein kinase 
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cascade in which each subsequent kinase is subject to activation by the previous 
kinase. The most upstream level of the pathway is composed of the MAP kinase 
kinase kinase (MAPKKK) that activates the MAP kinase kinase (MAPKK), which 
in turn activates the MAP kinase (MAPK) (Katz, Amit et al. 2007) (Figure 1.4). 
This three-tiered signaling system is shared by three major pathways named 
according to their MAPK protein: extracellular signal-related kinases (ERK1/2), 
p38 MAPK, and Jun amino-terminal kinases (JNK1/2/3) (Robinson and Cobb 
1997, Katz, Amit et al. 2007). The ERK1/2 pathway is regulated by growth factor 
stimulation (Katz, Amit et al. 2007). Although p38 and JNK1/2/3 can be activated 
by growth factors, however, are more often induced by stimuli such as osmotic 
stress, UV irradiation, oxidative stress, hypoxia and cytokines (Katz, Amit et al. 
2007, Raman, Chen et al. 2007).  Rin has been demonstrated to act upstream 
and regulate the activity of both ERK and p38 pathways (described below). 
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Figure 1.4. Receptor tyrosine kinase (RTK)-mediated Ras MAPK Cascade. 
Extracellular ligand binding causes the RTK to dimerize triggering 
autophosphorylation of tyrosine residues on the cytoplasmic tail of the RTK. 
Phosphorylation of specific receptor tyrosine residues allows binding of adaptor 
proteins, such as Shc and Grb2, through their SH2 domains.  These adaptors 
recruit GEFs such as Sos1, which can activate Ras when brought into proximity 
of the plasma membrane where Ras is localized. Following GTP binding, Ras 
activates downstream MAPKKK/MAPKK/MAPK signaling. These signaling 
proteins are often held in close proximity by scaffolding proteins to allow more 
efficient signaling. Following phosphorylation, the MAPK protein is able to 
dimerize and translocate to the nucleus where it activates transcription factors to 
initiate gene transcription to promote biological processes including cell survival, 
differentiation, and growth. 
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Raf/MEK/ERK MAPK Cascade  
 ERK is rapidly activated (within 10 minutes) in experimental models of 
contusive brain injury	  (Mori, Wang et al. 2002, Hu, Liu et al. 2004). Activated ERK 
has been primarily observed in neurons, initially localizing to the axons and at 
later time points translocating to the cell body (Dash, Mach et al. 2002). Although 
activation has been demonstrated, the physiological outcome of ERK activation 
is not well characterized. It has been demonstrated that inhibition of ERK 
signaling prior to injury leads to worsened behavioral and cognitive outcomes 
following head injury, suggesting that ERK activation is beneficial (Dash, Mach et 
al. 2002). However, a separate contusive TBI study found that mice treated with 
an ERK inhibitor displayed no change in motor function; however, they did have 
a significantly reduced lesion volume compared to vehicle treated controls, 
suggesting that ERK plays deleterious roles in TBI (Mori, Wang et al. 2002). In a 
diffuse head injury model, treatment with S-trans-farnesylthiosalicylic acid (FTS), 
which disrupts prenylated protein membrane association, diminished ERK 
activation, and led to decreased neurological defects, once again suggesting 
diminished ERK activation to be beneficial (Shohami, Yatsiv et al. 2003). 
Although functional results have varied in these studies, possibly due to 
differences in the type or severity of injury or differences in cells or regions 
affected, it has been consistently demonstrated that ERK is activated by 
mechanical strain (Neary 2005).  
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 Initial yeast-two hybrid analysis indicated interaction between Rin and the 
Ras binding domain of Raf1 suggesting that Rin may function to regulate ERK 
signaling (Shao, Kadono-Okuda et al. 1999). Subsequent studies demonstrated 
that although Rin could bind both Raf1 and B-Raf in a GTP dependent manner, 
Rin preferentially bound B-Raf (Shi, Han et al. 2005). In agreement with these 
binding studies, Rin was found to only activate signaling downstream of B-Raf. 
Importantly, RNAi-mediated Rin silencing was demonstrated to inhibit NGF-
induced B-Raf activation in PC6 cells (Shi, Han et al. 2005). Furthermore, 
expression of constitutively active Rin led to ERK activation, and pretreatment 
with the MEK inhibitor, PD98059, blocked Rin-mediated ERK activation 
(Spencer, Shao et al. 2002, Shi, Han et al. 2005). Together these data implicate 
Rin as an upstream regulator of the B-Raf-MEK1-ERK cascade. 
p38 MAPK Cascade 
The p38 MAPK cascade has been implicated in a multitude of processes 
within the CNS. Activation of the p38 MAPK cascade has been associated with 
neuronal death caused by numerous neurotoxic reagents including excitotoxicity 
(Cao, Semenova et al. 2004, Semenova, Maki-Hokkonen et al. 2007, Chaparro-
Huerta, Flores-Soto et al. 2008), nerve injury (Wittmack, Rush et al. 2005), and 
ischemia (Wang, Xu et al. 2002, Guo and Bhat 2007).  Furthermore, rapid 
activation of p38 has been observed following contusive brain injury (Mori, Wang 
et al. 2002). Expression of p38 is ubiquitous and the outcomes of its activation 
vary based on cell type. In microglia, p38α has been demonstrated to be critical 
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for the production of IL-1β and TNFα (Bachstetter, Xing et al. 2011) and following 
TBI microglial p38α regulates the acute phase cytokine response and microglial 
activation (Bachstetter, Rowe et al. 2013). Therefore, the ability of a protein or 
molecule to regulate p38 function could have broad therapeutic potential. 
Studies conducted in cell culture models indicate that Rin plays a role in 
regulating p38 signaling cascades. RNAi-mediated silencing of Rin blunts p38 
activation downstream of NGF stimulation demonstrating that Rin activation is 
critical in the p38 cascade (Shi, Han et al. 2005). Interestingly, silencing of Rin 
had no effect on the ability of other stimuli, including EGF, PMA, and calcium 
ionophore, to activate downstream p38 signaling (Shi, Han et al. 2005) 
suggesting signaling specificity downstream NGF.  It was also shown that Rin co-
expression with B-Raf was able to robustly stimulate p38 activation 
demonstrating a role for B-Raf in Rin-mediated p38 signaling (Shi, Han et al. 
2005). Current data suggests that Rin may function more prominently in p38 
signaling than upstream of ERK cascades (Shi, Han et al. 2005). 
Regulation of Rho family GTPases 
 RhoA, Cdc42, and Rac are members of the Rho subfamily of GTPases 
(Colicelli 2004). These proteins act as GDP/GTP-dependent binary switches, and 
have been shown to regulate many aspects of intracellular actin dynamics, 
controlling critical functions including cell migration, polarity, and mitosis (Jaffe 
and Hall 2005). In the CNS, the Rho subfamily of GTPases mediates neurite 
outgrowth, growth cone development, and dendritic arborization	  (Stankiewicz and 
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Linseman 2014). More recently the Rho family has been implicated in roles of 
neuronal survival and neurodegeneration (Stankiewicz and Linseman 2014). 
Indeed, expression of activated RhoA induces neuronal cell death (Semenova, 
Maki-Hokkonen et al. 2007) and Rac1 is associated with neuronal survival 
(Stankiewicz and Linseman 2014). Following TBI, Rac1 and RhoA proteins are 
activated and relocate to the membrane (Sabirzhanova, Liu et al. 2013). The 
physiological outcomes of Rho activation and relocation following TBI are 
unclear. However, effects could range from regeneration to cell death. 
 Literature indicates that Rin interacts with proteins in the Rho subfamily 
and has the ability to modulate cytoskeletal dynamics. It was demonstrated that 
Rin forms complexes with Par6-Rac/Cdc42 in a GTP-dependent manner 
(Hoshino, Yoshimori et al. 2005) and Rin expression promotes Rac/Cdc42 and 
RhoA activation (Hoshino and Nakamura 2003) suggesting Rin expression may 
modulate Rho family physiological functions. 
Rin-mediated Neurite Outgrowth 
 The most commonly studied physiological outcome of Rin activation is 
neuritogenesis, or the ability of a neuron to form cytoskeletal projections from the 
cell body. Although Rin activation induced neurite outgrowth (Hoshino and 
Nakamura 2003, Shi, Han et al. 2005), it should be noted that its effect is not 
robust and has been demonstrated in immortalized cell lines, not within cultured 
neurons. However, expression of constitutively active Rin induced neuritogenesis 
in PC6 cells; furthermore, additional expression of B-Raf enhanced the 
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percentage of neurite bearing cells, the number of neuritis per cell and their 
branching (Shi, Han et al. 2005). It has been shown that p38 or ERK inhibition 
reduced neurite outgrowth following expression of constitutively active Rin (Shi, 
Han et al. 2005) (Figure 1.5). These data demonstrate a role for Rin in neuronal 
differentiation downstream of p38 and ERK.  Rin-dependent neurite outgrowth 
has also been demonstrated downstream of Rho subfamily activation. Indeed 
Rin-dependent differentiation of PC12 cells downstream of NGF was diminished 
by the expression of dominant negative Rac/Cdc42, suggesting a role for Rin in 
calcium-mediated cytoskeletal reorganization upstream of the Rho subfamily of 
GTPases (Hoshino and Nakamura 2003). Finally, Rin-dependent neurite 
outgrowth has been demonstrated through interaction with calmodulin (CaM). 
CaM is a ubiquitous expressed calcium sensing protein for a variety of cellular 
enzymes; it is able to respond to increases in intracellular calcium concentration 
and activate a variety of cellular processes including cytoskeletal organization 
(Rhoads and Friedberg 1997). Rin binds calmodulin (CaM) in a calcium-
dependent manner through its C-terminus (193-217 aa), suggesting that Rin may 
mediate calcium/CaM-modulated signaling pathways (Lee, Della et al. 1996). 
Indeed, it was found that Rin is able to form a complex with the actin binding 
protein IQGAP1 and CaM and this interaction was demonstrated to contribute to 
neurite outgrowth (Hoshino and Nakamura 2003) (Figure 1.5).   
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Figure 1.5 Rin-dependent signaling in neurite outgrowth. Rin signaling has 
been implicated upstream of ERK, p38, and Cdc42/Rac1 and in each of these 
cases shown to induce neurite outgrowth in PC6/12 cells. 
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Rationale for Investigating the Physiological Function of Rin 
Rin activation has been demonstrated downstream of a variety of stimuli; 
however, the physiological function of Rin in the CNS remains poorly 
characterized. Rin signaling upstream of ERK, p38, and Cdc42/Rac has been 
shown to contribute to neurite outgrowth (Hoshino and Nakamura 2003, Shi, Han 
et al. 2005), suggesting a potential role for Rin in plasticity following brain injury. 
Regardless, these studies were performed in cultured cell models that do not 
accurately reflect the physiological conditions of neurons. This is particularly 
problematic considering the expression of Rin is limited to neuronal populations 
(Lee, Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et al. 2008, 
Sharma, Schmitt et al. 2015), raising the question of whether or not these 
cultured cells express the necessary effector and regulatory proteins required for 
authentic replication of the function of endogenous Rin signaling. In order to 
study the function of Rin in an appropriate system, we generated a Rin null 
mouse line through genetic deletion of RIT2, and with this line we characterized 
the physiological roles of Rin using a number of experimental trauma models. In 
Chapter Three, we implemented a contusive brain injury model (CCI) to 
characterize the effects of Rin loss on trauma-induced neurogenesis and cell 
death. These studies indicate that Rin, unlike Rit, does not function in trauma-
induced neurogenesis or the survival of immature neurons within the dentate 
gyrus of the hippocampus. Rather, this set of experiments demonstrates a 
neuroprotective effect of Rin loss, as its genetic deletion increases neuronal 
survival in the hippocampal dentate gyrus and CA-3 subregion. Furthermore, we 
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were able to correlate neuronal protection with cognitive behavioral sparing. In 
Chapter 4, we examined the role of Rin in trauma-induced axonal degeneration 
following optic nerve stretch, an experimental model of white matter tract injury. 
These studies indicate that the loss of Rin protects cells from axonal 
degeneration and limits injury-induced inflammation. In Chapter 5, we employed 
a diffuse closed head injury (CHI) model of TBI to analyze the role of Rin in 
trauma-induced neuroinflammation. In this model, we show that Rin loss blunts 
pro-inflammatory IL-1β cytokine production acutely following injury while 
elevating anti-inflammatory IL-10 production in the cortex. Although we did not 
observe any observable alterations in microglia or astrocyte activation, there was 
an appreciable reduction in axonal degeneration in Rin null animals following 
CHI. These data suggest that the differences observed in cytokine profiles may 
be a result of reduced neuronal cytokine production. Together, the studies in this 
dissertation demonstrate broad neuroprotective effects of Rin loss in cell death, 
axonal degeneration and inflammation and could provide insight into treatment of 
brain trauma and neurodegenerative disorders. 
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CHAPTER TWO  
 
Materials and Methods 
 
Reagents 
Chapter 3 
Reagents: 5-Bromo-2-deoxyuridine (BrdU) (Thermo Fisher Scientific); formalin 
(Sigma #HT501128); FluoroJade C (FJC); ABC kit (Vector #PK-6100); DAB 
Peroxidase substrate kit (Vector SK-4100) 
Antibodies: rabbit antiNeuN (Millipore #MABN140); rabbit antiKi67 (Abcam 
#ab15580), rat BrdU (Abcam #ab6326), rabbit anti-Dcx (Abcam #ab18723); 
rabbit anti-GFAP (Dako #Z0334); goat anti-rabbit IgG TRITC (Jackson 
ImmnuoResearch #111-605-144); goat anti-rat IgG Cy3 (Jackson 
ImmnuoResearch #112-605-167); goat anti-rabbit IgG FITC (Jackson 
ImmnuoResearch #111-545-144); mouse anti-Rit (R0003U) and mouse-anti-Rit2 
clone 27G2 were generated in collaboration with Gamma-1 (Lexington, KY). 
Chapter 4 
Reagents: ABC kit (Vector #PK-6100); DAB Peroxidase substrate kit (Vector SK-
4100); formalin (Sigma #HT501128) 
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Antibodies: mouse anti-Neurofilament H Nonphosphorylated (SMI32) 
(Calbiochem #NE1023); rat anti-CD68 (BioRad # MCA 1957), biotin donkey anti-
rat IgG (Jackson ImmunoResearch #712-065-150); biotin donkey anti-mouse IgG 
(Jackson ImmunoResearch #715-065-150) 
Chapter 5 
Reagents: Methyl green, zinc chloride salt (VWR); DAB (Sigma); Halt Protease & 
Phosphatase Cocktail (Pierce #78442); PMSF (Sigma P7626); ABC kit (Vector 
#PK-6100); Custom mouse cytokine kit (MSD #K152A0H-1) 
Antibodies: rabbit anti-GFAP (Dako #Z0334); rat anti-CD45 (Thermo #MA1-
81247); rabbit anti-βAPP (Invitrogen #51-2700); biotin goat anti- rabbit IgG 
(Jackson ImmunoResearch #111-035-144); biotin goat anti-rat IgG (Vector #BA-
9401) 
Animals 
Rin-/- mice were purchased from Texas Institute for Genomic Medicine 
(mouse accession: NM_009065) (College Station, TX). RinWT allele was 
genotyped with primers 5’-GACACTGCATGAGACTGA ACC - 3’ and 5’-
CTATAACCTGTGAGTCAACGGAAA G - 3’ corresponding to the intronic region 
between exons 3 and 4 resulting in a band of approximately 750 nucleotides. Rin-
/- allele was genotyped with primers 5’ – AAATGGCGTTACTTAAGCTAGCTTGC 
- 3’ and 5’ - CTATAACCTGTGAGTCAACGGAAAG - 3’ corresponding to the 
intronic region between exon 3 and 4 and the LTR sequence on the gene trap 
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insertion resulting in a band of approximately 650 nucleotides. Animals were 
handled in accordance with standard use protocols and animal welfare 
regulations of the Institutional Animal Care and Use Committee (IACUC) of the 
University of Kentucky and the NIH Guide for the Care and Use of Laboratory 
Animals.  
Traumatic Injury Models 
 For all experiments herein, animals were randomly assigned into either 
injured or sham groups. All cell counts and analyses was conducted by 
experimenters blinded to both the genotype and experimental treatment of study 
animals.  
Controlled Cortical Impact (CCI)  
Surgeries were carried out in the laboratory of Kathryn Saatman by Shaun 
Carlson, Erica Littlejohn, and Travis Stewart and were performed as previously 
described (Pleasant, Carlson et al. 2011). All CCI injuries were performed on 
male mice to control for head size and limit injury severity variation. Briefly, 
isoflurane anesthetized twelve-week-old male mice received a craniotomy over 
the left hemisphere and were subjected to a unilateral controlled cortical impact 
(CCI) injury at a 1.0 mm impact depth and a nominal velocity of 3.5 m/s using a 
CCI impactor device (TBI-0310 Impactor; Precision Systems and 
Instrumentation). Sham animals underwent identical surgical procedures, but 
received no impact to the cortex. 
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Mono-ocular Nerve Stretch Injury (MONS) 
 Surgeries were performed in the laboratory of Kathryn Saatman by Binoy 
Joseph as previously described (Saatman, Abai et al. 2003). Briefly, 6-8-month-
old mice were anesthetized with a 65 mg/kg intraperitoneal injection of sodium 
pentobarbital and maintained on a heading pad throughout the surgery. The 
conjunctiva and extraocular muscles were cut around the circumference of the 
eye and a flexible sling with a longitudinal midline slit was placed under the eye 
positioning the optic nerve in the slit.  The sling was connected to a force 
transducer (ELF T500-1; Entran, Fairfield, NJ, USA) mounted in a series with a 
solenoid (Lucas-Ledex, Vandalia, OH, USA) and in parallel with a displacement 
transducer (Trans-Tek Inc., Ellington, CT, USA). Elongation of the optic nerve by 
2.0 mm (extending the nerve by approximately 20%) was obtained by 
programming of the solenoid and measured by the force transducer.  
Optic Nerve Transection 
 Operational procedures were modified from an optic crush protocol 
(Templeton and Geisert 2012). Six-to-eight-month-old male and female mice 
were anesthetized via an intraperitoneal injection of 65 mg/kg sodium 
pentobarbital and placed on a heating pad for surgery.  Once deeply 
anesthetized, the eyelashes and whiskers surrounding the right eye were 
trimmed and the right cornea was treated with bupivacaine to further numb the 
surgical area. Under a dissecting scope, an incision was made into the 
conjunctiva along the globe of the eye being careful to not cut the surrounding 
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musculature. The edge of the conjunctiva was held with forceps and rotated 
nasally bringing the optic nerve into view. Spring scissors were used to cut 
through the optic nerve 1-3 mm from the base of the eye. The incision was 
washed with 1.0 ml of sterile saline and the eye lids sutured closed. Mice were 
maintained on a heating pad until they were fully awake, then monitored daily 
until euthanasia. The contralateral eye underwent no surgical procedure and was 
used as the experimental control for transection studies.  
Closed Head Injury (CHI) 
 Surgeries were carried out by Adam Bachstetter and were performed as 
previously described (Bachstetter, Webster et al. 2015). Briefly, 5-6-month-old 
male and female mice were anesthetized using isoflurane and received a sagittal 
midline incision of the scalp and received a single midline cortical impact to the 
skull cap using a 5.0 mm diameter steel tip impounder (Leica Biosystems, 
Wetzler, Germany) at a controlled velocity of 5.0 ± 0.2 m/s with a dwell time of 
100 ms at a programmed impact depth of 1 mm. Sham animals underwent 
identical surgical procedures, but received no impact to the skull. Animals that 
displayed hemorrhaging or skull fracture/deformation were excluded from further 
analysis. 
Rin Immunoblotting 
Whole brain lysates were prepared from wild-type and Rin-/- animals using 
kinase lysis buffer [20 mM Hepes (pH 7.4), 150 mM NaCl, 50 mM KF, 50 mM β-
glycerolphosphate, 2 mM EGTA (pH8.0), 1 mM Na3VO4, 1% Triton X-100, 10% 
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glycerol, and 1× protease inhibitor cocktail set I (Calbiochem)]. Total protein 
concentration of the lysate was determined using a Bradford assay. Equal 
amounts of wild-type and Rin-/- lysates were ran on a SDS-PAGE gels and 
protein level was determined by immunoblotting with the appropriate antibodies. 
BrdU Administration 
To assess immature neuronal survival, BrdU (50mg/kg in 0.9% saline) 
was intraperitoneally injected daily for one week as previously described (Cai, 
Carlson et al. 2012). Following the final injection, mice were housed for 2 days 
prior to injury to allow a subset of the labeled pool adequate time to differentiation 
to an immature neuronal lineage.  
Tissue Preparation  
For CCI and MONS, animals were deeply anesthetized with FatalPlus and 
transcardially perfused with a heparin saline solution (heparin sodium 1:1000, RX 
grade, APP Pharmaceuticals in 0.9% NaCl) followed by 10% buffered formalin 
(Sigma). Tissue was post-fixed in the skull for 24 hr in 10% buffered formalin.  
Following post-fixation, the brains and optic nerves were dissected from the skull 
and cyroprotected using a 30% sucrose in 1X TBS until tissue sunk. Brains were 
snap frozen in isopentane (≤ -20oC) for 2 min and cut in a coronal plane at a 40 
µm thickness using a freezing sliding microtome (Dolby-Jamison). Optic nerves 
were frozen in OCT and cut in 10 µm sections using a freezing sliding microtome 
(Dolby-Jamison).  Following CHI, animals were anesthetized with FatalPlus and 
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transcardially perfused with heparin saline solution (heparin sodium 1:1000, RX 
grade, APP Pharmaceuticals in 0.9% NaCl) and the brain separated into two 
hemispheres, one for sectioning and one for protein extraction. The left 
hemisphere was tissue was post-fixed in 4% PFA for 24 hr before being 
transferred to 30% sucrose and processed in the same manner as the CCI 
brains. 
Cresyl Violet Brain Staining 
 Serial sections at 400 µm intervals were mounted onto gelatin-coated 
slides and dried overnight at RT. The following day slides were immersed in 
ddH20 for 2 min then dehydrated through an ethanol gradient of 70%, 80%, 95%, 
and 100% for 2 min at each concentration followed by rehydrated at 100%, 95%, 
80%, and 70%. Slide were then incubated in 0.5% cresyl violet for 2.5 min. Slides 
were once again dehydrated through a fresh EtOH gradient and immersed in 
xylene for 15 min prior to applying a coverslip with permount.  
Injury Volume Quantification  
 To determine the percent of cortex damage following CCI injury, cresyl 
violet (Nissl) stained serial brain sections, 400 µm apart, were visualized on an 
Olympus BX-51 light microscope equipped with a CCD camera. Neocortical 
tissue from bregma level 0 to -3.5 mm was analyzed via live imaging using 
Bioquant software (version 8.40.20, Bioquant Life Science). Regions containing 
neurons within the ipsilateral and contralateral neocortices were outlined 
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separately at 10X magnification verified through examination of cell body 
morphology at 2X magnification. Areas of the cortex that contained condensed 
nuclei were excluded from the “intact” tissue quantification. Contusion area was 
calculated as the difference between spared contralateral and ipsilateral 
neocortical areas. The contusion volume was determined using Cavalieri’s 
principal, integrating over the inter-section distance as previously described 
(Pleasant, Carlson et al. 2011). Data are represented as the percent contralateral 
neocortical volume. 
Fluoro-Jade C staining 
Serial brain sections at 400 µm intervals were mounted on gelatin coated 
slides and dried at 40-45o C for 15 min followed by overnight drying at RT. The 
following day, sections were washed in 80% (v/v) ethanol with 1% (w/v) NaOH, 
70% ethanol and dH2O followed by 10 min incubation in 0.06% (w/v) potassium 
permanganate. The sections were then washed in dH2O 5 times before 
incubation in 0.0001% Fluoro-Jade C solution (resuspended in 0.1% acetic acid) 
followed by 5 more washes in dH2O. Sections were counterstained with Hoechst, 
dried, cleared with xylene, and coverslipped with Cytoseal. FJC+ cells in three 
sections (pre-epicenter, epicenter, and post-epicenter) of the hippocampus for 
each animal were counted on a Nikon Eclipse E600 fluorescence microscope 
using a 40X objective. Data are expressed as the sum of FJC+ cells over three 
sections. Representative images were taken on a Nikon CKX31 A1 confocal 
microscope (20X objective).    
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Immunofluorescence  
Free floating brain sections at 400µm intervals were washed in 1X TBS 
prior to antigen retrieval using 2N HCl for 1 hr at RT and neutralized with 0.1M 
borate buffer at RT for 10 min. Following washing with 1X TBS, sections were 
blocked in blocking buffer (5% normal goat serum in TBS/Triton X-100 (0.1%)) 
for 30 min at RT. Incubation in primary antibody in blocking buffer occurred 
overnight at 4o C. Antibody dilutions were: rabbit anti-Dcx: 1:1500; rabbit anti-
Ki67 1:1000. On the following day, sections were washed with 1X TBS and 
incubated in secondary antibody diluted in blocking buffer for 1hr at RT. 
Secondary antibody dilutions were: goat anti-rabbit IgG FITC: 1:1000; goat anti-
mouse IgG Cy5: 1:1000; goat anti-rat IgG Cy3: 1:1000. Sections were then 
washed in 1X TBS prior to applying the coverslip with SlowFade Gold containing 
DAPI (Invitrogen).  
Labeled cells in the ipsilateral and contralateral inner granular layer (IGL) 
of the dentate gyrus were summed from three sections (pre-epicenter, epicenter, 
and post-epicenter at 400 µm intervals) using a Nikon Eclipse E600 fluorescence 
microscope using a 40X objective. Dentate gyrus volume was estimated by 
multiplying the area of the DAPI staining within the dentate gyrus (DG) 
(measured by Image J (NIH) in collected images using a Zeiss Axiovert 200M 
fluorescence microscope using a 10X objective) and multiplied by the thickness 
of each section (40 µm). Cell density was then calculated by dividing total cell 
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counts by the calculated volume of the DG. Representative images were taken 
on a Nikon CKX31 A1 confocal microscope (20X objective). 
Immunohistochemistry 
Serial brain sections of 400 µm intervals were washed in 1X TBS, blocked 
in blocking buffer (5% normal donkey serum in TBS/TritonX-100 (0.1%)) before 
incubation with rabbit anti-NeuN 1:1000 or rabbit anti-GFAP 1:1000 in blocking 
buffer overnight at 4o C. The following day sections were washed with 1X TBS 
before incubation in biotinylated donkey anti-rabbit IgG 1:1000 for 1 hr at RT.  
Sections were washed in 1X TBS and peroxidases were scavenged with 3% (v/v) 
of 30% H2O2 in a 50/50 mix of methanol and water for 30 min at RT.  Following 
washing, sections were incubated in AB/TBS (Vector Laboratories) solution for 1 
hr at RT. Immunostaining was visualized using cobalt-enhanced DAB (Vector 
Laboratories), mounted, dried overnight, and dehydrated prior to application of a 
coverslip with Permount media (Fisher).   
Prior to application of the coverslip, CHI tissues were counterstained with 
methyl green to allow analysis by Aperio Image-Scope XT digital slide scanner 
and Aperio Image-Scope software. Tissue was mounted onto gelatin-coated 
slides and dried overnight. The following day, tissue mounted slides were 
incubated in ddH20 for 2 min, then in a 1:4 dilution of methyl green (from 0.5% 
stock) in 0.1 M sodium acetate pH 4.2. Slides were washed with flowing H20 until 
water ran clear. Slides were then dipped in 0.5% acetic acid in acetone 15 times 
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to de-stain the tissue. Tissue then underwent EtOH dehydration prior to 
application of the coverslip with Permount (Fisher).  
Stereological Counts of Hippocampal CA-3 
Stereological counting of mature neuronal cells from the dorsal 
hippocampal CA-3 regions was conducted 10 d following CCI injury. Every 5th 
brain section (200 µm intervals) spanning bregma levels -1.0 mm to -2.2 mm was 
immunohistochemically labeled for NeuN and visualized with 60X oil immersion 
objective on an Olympus BX-51 microscope equipped with a motorized stage 
and stereology software (Bioquant Life Science. V8.40.20; Bioquant Image 
Analysis, Nashville, TN). Unbiased counting was restricted to the dorsal 
hippocampus as this is the area most affected by CCI and hippocampal 
morphology and packing of the ventral CA-3 would require a different set of 
sampling parameters. The dorsal CA-3 was overlaid with a counting grid (150 x 
150 um2) and neurons counted within the set dissector area (20 x 20 um2) and 
the total number of CA-3 neurons estimated by the equation, Σ= total cells 
counted x 1/ssf x1/asf x 1/tsf, where ssf is the selection sampling fraction, asf is 
the area sampling fraction and tsf is the thickness sampling fraction, as 
previously described (Madathil, Carlson et al. 2013). 
Neurological Severity Score (NSS)  
NSS was performed by Jennifer Brelsfoard in the Spinal Cord and Brain 
Injury Research Center at the University of Kentucky. Neurological severity score 
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was performed at 1d, 2d, 3d, and 6d following CCI. Deficits in motor coordination 
were analyzed as mice crossed beams of 3, 2, 1, and 0.5 cm width and a rod 
0.5cm in diameter. Animals were acclimated to the assessment 24 hr prior to 
injury, being allowed to explore the beams and rod for 30 sec. Following injury, 
14 possible points were given for traversing the beams and rod with normal limb 
movement. For beam traversing, points were deducted for footfalls, hanging 
upside-down, and unwillingness to traverse (one point each). Falling from the 
beam resulted in zero points. For the rod, one point was deducted for hanging 
upside-down and inability to cross and two points for falling off the rod (Schoch, 
Evans et al. 2012). 
Novel Object Recognition (NOR) 
NOR was performed by Jennifer Brelsfoard in the Spinal Cord and Brain 
Injury Research Center at the University of Kentucky. Animals were individually 
acclimated to a testing cage 24 hr prior to injury and allowed to freely explore for 
1 hr. Following acclimation, the animals were introduced to two identical objects 
placed on opposite sides of the cage and allowed to explore for 5 min. Seven 
days following CCI, animals were returned to the testing cage for 1 hr before 
reintroduction of two identical objects. Time exploring each object was recorded 
over a 5 min period. After a 4 hr delay, the animal was returned to the testing 
cage, where one of the familiar objects had been replaced with a novel object 
and the time exploring each object was recorded for a 5 min period. Recognition 
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index is calculated as time spent exploring the novel object divided by total 
exploration time as previously described (Madathil, Carlson et al. 2013).  
Radial Arm Water Maze (RAWM) 
RAWM testing was performed as previously described with slight 
modification (Alamed, Wilcock et al. 2006). Animals were tasked with locating a 
platform submerged approximately 0.5 cm under water in one arm of a pool 
containing 6 equally sized arms using visual cues surrounding the pool as a 
guide. The mice were placed in the pool at different starting locations and given 1 
min to locate the platform. If a mouse was unable to locate the platform within 
that time, it was subsequently placed on the platform for 15 sec. Each of two 
experimental days had 15 trials per mouse. Day 1 had alternating visual (1, 3, 5, 
7, 9, 11) and hidden (2, 4, 6, 8, 10, 12-15) trials, whereas day 2 was consisted on 
all hidden trials. During visual trials, an object was placed on the platform for 
visualization. Errors were tallied for each time the animal entered the incorrect 
arm of the maze and higher errors indicated more difficulty with the task. Mice 
were tracked using the EthoVisionXT system. Graphed block data was quantified 
by averaging the number of errors per hidden trial. Blocks 1-3 were derived from 
the first day of training trials 2 & 4; 6, 8 & 10; and 12-15 respectively. Blocks 4-6 
are calculated from the second day of testing by averaging trials 1-5, 6-10, and 
11-15 respectively.  
DLK Cloning 
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 DLK cloned within pDONR221 was purchased from the Arizona State 
University plasmid repository. The DLK insertion was PCR amplified using the 
following primers: 5’ – ATATGAATTCATATGGCTTGCCYCCAT - 3’ and 5’ – 
ATATGCGGCCGCTCATGGAGGGAGGG - 3’ before being sub-cloned into 
pCMV-Myc-N using the EcoRI and NotI restriction sites.   
Cell Culture and Transfection 
 HEK-293T were grown in Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco) supplemented with 5% fetal bovine serum (FBS, Sigma), 100 U/ml 
penicillin and 100 µg/ml streptomycin. Cells were maintained at 37o C in a 
humidified atmosphere of 5% CO2. HEK-293T cells were transfected using 
Transgin (Apharma) according to the manufacturer’s protocol. Briefly, 1x 106 cells 
were seeded in a six-well plate 24 hr prior to transfection to yield a 70-80% 
confluent dish for transfections. Lipid-DNA complexes were prepared mixing 2 µg 
plasmid DNA with 2 µl Transgin reagent in 100 µl of Opti-MEM (Gibco) and 
incubated at RT for 20 min. The lipid-DNA complexes were added drop-wise to 
the cell monolayer after the growth media was replaced with 1 ml Opti-MEM. 
Cells were incubated with lipid-DNA complexes for 4-6 hrs before the Opti-MEM 
was replaced with fresh DMEM containing 5% FBS for 48 hrs prior to making 
lysates. 
Cell Lysate Preparation 
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 Transfected cells were lysed and harvested with RIPA buffer (40 mM 
HEPES, 2 mM EDTA, 10 mM pyrophosphate, 10 mM glycerophosphate, 1% 
sodium deoxycholate, 1% NP40, 0.1% SDS) and transferred to an ependorf tube 
on ice. Lysates were cleared at 14,000 rpm. To prepare total protein lysates, 150 
µg of protein lysate was mixed with 4X SDS-PAGE sample buffer (200 mM Tris-
HCl pH 6.8, 8% SDS, 40% glycerol, 4% β-mercaptoethanol, 50 mM EDTA, and 
0.08% bromophenol blue). 
Co-immunoprecipitation (Co-IP) 
Protein G separose beads were washed with 10X volume of 1X PBS, 
vortexed, and spun at 5,500 rpm followed by washing with 10X volume of lysis 
buffer. Beads were resuspended in 200 µl lysis buffer with 4 µg FLAG antibody 
per IP. Protein lysate (750 µg) was added to the separose/antibody mixture and 
rotated at 4o C for 2 hrs. Following incubation beads were spun at 5,500 rpm and 
the supernatant aspirated. Beads were then washed with lysis buffer once, lysis 
buffer with 500 mM NaCl twice, and lysis buffer twice more. Bound proteins were 
eluted by 5 min incubation at 100o C in 1X SDS-PAGE sample buffer. Bound 
protein along with protein lysate (25 µg) and co-immunoprecipitation (1/2 
reaction) was ran on a 12% SDS-PAGE gels, transferred onto nitrocellulose 
membranes and subjected to immunoblotting with indicated antibodies.  
Semi-quantification of Axonal Immunohistochemistry 
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Optic nerve immunohistochemistry was performed similarly to 
immunohistochemistry of brain sections using one 10 µm section of optic nerve 
per animal. Sections were washed in 1X TBS/TritonX-100 (0.1%), and 
peroxidases were scavenged with 3% (v/v) of 30% H2O2 in a 50/50 mix of 
methanol and water for 30 min at RT.  Following another set of washes, tissue 
was incubated in blocking buffer (5% normal donkey serum in TBS/TritonX-100 
(0.1%)) before incubation with mouse anti-SMI-32 1:1000 or rabbit anti-CD68 
1:1000 in blocking buffer overnight at 4o C. The following day sections were 
washed with 1X TBS/TritonX-100 (0.1%) before incubation in biotinylated donkey 
anti-rabbit IgG 1:1000 or biotin donkey anti-mouse 1:1000 for 1 hr at RT.  
Sections were washed in 1X TBS/TritonX-100 (0.1%).  Following washing, 
sections were incubated in AB/TBS (Vector Laboratories) solution for 1 hr at RT. 
Immunostaining was visualized using cobalt-enhanced DAB (Vector 
Laboratories), mounted, dried overnight, and dehydrated prior to application of 
the coverslip with Permount (Fisher).   
The entire optic nerve was imaged at 10X magnification in an AX-80 and 
sequential images were merged to create a montage. Montages were overlaid 
with a grid subdivided into 20 x 20 µm squares over 3200 µm of the nerve 
beginning at the optic chiasm junction. Each square was scored for the presence 
or absence of immunostaining and semi-quantitatively quantified by dividing the 
number of squares positive for staining by the total grid squares overlaying the 
nerve. Data are expressed as percent optic nerve grid-squares containing 
positive staining.  
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Quantification of Cortical Immunohistochemistry Using Aperio Image-
Scope 
The Aperio ScanScope XT digital slide scanner was used to create a 
single high-resolution image of the stained slides at a magnification of 20X. For 
GFAP staining, 200 x 200 µm boxes were positioned along the neocortex using 
the Aperio ImageScope software and the Aperio-positive pixel algorithm (version 
9) was used to quantify positive pixels of specific staining that were then 
normalized to the total pixel area outlined to account for variation in the size of 
the region being sampled. For β−APP staining, areas of positive staining were 
circled using the the Aperio ImageScope software and the Aperio nuclear 
algorithm (version 9) to obtain the number of β−APP-positive axons and the total 
neocortex was outlined and an area derived using the Aperio-positive pixel 
algorithm (version 9). β−APP-positive axons were normalized to the total area to 
obtain the number of β−APP-positive axons/mm2.  
Tissue Homogenization and Mouse Cytokine ELISA 
 Following perfusion with PBS, the brain was removed and cut into two 
hemispheres. The left hemisphere was post-fixed for immunohistochemistry 
(refer to Tissue Preparation Section), the cortex of the right hemisphere was 
dissected for ELISA. Lysis buffer (200 mM PMSF, 0.02% Halt and 0.5M EDTA in 
1X PBS) was added at a volume of 20X the tissue weight and stored on ice 
before homongenization for 30 s using an Omni TH homogenizer with plastic tip. 
Samples were centrifuged at 12,000 X g for 20 min (Beckman Microfuge18) at 4o 
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C. The supernatant was then aliquoted into a 96 well plate for long-term storage 
at -80oC. A BCA assay was performed to determine the protein concentration of 
each sample. Custom Mouse Cytokine kits were purchased from MSD to analyze 
IL-1β, IL-6, IL-10, and TNF-α per the manufacturer protocol.  
Statistical Analysis 
All data are represented as mean ± SEM. Relevant statistics are 
described in figure legends and generated using GraphPad Prism (unless 
otherwise stated). In Chapter 3, numbers of FJC+ cells and volumetric cortical 
tissue loss were analyzed using Student’s t-test. The density of Dcx+, and Ki67+, 
BrdU+/Dcx+ neurons in dentate gyrus following CCI, NOR and NeuN+ cells in CA-
3 were analyzed using a two-way ANOVA followed by Bonferroni post-hoc when 
appropriate. NSS was analyzed through non-parametric ANOVA at each time 
point with Dunn’s comparison when appropriate. The level of statistical 
significance was set at p < 0.05. Analysis of the optic nerve in Chapter 4 was 
analyzed via ANOVA followed by Newman-Keuls post hoc test. Closed Head 
Injury data in Chapter 5, was analyzed by ANOVA followed by Turkey-Kramer 
post hoc test. 
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CHAPTER THREE 
 
Genetic Deletion of the Rin GTPase Promotes Neuronal Sparing and 
Reduces Behavioral Deficits following Traumatic Brain Injury 
 
Introduction 
TBI is a progressive disorder, in which the primary injury results in the 
initiation of a complex cascade of secondary biochemical and metabolic changes 
leading to cell death and tissue damage that can persist and evolve over a period 
of hours to weeks following the initial injury (McIntosh, Saatman et al. 1998, 
Beauchamp, Mutlak et al. 2008, Borgens and Liu-Snyder 2012). The 
hippocampus, which is critical for retrieval of short-term memory tasks and 
episodic memory, is particularly vulnerable to the effects of TBI leading to 
disruption of cognition, learning, and memory (Levin 1998, Kesner 2007, 
Hunsaker, Lee et al. 2008). Imaging studies have identified a link between post-
TBI hippocampal atrophy and the severity of cognitive dysfunction	  (Bigler, Blatter 
et al. 1997, Ariza, Serra-Grabulosa et al. 2006). This same correlation is 
observed in animal models of TBI, suggesting conservation of fundamental injury 
mechanisms (Hicks, Smith et al. 1993, Fujimoto, Longhi et al. 2004). The 
controlled cortical impact model (CCI) injury results in deficits in motor function, 
learning, and memory (Fox and Faden 1998, Levin 1998, Saatman, Feeko et al. 
2006). Hippocampal neuronal damage resulting from CCI is predominantly 
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located in the dentate gyrus and cornu-ammonis-3 (CA-3) subregions of the 
hippocampus	  (Dixon, Clifton et al. 1991, Saatman, Feeko et al. 2006).  
At a cellular level, cognitive impairment following TBI has not only been 
correlated with hippocampal cell death, but also disruption of neurogenesis 
(Rola, Mizumatsu et al. 2006, Cai, Carlson et al. 2012, Carlson, Madathil et al. 
2014). Neurogenesis within the dentate gyrus of the hippocampus continually 
generates new granule neurons that integrate into the circuitry throughout life 
(Gage 2000). Neurogenesis is a dynamic process, and studies have 
demonstrated that the levels of neurogenesis can be modulated numerous 
factors including: age, sex, stress, growth factors, and environmental enrichment 
(Kempermann, Kuhn et al. 1997, Ming and Song 2005, Ming and Song 2011, 
Carlson, Madathil et al. 2014). Following TBI, immature (Dcx+) neurons within the 
hippocampus are particularly vulnerable to secondary injury mechanisms and 
undergo high levels of apoptosis (Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant 
et al. 2008). This setback in neurogenesis caused by immature neuronal loss is 
thought to contribute the TBI-induced cognitive deficits (Yu, Zhang et al. 2008, 
Blaiss, Yu et al. 2011). Brain injury also induces proliferation of neuronal stem 
cells in the sub-granular zone of the hippocampus (Dash, Mach et al. 2001, Rola, 
Mizumatsu et al. 2006). Increases in stem cell proliferation are thought to 
contribute to enhancement of neurogenesis and allow the slow recovery of 
immature neuronal numbers back to baseline levels, comparative to sham-
injured controls (Rola, Mizumatsu et al. 2006). Establishing molecular 
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mechanisms that contribute to neuroprotection of hippocampal neurons may 
provide novel therapeutic strategies.  
 Together with their associated regulatory and effector protein networks, 
Ras-related GTPases serve as master regulators of numerous cellular signaling 
pathways, that contribute to almost every aspect of cellular physiology 
(Wennerberg, Rossman et al. 2005). Ras family G-proteins are best known for 
their functions in the regulation of cellular proliferation, differentiation, survival, 
migration, and fate specification (Colicelli 2004, Wennerberg, Rossman et al. 
2005). While the physiological role of many Ras family GTPases is known, there 
remains a subset whose cellular functions have not been defined (Reuther and 
Der 2000, Shi, Cai et al. 2013). This is the case for Rin (RIT2), which despite 
sharing high levels of amino acid identity and significant overlap in known 
downstream cellular effectors with the closely related Rit (RIT1) GTPase, would 
appear to have a distinct cellular function as genetic deletion of RIT1 is not 
complemented by endogenous RIT2 (Lee, Della et al. 1996, Wes, Yu et al. 1996, 
Shao, Kadono-Okuda et al. 1999).  Rit and Rin display distinct patterns of tissue 
and developmental expression, with Rit expressed throughout development and 
having a broad tissue distribution, while Rin expression is delayed to later stages 
of embryonic neuronal development and proteomic data suggests Rin expression 
is restricted to neuronal lineages (Lee, Della et al. 1996, Spencer, Shao et al. 
2002, Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015).  
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Studies in cell lines have demonstrated that Rin is activated by growth 
factor stimulation, contributes to TrkA-mediated p38 MAP kinase signaling in 
pheochromocytoma cells, and modulates neurite outgrowth (Hoshino and 
Nakamura 2002, Hoshino and Nakamura 2003, Shi, Han et al. 2005). However, 
as many of these studies were performed in cells lacking endogenous Rin 
expression, it is unclear whether these results accurately reflect the physiological 
function of Rin (Shi, Cai et al. 2013). We have recently described an unexpected 
role for Rit signaling in TBI-induced neurogenesis, functioning to promote 
selective survival for immature hippocampal neurons following contusion brain 
injury (Cai, Carlson et al. 2012). Because of similarities to Rit signaling, and its 
distinct neuronal expression, we postulated that Rin would also contribute to 
functional recovery following TBI. In this chapter, we use a novel transgenic RIT2 
knockout mouse model; we show that following severe contusion brain injury, Rin 
deficiency reduces regional hippocampal neurodegeneration and improves post-
traumatic cognitive function. 
Results 
Genetic Rin loss does not alter brain morphology 
Previous studies using cell culture models identified a putative role for Rin 
in neuronal differentiation and stress signaling (Hoshino and Nakamura 2002, 
Hoshino and Nakamura 2003, Shi, Han et al. 2005). These studies are limited by 
the fact that only a few cell lines express endogenous Rin, making it unclear 
whether the results accurately reflect in vivo Rin function	  (Shi, Cai et al. 2013). 
Therefore, to begin to characterize the physiological role of Rin signaling, we 
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obtained a RIT2 knockout mouse from the Texas Institute of Genomic Medicine 
(TIGM) generated using a gene trap insertion strategy (Figure 3.1A). Western 
blot analysis from whole brain lysates was used to demonstrate the loss of 
endogenous Rin protein in the gene trap line (Figure 3.1B). Rin-null mice were 
born at expected Mendelian ratios and survived to adulthood with no apparent 
physical or gross morphological abnormalities (data not shown). As available 
evidence suggests that Rin is expressed solely within the nervous system (Lee, 
Della et al. 1996, Wes, Yu et al. 1996), we further characterized gross brain 
anatomy within a Rin null background. Overall brain structure was unaltered and 
no obvious discrepancies in cell body (Nissl), mature neurons (NeuN), or 
astrocyte (GFAP) distribution were observed (Figure 3.1C). Taken together, 
these data indicate that Rin function is not essential for early neuronal 
development or global brain architecture.  
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Figure 3.1. Generation and characterization of Rin null-mutant mice. A. 
Schematic representation of the Rit2 allele and gene trap VICTR 48 insert 
utilized to generate Rin-/- mice. LTR, viral long terminal repeat; SA, splice 
acceptor; NEO, neomycin resistance; pA, SV40 poly adenylation sequence; 
PGK, phosphoglyserate kinase; BTK, first exon of the murine Bruton’s tyrosine 
kinase gene; arrows indicate frt, flippase recognition targets, within the VICTR 48 
insert. B. Western blot of brain lysates from wild-type (WT), Rin+/- and Rin-/- mice 
demonstrating loss of Rin protein at both a short (top panel) and long exposure 
(second panel) with no alterations to its closest homolog Rit (third panel). C. 
Representative hemisphere images from naïve wild-type and Rin-/- mice stained 
with GFAP, Nissl, and NeuN. Insets from of NeuN staining are included from the 
cortex and hippocampal CA-1. No gross alterations in brain morphology or 
development were noted due to global Rin loss. 
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Rin deficiency promotes hippocampal cell survival 
CCI injury results in robust cortical tissue loss at the injury site together 
with acute degeneration of the underlying hippocampal structure that can be 
analyzed using Fluoro-jade C (FJC) (Smith, Soares et al. 1995, Hall, Sullivan et 
al. 2005, Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant et al. 2008, Pleasant, 
Carlson et al. 2011). To analyze the in vivo effect of Rin deficiency on 
neurodegeneration following brain injury, we performed controlled cortical impact 
(CCI) injury on cohorts of wild-type and Rin-/- mice. CCI resulted in hippocampal 
degeneration concentrated primarily within the dentate gyrus regardless of 
genotype. The volume of neocortical damage was equivalent for wild-type (13 
±1%; n=4) and Rin-/- animals (13 ± 2%; n=6) (t-test, p=0.94) 48 hr following 
moderate CCI. (Figure 3.2A). However, Rin-/- mice displayed significantly 
diminished numbers of FJC-positive cells (WT 155 ± 13 cells n=5; Rin-/- 115 ± 12 
cells, n=7, t-test p<0.05) (Figure 3.3 A, C). Sub-regional quantification revealed 
that FJC-positive neurons trended downward in both the inner granular layer 
(IGL), the location where immature neurons and neural stem cells reside, as well 
as in the outer granular layer (OGL) of the dentate gyrus. Although fewer FJC-
positive cells were observed in the CA1 or CA3 sub-regions, Rin loss was shown 
to significantly attenuate CA3 cell death following CCI (WT 30 ± 4 cells n=5, Rin-/- 
16 ± 3 cells, n=7; t-test p<0.05) (Figure 3.3A). FJC staining was not observed in 
the hippocampus of sham-operated mice regardless of genotype.  
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Figure 3.2. Cortical contusion volume changes equivalent in wild-type and 
Rin-/- mice following contusive brain injury. A. Representative images of Nissl 
stained brains demonstrating relative cortical loss in wild-type and Rin-/- animals 
48 hr following CCI. B. Quantification of contralateral cortical volume compared 
to the ipsilateral cortical volume demonstrates equal cortical damage in wild-type 
and Rin-/- animals following head injury. 
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Figure 3.3. Rin loss attenuated trauma-induced hippocampal 
neurodegeneration. A. the dentate gyrus (DG), CA-1, and CA-3 regions of the 
hippocampus and B. the outer granular layer (OGL) and inner granular layer 
(IGL) suggest decreased degeneration within the dentate gyrus and CA-3 in the 
absence of Rin. Data are presented as mean ± SEM (wild-type n= 5, Rin-/- n=7; t-
test * p<0.05) C. Representative confocal images of the ipsilateral dentate gyrus 
for wild-type and Rin-/- mice 48hrs following CCI co-stained with FJC (green) and 
DAPI (blue). 
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Rin deficiency does not alter the survival of newborn neurons in the 
hippocampus following CCI 
Immature neuronal numbers within the subgranular layer are reduced 
acutely following CCI (Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant et al. 
2008); however, enhanced post-injury neurogenesis ensures the recovery of 
newborn neuronal numbers in the weeks following CCI (Rola, Mizumatsu et al. 
2006, Yu, Zhang et al. 2008, Carlson, Madathil et al. 2014).  Because protection 
was seen within the dentate gyrus of brain-injured Rin-/- mice, we next asked 
whether Rin might contribute to the regulation of post-traumatic hippocampal 
neurogenesis. BrdU/Dcx co-labeling detected equivalent numbers of newborn 
immature neurons in naïve wild-type and Rin-/- mice 48h after the last of seven 
daily BrdU injections, indicating that basal neurogenesis is unaffected by Rin 
deficiency (Figure 3.4). However, concussive injury resulted in a marked 
decrease of BrdU+/Dcx+ neurons in the ipsilateral dentate gyrus in wild-type mice 
(27.4% reduction relative to shams 48hr post-CCI) (Figure 3.4B). An equivalent 
reduction was observed in the ipsilateral dentate gyrus of Rin-/- mice (32.8% 
reduction relative to sham) (Figure 3.4B). As expected, neuronal loss was 
confined to the injured hemisphere and no alterations in contralateral BrdU+/Dcx+ 
cell numbers were observed regardless of genotype (Figure 3.4C).  
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Figure 3.4. Rin loss had no effect on newborn neuron survival following 
contusion injury. A. Representative confocal images at of wild-type and Rin-/- 
mice labeled with Dcx (green), BrdU (red), and DAPI (blue). BrdU (50mg/kg) was 
injected for 1 week prior to CCI or sham injury. The insets are at 5X higher 
magnification; the arrowheads indicate BrdU/Dcx double positive cells. B. 
Quantification of double-positive Dcx/BrdU cells 48hrs post-CCI in the ipsilateral 
hemisphere show a main effect of injury [F(1,29)= 14.67, p<0.001] but not 
genotype [F (1,29)=0.21, p=0.652] or interaction between genotype and injury [F 
(1,29)=0.24, p=0.628] C. Quantification of double-positive Dcx/BrdU cells 48 hrs 
post-CCI in the contralateral hemisphere show no main effect of injury [F(1,29)= 
0.11, p=0.745], genotype [F (1,29)=0.30, p=0.589] or interaction between 
genotype and injury [F (1,29)=0.01, p=0.924]. These data demonstrate that Rin 
loss has no effect on immature neuronal cell death 48hr following TBI. Data 
expressed as mean ± SEM (WT sham n=6, WT CCI n=8, Rin-/- sham n=7, Rin-/- 
CCI n=12). 
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Acute post-traumatic loss of immature neurons is followed by the 
stimulation of neural progenitor cells, leading to increased hippocampal 
neurogenesis and the return of immature (Dcx+) cell numbers to pre-injury levels 
(Weinstein, Burrola et al. 1996, Gould and Tanapat 1997, Magavi, Leavitt et al. 
2000, Kernie, Erwin et al. 2001).  To determine whether Rin loss altered 
progenitor cell proliferation in response to brain injury, we quantified cells within 
the inner granular layer of the dentate gyrus actively in the cell cycle (Ki67+) 
(Figure 3.5A). Wild-type and Rin-/- animals displayed similar increases in Ki67+ 
cells 48hr following trauma (WT 475%, Rin-/- 434%, increase compared to sham) 
(Figure 3.5B). As expected, there was no TBI-induced increase in proliferation 
contralateral to the injury (Figure 3.5C).  
At 10 d post-CCI, total immature neuronal numbers (Dcx+ cells) in the 
ipsilateral dentate gyrus of wild-type mice had returned to sham levels (WT sham 
17 ±1.0 x103/mm3 cells, n= 6; WT CCI 19 ±2 x103/mm3 cells, n=8) (Figure 3.6A, 
B). Rin-/- mice displayed a similar trend (Rin-/- sham, 16118 ±731 cells, n= 7; Rin-/- 
CCI, 21258 ±1110 cells, n=7) (Figure 3.6B, C). In keeping with these results, 
immature neuronal recovery (percent ipsilateral/contralateral Dcx+ cells) was 
similar in wild-type and Rin-/- mice (Figure 3.6D). Taken together, these data 
suggest that Rin function is not required for post-traumatic induction of 
neurogenesis. 
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Figure 3.5. Rin deficiency does not alter TBI-induced proliferation in the 
inner granular layer of the dentate gyrus. A. Representative confocal images 
of wild-type and Rin-/- mice labeled with Ki67 (red), and DAPI (blue). B. 
Quantification of Ki67+ cells 48hrs post-CCI in the ipsilateral hemisphere show a 
main effect of injury [F(1,15)= 135.67, p<0.0001] but not genotype [F (1,15)=0.98, 
p=0.338] or interaction between genotype and injury [F (1,15)=0.199, p=1.79] C. 
Quantification of Ki67+ cells 48 hrs post-CCI in the contralateral hemisphere 
show no main effect of injury [F(1,15)= 4.08, p=0.062], genotype [F (1,15)=0.16, 
p=0.698] or interaction between genotype and injury [F (1,15)=0.38, p=0.548]. 
Data are expressed as expressed as mean ± SEM (WT sham n=3, WT CCI n=5, 
Rin-/- sham n=6, Rin-/- CCI n=6) 
	   71	  
 
 
 
 
 
 
	   72	  
Figure 3.6. Rin loss did not alter the recovery of immature neuron density 
following controlled cortical impact A. Representative confocal images of 
wild-type and Rin-/- mice labeled with Dcx (green) and DAPI (blue) 10 d following 
CCI. B. Quantification of Dcx+ cells 10 d post-CCI in the ipsilateral hemisphere 
show a main effect of injury [F(1,24)= 4.93, p<0.0361] but not genotype [F 
(1,24)=0.02, p=0.8789] or interaction between genotype and injury [F 
(1,24)=1.45, p=0.2339] C. Quantification of Dcx+ cells 10 d post-CCI in the 
contralateral hemisphere show no main effect of injury [F(1,24)= 2.53, p=0.126], 
genotype [F (1,24)=0.08, p=0.779] or interaction between genotype and injury [F 
(1,24)=0.03, p=0.854] D. Recovery of immature neurons following CCI, quantified 
as a percentage of Dcx+ cells on the ipsilateral dentate gyrus compared to the 
contralateral side shows no change in recovery in the Rin-/- animals.  Data are 
expressed as mean ± SEM (wild-type sham n=6, WT CCI n=8, Rin-/- sham n=7, 
Rin-/- CCI n=7). 
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Rin deficiency promotes hippocampal CA-3 neuronal survival 
To determine whether neuronal protection was sustained in Rin-/- mice, we 
examined mature neuronal survival 10d following CCI within the CA-3 pyramidal 
layer and dentate hilus (Figure 3.7). Stereological counts demonstrate that the 
numbers of NeuN+ cells within the CA-3 (59.9% neuron loss relative to sham) 
and hilus (64.7% neuron loss relative to sham) were markedly decreased in wild-
type injured animals (Figure 3.7B, C). While the number of NeuN-positive 
neurons was decreased in Rin-/- mice following injury, NeuN+ cell reduction was 
significantly blunted in both the CA-3 (31.8% neuron loss relative to sham) and 
hilus (50% neuron loss relative to sham) (Figure 3.7B, C).  
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Figure 3.7. Rin loss promotes hippocampal neuronal survival following 
brain injury. A Representative NeuN images of the ipsilateral hippocampus at 
10d following severe CCI. B. Quantification of stereological estimates of total 
mature neuronal cells in the dorsal ipsilateral hippocampus display neuronal 
protection within the CA-3 10d after CCI [main effect of injury, F(1,16)= 102.03, 
p<0.0001; main effect of genotype, F (1,16)=13.39, p=0.002; Interaction of 
genotype and injury F (1,16)=8.63, p=0.0097; two-way ANOVA followed by 
Bonferroni post-hoc, *p<0.05]. Data are expressed as mean ±SEM (WT sham 
n=5, WT CCI n=6, Rin-/- sham n=4, Rin-/- CCI n=5). C. NeuN counts within the 
ipsilateral hilus of the dentate gyrus display hilar protection. [main effect of injury, 
F(1,16)= 170.12, p<0.0001; main effect of genotype, F (1,16)=6.13, p=0.025; 
Interaction of genotype and injury F (1,16)=4.34, p=0.0535; two-way ANOVA 
followed by Bonferroni post-hoc, *p<0.05). Data are expressed as mean±SEM 
(WT sham n=5, WT CCI n=6, Rin-/- sham n=4, Rin-/- CCI n=5). 
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Rin loss reduces post-CCI behavioral dysfunction 
 To determine whether the neuroprotection afforded by Rin loss correlated 
with behavioral improvements following CCI, we evaluated motor function using a 
modified neurological severity score (NSS) assay and hippocampal-mediated 
cognitive performance through a novel object recognition (NOR) task (Schoch, 
Evans et al. 2012, Madathil, Carlson et al. 2013). Both wild-type and Rin-/- sham-
injured animals performed equivalently suggesting no baseline motor or cognitive 
defects (Figure 3.8). Brain injured cohorts displayed significant loss of motor 
coordination regardless of genotype as indicated by low NSS scores in the days 
following injury, which were equivalent at each time point assessed (Figure 
3.8A). Cognitive evaluation demonstrated significant impairment in wild-type 
mice following severe CCI as indicated by a recognition index of 51.6 ± 5.0%, 
which indicates no preference for the novel object over a familiar one (Figure 
3.8B).  Rin-/- brain-injured mice, however, displayed cognitive sparing as 
indicated by a recognition index of 66.3 ± 2.7%, a score more closely resembling 
sham groups (WT sham 72.4 ± 2.4%, n=10; Rin-/- sham 72.6 ±1.8%, n=8) 
(Figure 3.8B). These data suggest that Rin loss led to improved memory of the 
familiar object. 
 
 
 
	   77	  
 
 
 
 
 
 
 
 
	   78	  
Figure 3.8. Rin loss reduced cognitive impairment after CCI A. Neurological 
severity score, derived from a series of beam walking tasks, showed no 
difference in motor function at 24 hr to 6 d following CCI. Data are expressed as 
mean ± SEM (Non-parametric Kruskal-Wallis test; WT sham n=10, WT CCI 
n=10, Rin-/- sham n=9, Rin-/- CCI n=8) B. Novel object recognition cognitive 
paradigm in wild-type and Rin-/- mice suggest enhanced cognition of Rin-/- mice at 
7 d after severe CCI injury [main effect of injury, F(1,32)= 15.6, p<0.001; main 
effect of genotype, F (1,32)=4.64, p=0.039; Interaction of genotype and injury F 
(1,32)=4.43, p=0.043; two-way ANOVA followed by Bonferroni post-hoc, 
*p<0.05]. Recognition index is represented as the percentage of time exploring 
the novel object; the dotted line represents a recognition index of 50%; data 
represented as mean ± SEM (WT sham n=10, WT CCI n=10, Rin-/- sham n=8, 
Rin-/- CCI n=8. 
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Discussion 
Here for the first time, we implicate Rin GTPase function in the regulation 
of neuronal cell loss following TBI. Because the hippocampus has been 
described as particularly vulnerable to contusive brain injury (CCI) (Levin 1998, 
Rola, Mizumatsu et al. 2006) we focused our characterization on post-traumatic 
neuroprotection within this structure. Employing a novel transgenic RIT2 
knockout mouse model, we demonstrate that Rin deficiency promotes 
hippocampal neuronal protection, in addition to improving cognitive function 
following severe brain injury.  However, Rin loss does not affect post-injury 
hippocampal neurogenesis, suggesting a key role for Rin in the regulation of 
mature neuron cell loss following TBI.  
Previous work from this lab has identified important roles for Rit GTPase 
signaling in the regulation of both insulin-like growth factor-1 (IGF-1) and trauma-
induced neurogenesis (Mir, Cai et al. 2017, Mir, Cai et al. 2017).  RIT1-/- 
transgenic mice exhibit an increased loss of adult-born immature hippocampal 
neurons after severe brain injury (Cai, Carlson et al. 2012). Furthermore, 
neuronal-selective expression of constitutively activated Rit has been 
demonstrated to increase levels of basal neurogenesis in the subgranular zone 
of the hippocampal dentate gyrus (Mir, Cai et al. 2017). Additionally, its loss 
promotes neuronal death in response to oxidative stress (Cai, Carlson et al. 
2012), thus demonstrating a role for Rit in the regulation of activity-dependent 
plasticity and general neuronal survival. The finding that Rin deficiency had no 
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effect on injury-induced neurogenesis or immature neuronal survival 
demonstrates that Rit and Rin have distinct physiological roles in the 
hippocampus. Divergent functions of these closely related GTPases was not 
entirely unforeseen given that a constitutively active mutation of Rin failed to 
promote transformation of NIH-3T3 (Rusyn, Reynolds et al. 2000), and that RIT1 
deletion results in a neuronal phenotype that cannot be complemented by RIT2 
or any other Ras family GTPase (Cai, Rudolph et al. 2011). What is surprising is 
that our studies suggest that while Rit serves as a critical regulator of an 
important survival mechanism for cells in response to stress (Cai, Rudolph et al. 
2011, Shi, Cai et al. 2013), Rin would appear to play diametrically opposite role 
in neurons, promoting neuronal loss in response to injury. Further studies are 
needed to decipher the molecular underpinnings that confer independent roles 
for Rin and Rit in the CNS. 
Post-trauma restorative neurogenesis and neuronal survival within the 
hippocampus have been reported to be important mediators of post-traumatic 
outcomes (Levin 1998, Madsen, Kristjansen et al. 2003, Kesner 2007, Hunsaker, 
Lee et al. 2008, Jessberger, Clark et al. 2009, Blaiss, Yu et al. 2011). The finding 
that Rin loss promotes neuroprotection in the CA-3 and hilar sub-regions of the 
hippocampus 10 d post-CCI (Figure 3.6), without altering neurogenesis (Figure 
3.3, 3.4, 3.5), supports a selective role for endogenous Rin in the regulation of 
molecular cascades that promote neuronal loss following brain-injury. 
Furthermore, these data suggest that enhanced mature neuron survival is the 
primary mechanism for cognitive sparing seen in our Rin-/- transgenic model. 
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Studies are underway to determine whether Rin silencing serves to decrease cell 
loss following brain injury. 
Interestingly, although Rin loss was not shown to alter immature neuronal 
numbers within the hippocampus following injury, there does appear to be a 
reduction in ectopic migration of Dcx+ neurons in the granular layer (Figure 3.5). 
Ectopic migration of Dcx+ cells has been reported at 7 d in models of focal TBI 
(Shapiro 2017); however, the consequences of aberrant hippocampal cell 
migration are not completely characterized in models of TBI. Epilepsy, however, 
is characterized by abnormal integration of hippocampal dentate granule cells 
(Hester and Danzer 2014). Inappropriate axonal contacts of irregularly migrating 
cells have been demonstrated to form dysregulated recurrent excitatory loops, 
and it is believed that abnormal neurogenesis may be epilepyogenic (Hester and 
Danzer 2014). Closer examination of Dcx+ migration in Rin-/- mice is needed to 
elucidate the potential role for Rin in immature neuronal migration. However, 
limiting ectopic cell migration following injury may also be an avenue of protection 
in the absence of Rin. 
Furthermore, we have demonstrated that Rin deficiency leads to cognitive 
behavioral sparing following severe contusion injury, but does not improve 
coordinated motor function. Improved cognitive function is consistent neuronal 
sparing observed throughout the hippocampus (Figures 3.3, 3.7B), a critical 
structure for many aspects of learning and memory. Motor movements are 
greatly controlled within the cortex, and it has been previously noted that the 
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degree of motor impairment following injury is correlated with cortical injury 
volume (Tsenter, Beni-Adani et al. 2008). In these studies, wildtype and Rin null 
mice displayed equivalent cortical loss following injury (Figure 3.2); therefore, it 
is not surprising that Rin loss did not lead to motor improvements (Figure 3.7A). 
The question of why Rin loss selectively protects hippocampal but not cortical 
neurons remains to be answered.  
The notion that endogenous Rin is involved in the regulation of molecular 
cascades that control neuronal loss following injury is striking given that many of 
Ras subfamily GTPases are known to function in cell survival (Colicelli 2004, 
Wennerberg, Rossman et al. 2005). Nonetheless, Ras GTPase-regulated MAPK 
cascade activation has been found to regulate cell death and autophagy 
pathways that in turn play central roles in neuronal survival signaling (Donninger, 
Calvisi et al. 2015, Cook, Stuart et al. 2017, Zhang, Zheng et al. 2017). ERK, 
JNK, and p38 MAPK signaling cascades have been described as mediators of 
cell death following focal ischemic injury and their inhibition shown to improve 
outcomes following injury (Sugino, Nozaki et al. 2000, Nozaki, Nishimura et al. 
2001, Yang, Gu et al. 2017). Interestingly, ERK activation has been 
demonstrated to have a pro-apoptotic role in mature neurons; however, ERK 
phosphorylation is not observed during immature neuronal death (Lesuisse and 
Martin 2002). Previous studies from the lab demonstrate a role for Rin in ERK 
activation (Shi, Han et al. 2005). Furthermore, studies have identified a 
prominent role for Rin in p38 stress kinase signaling, as RNAi-mediated Rin 
silencing was found to disrupt p38 activation downstream of nerve growth factor 
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in pheochromacytoma cells (Shi, Han et al. 2005). Further studies are needed to 
characterize the activation of MAPK signaling cascades in our transgenic Rin null 
mice following contusive brain injury model. Studies are underway to determine 
whether expression of a constitutively active Rin mutant is able to modulate 
neuronal MAPK signaling. 
In this chapter, we have identified a novel role of Rin following severe 
focal contusion by demonstrating increased hippocampal neuroprotection and 
improved cognition following genetic silencing of Rin. These results suggest a 
role for Rin signaling cascades leading to cell death following severe focal injury 
and suggest Rin as a possible therapeutic target following TBI. The severe 
nature of the CCI injury model makes it difficult to parse out the contributions of 
Rin to specific secondary injuries following TBI. Therefore, in the chapters to 
follow, we have employed alternative experimental injury models that allow us to 
analyze the role of Rin in axonal degeneration along white matter tracts and 
neuroinflammation. 
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CHAPTER FOUR 
 
Rin Contributes to Trauma-induced Axonal Injury 
 
Introduction 
 Traumatic axonal injury (TAI) is a common feature of diffuse TBI, generally 
resulting from high-velocity rotational forces that result in stretching and shearing 
of axons, and although severe injury can lead to primary axotomy, more often the 
injury manifests as a interruption of protein transport and breakdown of 
cytoskeletal elements (Hill, Coleman et al. 2016). These events activate 
secondary injury cascades which, if not resolved, leads to disconnection of the 
distal axon at the site of injury and its eventual degeneration (Hill, Coleman et al. 
2016). Disruption of white matter tract integrity contributes to cognitive and motor 
impairments observed following TBI, and white matter degeneration has been 
shown to persist years following the initial insult (Johnson, Stewart et al. 2013). 
The key histological components of TAI include retraction bulbs and axonal 
swellings that result from a breakdown of microtubules and an accumulation of 
proteins in the axon due to impaired protein transport (Tang-Schomer, Johnson 
et al. 2012). Although disruption of the axonal cytoskeletal structure and transport 
can lead to neuronal cell death, this is not always the case. Recent research 
suggests that, over time, diffuse axonal damage can be corrected through 
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reorganization and repair of the proximal axon following disconnection (Wang, 
Fox et al. 2013). 
Primary axotomy is generally considered to be an uncommon feature of 
TAI unless the injury was the result of by direct tissue injury, such as laceration 
(Christman, Grady et al. 1994). In these cases, the axon is divided into two parts: 
a proximal portion that remains attached to the cell body and a distal stump that 
has lost its connection to the nucleus. Eventually, the distal stump will inevitably 
undergo degeneration. Historically it was believed that the wasting away of the 
distal axon was a passive process, or a consequence of separation from the cell 
body and occurred when the axon lost essential proteins that could no longer be 
synthesized (Gerdts, Summers et al. 2016). However, the discovery of the 
Wallerian degeneration slow (Wlds) mutant mouse challenged this dogma (Lunn, 
Perry et al. 1989, Glass, Brushart et al. 1993). It was found that in this mutant, 
arising from a fusion between a metabolic cofactor, nicotinamide mononucleotide 
adenylyl transferase 1 (NMNAT1), and an ubiquitin ligase, ubiquitination factor 
e4b (Ube4b), axonal degradation following axonal transection was delayed for up 
to three weeks (Wang, Medress et al. 2012, Gerdts, Summers et al. 2016). 
Although the protective mechanism of the Wlds chimera is still unclear, it has 
been demonstrated that increased NMNAT1 activity and NAD+ levels contribute 
to axonal protection following injury (Araki, Sasaki et al. 2004). Indeed, 
manipulations that increase axonal expression of NMNAT1 (Sasaki, Vohra et al. 
2009, Babetto, Beirowski et al. 2010) or direct transduction of NMAMT into 
severed axons acutely following injury (Sasaki and Milbrandt 2010) have been 
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shown to confer axonal protection. Following TBI, Wlds mutant mice display 
decreased axonal injury and delayed cognitive and motor impairment (Fox and 
Faden 1998) suggesting a potential therapeutic outlet against the detrimental 
outcomes of TAI once the molecular mechanisms of the chimera are understood. 
 Nevertheless, the Wlds mouse encodes a gain-of-function mutation and, in 
itself, does not reveal the presence of a pro-degenerative program; however if 
degenerative cascades exist, then loss of these signaling components should 
provide protection from axonal degradation (Gerdts, Summers et al. 2016). The 
first protein identified as a candidate within a conserved axonal pro-degenerative 
pathway was dual leucine zipper kinase (DLK), a mitogen-activated protein 
kinase kinase kinase (MAPKKK) (Miller, Press et al. 2009). Genetic deletion of 
DLK has been demonstrated to transiently delay axonal degeneration of the 
sciatic nerve following injury, slowing Wallerian degeneration (Miller, Press et al. 
2009). Since its identification, DLK has been shown to control a multitude of 
seemingly opposing neuronal processes including not only Wallerian 
degeneration and cell death, but also axonal regeneration and growth {reviewed 
in (Tedeschi and Bradke 2013)}. However, the regulatory proteins and effectors 
that allow for DLK to function in apparently contradictory roles are not completely 
characterized. 
Early biochemical analysis shows that overexpression of DLK activates 
the stress-activated protein kinases (SAPK), JNK, and p38; signaling through 
these pathways is largely involved in responses to cellular stressors, such as 
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osmotic stress, UV irradiation, hypoxia, oxidative stress, and pro-inflammatory 
cytokines, and SAPK activation often leads to cell death (Fan, Merritt et al. 1996, 
Tibbles and Woodgett 1999). Ras family GTPases are known regulators of p38 
and JNK signaling pathways (Robinson and Cobb 1997), suggesting that a Ras 
family GTPase may lie upstream of DLK. However, one has not been described 
to date. Rin GTPases have been found to activate p38 stress kinase signaling 
(Shi, Han et al. 2005), and their loss promotes neuronal survival (Chapter 3), 
indicating that Rin signaling promotes cell death. These observations suggest 
that Rin may be able to bind and activate DLK.  
 My previous research has indicated that the loss of Rin protects mature 
neurons from death following contusive brain injury. Furthermore, protection 
provided by Rin loss was shown to occur at particularly high levels within the CA-
3 region of the hippocampus following contusive TBI (Chapter 3). Because 
neurons within the hippocampal CA-3 region are suggested to undergo a high 
degree of stretch following CCI injury (Mao, Elkin et al. 2013) we hypothesized 
Rin loss diminished axonal injury leading to neuronal protection. Herein, we test 
the hypothesis that Rin signals through a pro-degenerative cascade, with the 
implication being that genetic deletion of RIT2 will result in decreased axonal 
degeneration following trauma. To test this hypothesis, we employed both an 
optic nerve stretch injury model to produce axonal degeneration across the optic 
nerve to investigate the role of Rin in axonal breakdown (Saatman, Abai et al. 
2003, Serbest, Burkhardt et al. 2007), and an optic nerve transection model to 
investigate the role of Rin in Wallerian degeneration. 
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Results 
Rin loss mitigates trauma-induced axonal degeneration following stretch 
injury 
To test the hypothesis that Rin loss would protect neurons from traumatic 
axonal injury, we performed optic nerve stretch on cohorts or wild-type and Rin-/- 
mice to generate an isolated white matter tract injury along the optic nerve (Smith 
2000, Saatman, Abai et al. 2003). The optic nerve stretch model allows analysis 
of isolated trauma-induced axonal damage circumventing difficulties of targeting 
white matter tracts in the brain, which has a more complex anatomy (Saatman, 
Abai et al. 2003).  In this model, rapid unilateral stretch of retinal ganglion axons 
causes damage to the elements of the axonal cytoskeleton, the major component 
of which are neurofilaments (Smith 2000). Following stretch, the region of the 
optic nerve spanning between the globe of the eye and optic chiasm was 
examined for injury using SMI-32, a marker of dephosphorylated neurofilament, a 
well-established marker of axonal/neurofilament damage (Christman, Grady et al. 
1994). At 24hrs following injury, minute accumulation of SMI-32 can be observed 
throughout the optic nerve of injured axons in both wild-type and Rin-/- animals 
(Figure 4.1A) suggesting equivalent intensities of injury in each genotype. 
However, levels were not significantly higher than sham controls, consistent with 
the progressive nature of this injury (Saatman, Abai et al. 2003) (Figure 4.1B).   
By 7d post-stretch injury, degeneration progressed along the optic nerve, 
exhibited by an increase of SMI-32 positive immunostaining in injured wild-type 
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animals compared to wild-type sham controls (p<0.001 one-way ANOVA 
followed by Newman-Keuls post-hoc test) (Figure 4.2). Rin null sham and injured 
mice displayed equivalent levels of SMI-32 accumulation along the optic nerve 
suggesting that Rin loss blocks the progression of axonal injury. This finding is 
further illustrated by a significant decrease of SMI-32 staining in Rin-/- mice 
compared to wild-type following injury (p<0.05 one-way ANOVA followed by 
Newman-Keuls post-hoc test) (Figure 4.2B). Taken together these data suggest 
that although both wild-type and Rin null animals displayed some degree of acute 
injury, Rin loss reduces the progression of degeneration. 
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Figure 4.1. Rin loss does not alter early axonal degeneration 24 hr following 
optic stretch injury. A. Representative images of dephosphorylated 
neurofilament (SMI-32) in the optic nerve 24 hrs following optic stretch injury in 
wild-type and Rin-/- animals. B. Quantification of SMI-32 in the optic nerve 
following injury indicates that early degeneration between wild-type and Rin-/- 
animals are comparable 24 hr following stretch injury. Data are expressed as 
mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; ANOVA followed by Newman-
Keuls post hoc test p>0.05. 
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Figure 4.2. Rin loss blunts axonal degeneration 7 d following optic stretch 
injury. A. Representative images of dephosphorylated neurofilament (SMI-32) in 
the optic nerve 7 d following optic stretch injury in wild-type and Rin-/- animals. B. 
Quantification of SMI-32 in the optic nerve following injury indicates that Rin loss 
blunts the progression of axonal damage following stretch injury. Data are 
expressed as mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; ANOVA followed by 
Newman-Keuls post hoc test *p<0.05. 
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Rin loss diminishes trauma-induced microglia activation following optic 
stretch injury 
Because Rin null mice displayed decreased axonal degeneration following 
stretch, we hypothesized that microglial activation would also be blunted. Post-
injury inflammation was analyzed using immunohistochemical detection of cluster 
of differentiation 68 (CD-68), a marker for activated microglia. At 24hrs following 
injury, minimum accumulation of CD-68 was detected throughout the optic 
nerves of both wild-type and Rin-/- stretch-injured mice (Figure 4.3A) in 
agreement with the minute degree of axonal injury observed via SMI-32 labeling. 
Once again, there was no statistical difference between sham and injured 
cohorts (Figure 4.3B). 
By 7d post-stretch robust microglial activation was observed along the 
optic nerve demonstrated by an increase of CD-68 positive immunostaining in 
the injured wild-type cohort compared to wild-type sham controls (p<0.01 ANOVA 
followed by Newman-Keuls post-hoc test) (Figure 4.4). However, Rin-/- sham and 
stretch-injured mice displayed equivalent levels of microglial activation along the 
optic nerve. This finding is further illustrated by a significant decrease in 
microglial activation in Rin-/- mice compared to wild-type cohorts following injury 
(p<0.05 ANOVA followed by Newman-Keuls post-hoc test) (Figure 4.4B). 
Furthermore, a strong correlation was found between the degree of axonal 
degredation (SMI-32 positive immunostaining) and microglial activation (CD-68 
positive immunostaining) (Pearson’s coefficient 0.72) (Figure 4.5). Together 
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these data suggest that the diminishment of axonal injury in Rin null mice results 
in a reduced need for microglial activation post-injury. 
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Figure 4.3. Rin loss does not alter early microglial activation 24 hr following 
optic stretch injury. A. Representative images of phagocytic macrophages (CD-
68) in the optic nerve 24 hrs following optic stretch injury in wild-type and Rin-/- 
animals. B. Quantification of CD-68 in the optic nerve following injury indicates 
that early inflammation between wild-type and Rin-/- animals are comparable 24 
hr following stretch injury. Data are expressed as mean ± SEM (wild-type n= 6-
12, Rin-/- n= 5-11; one-way ANOVA followed by Newman-Keuls post hoc test p 
>0.05. 
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Figure 4.4. Rin loss blunts microglia activation 7 d following optic stretch 
injury. A. Representative images of phagocytic macrophages (CD-68) in the 
optic nerve 7d following optic stretch injury in wild-type and Rin-/- animals. B. 
Quantification of CD-68 in the optic nerve following injury indicates that Rin loss 
blunts inflammatory responses 7d following stretch injury. Data are expressed as 
mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; one-way ANOVA followed by 
Newman-Keuls post hoc test **p<0.01. 
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Figure 4.5. Relationship between axonal damage (SMI-32) and microglial 
activation (CD-68) following optic stretch injury. The percent area of SMI-32 
and CD-68 coverage on the optic nerve following injury displays a high degree of 
correlation. r2= 0.7215  
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Rin interacts with the MAPKKK, Dual Leucine Zipper Kinase (DLK) 
Levels of DLK have been determined to increase following injuries to the 
optic nerve (Watkins, Wang et al. 2013) leading to subsequent activation of JNK 
and the downstream transcription factor, c-Jun (Chen, Rzhetskaya et al. 2008, 
Ghosh, Wang et al. 2011, Watkins, Wang et al. 2013, Welsbie, Yang et al. 2013). 
Given that MAPK cascades, including JNK, are known to be regulated by Ras 
family GTPases, we sought to determine if Rin could lie in this pathway (Figure 
4.6A). To determine whether Rin was a possible upstream regulator of DLK, we 
performed co-immunoprecipitation experiments in HEK-293T cells by 
overexpressing Myc tagged DLK and FLAG tagged GTPase constructs (Rin, Rit, 
and H-Ras). Rin and Rit share a high degree of sequence similarity, including an 
identical effector domain, whereas the effector domain of H-Ras, a closely 
related Ras protein, has a distinct, yet still structurally similar effector loop 
(Figure 4.6B). Both Rin and Rit were found capable of co-immunoprecipitating 
with DLK (Figure 4.6C lane 3 & 4). H-Ras, however, did not interact with DLK 
(Figure 4.6C lane 5). These data suggest that Rin and Rit could potentially lie 
upstream of the DLK cascade and ablation of these proteins could alter DLK-
mediated signaling.  
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Figure 4.6. Rin associates with Dual Leucine Zipper Kinase (DLK), an 
upstream regulator of axonal degeneration. A. Schematic representation of 
the DLK MAPK cascade, which has been demonstrated to signal axonal 
degeneration following injury, and the hypothesis that Rin GTPase lies upstream 
of DLK activation. B. Amino acid alignment of the G2 effector domains of Rin, Rit 
and H-Ras. C. HEK-293T cell co-immunoprecipitation between DLK and Rin, Rit 
and H-Ras shows interaction between the Rit sub-family of GTPases with DLK, 
but no interaction with H-Ras. 
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Transection-induced Wallerian degeneration unaffected by Rin loss  
Because Rin loss reduced axonal degeneration following stretch injury 
and literature has demonstrated a role for DLK in pro-degenerative cascades 
following optic injury (Miller, Press et al. 2009, Tedeschi and Bradke 2013, Yang, 
Wu et al. 2015), we sought to determine whether the loss of Rin could delay 
Wallerian degeneration. Resolution of this question, however, could not be 
adequately provided using the optic nerve stretch model. The diffuse nature of 
the stretch injury, which causes breaks throughout length of the optic nerve does 
not allow for analysis of the directionality of axonal breakdown or permit 
distinction between the proximal and distal axons. Also problematic is the notion 
that every axon does not receive an equivalent injury and stretch injury does not 
immediately lead to axonal disconnection. Therefore, we used axonal transection 
of the optic nerve to generate a localized, normalized injury to assess the impact 
of Rin loss on Wallerian degeneration. 
Following transection in wild-type and Rin-/- mice, axonal degeneration 
was analyzed by immunostaining for SMI-32. At 24 hr post-transection, 
equivalent SMI-32 positive immunostaining was observed in the distal nerve of 
both wild-type and Rin-/- mice (Figure 4.7). By 7 d post-transection, axonal injury 
had spread all the way to the optic chiasm in both wild-type and Rin-/- animals. 
These data suggest that Rin loss does not result in a dramatic alteration in the 
rate of Wallerian degeneration in the distal axon following transection.    
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Figure 4.7. Rin loss has no effect on axonal degeneration 24hr following 
optic nerve transection. Representative images of the dephosphorylated 
neurofilament (SMI-32) in the optic nerve 24 hr following optic transection at 4X 
magnification show comparable progression of axonal degeneration from the site 
of transection (on the right side of the image). The contralateral nerve was used 
as a negative control. (Wild-type n=4 and Rin-/- n=4). 
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Figure 4.8. Rin loss has no effect on axonal degeneration 7d following optic 
nerve transection. Representative images of the dephosphorylated 
neurofilament (SMI-32) in the optic nerve 7 d following optic transection at 20X 
magnification show comparable progression of axonal degeneration from the site 
of transection. Images are taken at the optic chiasm and indicate that axonal 
degradation has progressed along the entire optic nerve by 7 d. (Wild-type n=4 
and Rin-/- n=4) 
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Discussion 
In the present chapter, our data support a role for Rin in pro-degenerative 
cascades following trauma-induced axonal stretch injury. We demonstrate that 
the loss of Rin blunts axonal degeneration (Figure 4.2) and diminishes trauma-
induced inflammation (Figure 4.4). In looking to identify the molecular cascade 
downstream of Rin that might be involved in axonal degeneration, we identified a 
direct interaction with DLK (Figure 4.6). As DLK has been should to play a 
critical role in Wallerian degeneration, we also examined the effect of Rin loss on 
the degeneration of distal axons following optic nerve transection (Figures 4.7 
and 4.8). While not conclusive, these preliminary transection studies suggest that 
Rin is not required for Wallerian degeneration.	  
A growing body of evidence indicates that axonal degeneration results 
from a complex interplay between proteins promoting axonal survival and 
degeneration, suggesting axonal integrity is a dynamically regulated process that 
can be therapeutically exploited (Gerdts, Summers et al. 2016). Using the power 
of Drosophila genetics to unravel the molecular process(es) underlying Wallerian 
degeneration, DLK was identified as one of the first pro-degenerative proteins, 
whose inhibition delayed acute axonal degeneration (Miller, Press et al. 2009).  
Subsequent studies identified two other MAPKKKs, MEK2 and MEKK4, that are 
also involved in axonal breakdown through activation of JNK (Yang, Wu et al. 
2015). Furthermore, MAPK activation has been demonstrated to increase the 
turnover of SCG10, an axonal survival protein within the axon, to speed 
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degeneration (Shin, Miller et al. 2012). Herein, we have demonstrated an 
interaction between Rin and DLK through co-immunoprecipitation (Figure 4.6) 
and provided strong evidence that Rin loss blunts axonal degeneration following 
a stretch model of traumatic injury (Figure 4.1 and 4.2). These data suggest a 
possible role for Rin upstream of the MAPK pro-degenerative cascade. However, 
more research is needed to support this hypothesis and demonstrate Rin 
dependent activation of JNK and turnover of SCG10.  
It should be noted that the linkage between Rin and the degenerative 
MAPK cascade might not necessarily be direct. Although no Ras GTPase has 
been demonstrated to regulate DLK, Rho family GTPases (Rac and Cdc42) have 
been demonstrated to signal through DLK (Fan, Merritt et al. 1996). Indeed, the 
ability of constitutively active mutations of Rac1 and Cdc42 to signal through 
SAPK pathways is significantly inhibited by expression of catalytically inactive 
DLK (K185A) (Fan, Merritt et al. 1996). This does not negate the possibility of Rin 
upstream of DLK as there are many ways to regulate any signaling pathway. 
Therefore, Rin may still directly activate DLK. It is also possible that Rin could 
indirectly signal through the degenerative MAPK cascades. Rin overexpression 
has been demonstrated to activate Rho family GTPases, including both Rac1 
and Cdc42 (Hoshino and Nakamura 2003); therefore, it is possibly that Rin may 
control DLK upstream of the Rho family of GTPases.  
More recently, Sarm1 has been implicated in axonal breakdown and its 
loss is associated with axonal survival weeks following TBI and sciatic nerve 
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injury (Osterloh, Yang et al. 2012, Gerdts, Summers et al. 2013, Henninger, 
Bouley et al. 2016). Furthermore, its activation is sufficient to induce axonal 
degeneration in the absence of external injury (Gerdts, Summers et al. 2013, 
Gerdts, Brace et al. 2015, Yang, Wu et al. 2015), suggesting it is a central 
regulator of Wallerian degeneration. NMNAT is a critical enzyme for NAD 
biosynthesis from ATP and nicotinamide and has been demonstrated to protect 
against axonal degeneration (Sasaki and Milbrandt 2010, Jayaram, Kusumanchi 
et al. 2011). NMNAT2 is a survival protein that is continually turned over and 
transported to the axon through anterograde transport (Gilley, Orsomando et al. 
2015). It has been demonstrated that the loss of NMNAT2 expression within the 
axon due to inhibition of anterograde transport triggers Sarm1 activation	  (Gilley, 
Orsomando et al. 2015, Sasaki, Nakagawa et al. 2016) which then depletes 
axonal stores of NAD+ leading to a metabolic disaster (Yang, Wu et al. 2015). 
Recently it has been suggested that these two models, MAPK and Sarm1, are 
intertwined in the control of Wallerian degradation following a demonstration that 
MAPK cascades signal upstream of Sarm1 (Walker, Summers et al. 2017). 
Unification of the pro-survival and pro-degenerative responses into a single 
pathway suggests that Rin signaling may lie upstream of Sarm1 and analyzing its 
effect on NMNAT levels and NAD+ depletion following traumatic injury could 
provide a better understanding of the long-term protection seen in Rin null 
animals following optic stretch. If Rin lies upstream of the MAPK/Sarm1 
pathways, then expression of constitutively activated Rin should mediate cell 
death and axonal degeneration, increasing JNK activation, Sarm1 activation, 
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depletion of NMNAT2, and NAD+ depletion. In the absence of Rin these 
pathways should be down regulated, diminishing metabolic catastrophe following 
optic nerve damage. 
Herein we demonstrated that Rin loss was able to lessen degeneration 
associated with axonal stretch induced TAI (Figure 4.2), but had no obvious 
effect following axon transection (Figures 4.7, 4.8). We propose that this may be 
due to inherent differences between the two models of injury. Optic stretch is a 
less severe form of TAI, resulting in disruption of axonal transport. Protein 
accumulation in the axon, if not alleviated, leads to axonal breakage and 
retraction. This process is slow compared to the immediate axotomy caused by 
transection of the optic nerve. Currently the upstream stimuli capable of Rin 
activation following traumatic brain injury are unknown. Therefore, it is feasible 
that Rin would be activated following stretch but not following primary axotomy. 
However, inhibition of stress MAPK cascades has been shown to delay Wallerian 
degeneration for a matter of hours; therefore, it is possible that Rin plays a role in 
Wallerian degeneration that we missed. Future studies should examine 
degeneration at time points closer to the time of injury, as more modest 
protection may not last for 24hrs. Further studies are needed to more thoroughly 
examine Wallerian degeneration in the absence of Rin before any final 
conclusion can be drawn.   
In summary, the data presented in this chapter demonstrates a role for Rin 
in trauma-induced axonal injury, as its loss blunts both axonal degeneration and 
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microglial activation up to 7d following injury. This data is in line with our previous 
finding that Rin loss decreases cell death within the CA-3 region of the 
hippocampus (Figure 3.7), an area suggested to undergo a higher degree of 
stretch following CCI injury (Mao, Elkin et al. 2013). This data suggests the 
intriguing possibility that the neuronal protection afforded by Rin loss identified in 
Chapter 3 may result from decreased axonal degeneration. However, more work 
is needed to determine the mechanism of Rin activation in traumatic axonal injury 
including how the interaction between Rin and DLK may be involved in pro-
degenerative pathway.   
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CHAPTER 5 
 
 A Role for the Rin GTPase in Cytokine Production and Neuroinflammation 
Introduction 
 Neuroinflammation is a major pathological component of secondary injury 
cascades following TBI (Karve, Taylor et al. 2016). Within minutes of trauma, the 
injured brain elicits a robust inflammatory response fundamental to wound repair 
and regeneration (Gurtner, Werner et al. 2008, Woodcock and Morganti-
Kossmann 2013). Resident astrocytes and microglia predominate in the brain’s 
innate response to injury, not only through the secretion of inflammatory factors, 
but also by forming a physical barrier around the site of injury (glial scar), and 
allowing for the phagocytosis of cellular debris and recognition of foreign 
antigens (Morganti-Kossmann, Satgunaseelan et al. 2007, Hernandez-Ontiveros, 
Tajiri et al. 2013, Karve, Taylor et al. 2016). 
Microglia, the resident immune cells of the CNS, constantly survey the 
brain microenvironment (Nimmerjahn, Kirchhoff et al. 2005). Following injury, 
they rapidly respond to damage associated molecular patterns (DAMPs), 
chemoattractants, and various forms of cell debris (Davalos, Grutzendler et al. 
2005, Nimmerjahn, Kirchhoff et al. 2005) through pattern recognition receptors 
on their cell surface	  (Chen and Nunez 2010). Receptor activation leads to the 
secretion of cytokines that can either initiate an inflammatory response (for 
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example, IL-1β and TNF-α) or a wound healing response (for example, IL-10) 
(Morganti-Kossmann, Satgunaseelan et al. 2007, Chen and Nunez 2010).  
Stress activated protein kinases, such as p38, respond to various cellular 
and environmental stimuli, including UV irradiation, hypoxia, oxidative stress, and 
pro-inflammatory cytokines (Tibbles and Woodgett 1999). The p38 MAPK 
cascade has been demonstrated to serve as a crucial component for the 
production of IL-1β and TNF-α and neuronal degeneration in vitro (Bachstetter, 
Xing et al. 2011, Xing, Bachstetter et al. 2011) and in the regulation of microglial 
morphological activation in vivo (Bachstetter, Rowe et al. 2013). Although p38 
stimulation has been extensively studied in stress response, it has also been 
demonstrated to play fundamental roles in development, proliferation, survival, 
and differentiation (Martin-Blanco 2000, Nebreda and Porras 2000). Following 
brain injury, p38 activation is observed within minutes (Mori, Wang et al. 2002). 
Numerous reports have shown that activation of the p38 MAPK cascade is 
associated with neuronal death caused by numerous neurotoxic reagents 
including excessive and unregulated neurotransmitter release (excitotoxicity) 
(Cao, Semenova et al. 2004, Semenova, Maki-Hokkonen et al. 2007, Chaparro-
Huerta, Flores-Soto et al. 2008), nerve injury (Wittmack, Rush et al. 2005), and 
ischemia (Wang, Xu et al. 2002, Guo and Bhat 2007). Because p38 plays an 
essential signaling role in injured neurons and work from our lab has previously 
demonstrated that the Rin GTPase lies upstream of p38 following nerve growth 
factor stimulation (Shi, Han et al. 2005), we were interested in determining if Rin 
loss would alter post-injury inflammation.  
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Results 
Rin loss suppresses the acute pro-inflammatory response following CHI 
To assess the role of Rin loss on inflammatory signaling and cytokine 
production, we used a diffuse closed head injury model (CHI) that generates 
traumatic axonal injury without causing contusion or tissue loss, but still induces 
robust astrocyte and microglial activation (Kelley, Farkas et al. 2006, Kelley, 
Lifshitz et al. 2007, Cao, Thomas et al. 2012). Although CHI induces mild 
leakage of the blood brain barrier, the lack of a necrotic core limits the infiltration 
of circulating immune cells (Kelley, Lifshitz et al. 2007) so that the majority of the 
inflammatory responses observed come from resident glial cell populations within 
the brain.  
Inflammation is central to brain repair following injury. Normally, cytokine 
production increases between 6 and 24 hrs following diffuse head injury, 
contributing to glial activation and debris clearance, then subsequently decreases 
by 7d after injury (Lloyd, Somera-Molina et al. 2008, Bachstetter, Rowe et al. 
2013).  However, inflammation that is excessive or prolonged can result in 
neuronal dysfunction and neurological deficits by contributing to infection, 
edema, or generation of reactive oxygen species (Lloyd, Somera-Molina et al. 
2008). 
We assessed cytokine production acutely (9 hr) following diffuse head 
injury. Wild-type animals displayed significant elevation of the pro-inflammatory 
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cytokines, IL-1β (285% increase compared to sham controls, Figure 5.1A) and 
TNF-α (39% increase compared to sham controls, Figure 5.1C), within the 
neocortex. Levels of the pro-inflammatory cytokine, IL-6 (Figure 5.1B), were also 
elevated following CHI, but did not reach statistical significance. Although Rin-/- 
animals also displayed elevation of IL-1β (91% increase compared to sham-
injured controls, Figure 5.1A), its production was significantly blunted compared 
to wild-type injured mice. Levels of IL-6 (Figure 5.1B) and TNF-α (Figure 5.1C) 
also trended upwards, however were not statistically different from sham-injured 
controls. Although Rin loss did not significantly blunt TNF-α production, there 
was a clear downward trend in Rin-/- injured mice compared to wild-type injured 
mice. Levels of IL-10, an anti-inflammatory cytokine, were also measured acutely 
following injury, and were unchanged in wild-type injured mice compared to 
controls (Figure 5.1D). Rin-/- mice, however, displayed significantly elevated IL-
10 (69% increase compared to sham-injured controls, Figure 5.1D). No 
significant differences were observed between wild-type and Rin-/- sham animals 
at any time point indicating that global Rin loss does not alter baseline cytokine 
production (Figure 5.1). 
By 7 d post-CHI, IL-6 and TNF-α cytokine production in wild-type mice had 
returned to baseline (sham-injured) levels. However, IL-1β production in wild-type 
mice remained elevated at 7 d following CHI (Figure 5.1A-C). Levels of IL-1β 
and TNF-α remained significantly elevated 7 d following CHI in Rin null mice 
(90% and 68% increase, respectively, Figure 5.1A, C) suggesting the possibility 
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of a diminished, but prolonged, inflammatory response in the absence of Rin. 
Both IL-6 and IL-10 production in Rin-/- injured mice were equivalent to sham-
operated controls by 7 d post-CHI (Figure 5.1B, D). Collectively, these data 
suggest a function for Rin in the control of cytokine production in the neocortex 
following diffuse head injury.  
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Figure 5.1 Rin loss alters cytokine production following diffuse brain injury. 
Protein levels of IL-1β (A), IL-6 (B), TNF-α (C), and IL-10 (D) in the neocortex 
were measured by MSD multiplex immunoassay 9hr and 7d following CHI. 
Acutely following injury, Rin loss lead to a blunting of the pro-inflammatory 
cytokine IL-1β and decreased IL-6 and TNF-α although levels did not reach 
significance. Anti-inflammatory cytokine, IL-10, production was enhanced after 
CHI in Rin KO mice. At 7d Rin loss enhanced IL-1β and TNF-α whereas levels of 
IL-10 and IL-6 had returned to baseline. Data are expressed as mean ± SEM; 
n=9-11; One-way ANOVA followed by Turkey-Kramer post hoc test *p<0.05, 
**p<0.01, ***p<0.001. IL-1β was log transformed prior to analysis to adjust for 
normality. 
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Astrocyte activation unchanged by Rin loss 
 Since we determined that Rin loss blunted, but prolonged, acute pro-
inflammatory, IL-1β, cytokine production following CHI (Figure 5.1A) we next 
asked whether glial activation was altered downstream of diffuse TBI. Following 
trauma, astrocytes become activated; this process of astrogliosis is characterized 
by cellular proliferation and hypertrophy (increased expression of glial fibrillary 
acidic protein (GFAP), elongation of cellular processes, and cytoplasmic 
enlargement) (Saatman, Feeko et al. 2006, Bardehle, Kruger et al. 2013, Burda, 
Bernstein et al. 2016). To this end, we performed IHC for GFAP, a marker of 
astrocytes, to analyze changes in astrogliosis in the absence of Rin. At baseline, 
GFAP is expressed at low levels within the mouse cortex as represented in the 
sham control micrographs of Figure 5.2A. At 9 hr post-injury, GFAP expression 
was not significantly increased from sham-injured controls. However, by 7 d 
following injury, both wild-type and Rin null mice displayed an increase in the 
expression of GFAP within the neocortex indicating injury-induced astrocyte 
activation (Figure 5.2A). Quantification of GFAP staining in the neocortex 
showed no discernable differences in astrocyte activation between sham and 
injured animals 9 hr post-CHI, regardless of genotype (Figure 5.2B). However, 
by 7 d following injury, GFAP was robustly increased in both wild-type (443% 
increase compared to sham controls) and Rin-/- mice (155% increase compared 
to sham controls). Although there was a clear trend towards blunted astrogliosis 
in Rin-/- mice, no significant difference was observed between wild-type CHI and 
Rin-/- CHI cohorts (p=0.578, one-way ANOVA followed by Turkey-Kramer post-
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hoc test) (Figure 5.2B).  These data suggest that astrogliosis remains intact 
following diffuse head injury in the absence of Rin expression. 
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Figure 5.2. Astrogliosis in Rin null mice remains intact following diffuse 
head injury. A. Representative images of GFAP immuno-staining 9 hr and 7 d 
post-CHI indicate that astrocyte activation occurs 7 d following injury regardless 
of genotype. B. Quantification of GFAP staining shows a significant increase in 
astrogliosis in wild-type mice 7 d post-injury and no significant difference was 
observed between WT CHI and Rin KO CHI cohorts suggesting Rin loss does 
not affect injury-induced astrocyte activation. Data are expressed as mean ± 
SEM as a percent of wild-type sham-injured mice; n=9-11; one-way ANOVA 
followed by Turkey-Kramer post hoc test **p<0.01. 
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Microglial activation following injury unaltered by Rin loss 
 To determine whether changes in mircoglia activation could account for 
the diminishment in pro-inflammatory cytokine production observed in Rin null 
mice, we performed IHC for CD-45. CD-45 is a transmembrane protein tyrosine 
phosphatase expressed at low levels on resident microglia, however, its 
expression has been shown to increase acutely following traumatic injury 
(Sedgwick, Schwender et al. 1991, Bachstetter, Rowe et al. 2013). Due to high 
background, CD-45 IHC staining was scored on a 7-point scale for CD-45 
immuno-positive cells within the cortex, hippocampus, and corpus callosum by 
an experimenter blinded to genotype and treatment.  Both wild-type and Rin-/- 
mice displayed increased staining of CD-45 expression 9 hr following CHI 
(Figure 5.3A, B). CD-45 is also expressed on leukocytes, or circulating blood 
cells, that can infiltrate following trauma due to breakdown of the blood brain 
barrier. These cells can be morphologically distinguished from microglia due to 
their lack of arborization. Quantification of infiltrating leukocytes showed no 
differences between cohorts (Figure 5.3C). Together these data suggest that Rin 
loss does not alter microglial activation following diffuse head injury. 
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Figure 5.3. Rin null mice display normal microglial activation following CHI 
A. Representative images of CD-45 immune-staining 9hr indicate that microglial 
activation is intact in Rin null mice. B. Quantification of CD45 staining on a 7-
point scale displays increased microgliosis in wild-type mice 9hr post-injury and 
no significant difference was observed between wild-type CHI and RinKO CHI 
cohorts suggesting Rin loss does not affect injury-induced microglial activation. 
Data are expressed as mean ± SEM; one-way ANOVA followed by Turkey-
Kramer post hoc test; n=9-11.  
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Axonal protection afforded by Rin loss 
Because the changes observed in cytokine profiles following injury could 
not be explained by changes in glial activation, we evaluated injury at the level of 
the neuron. Diffuse models of TBI do not result in high levels of cell death and 
tissue loss; however, does lead to traumatic axonal injury throughout the 
mediodorsal neocortex (Kelley, Farkas et al. 2006, Kelley, Lifshitz et al. 2007, 
Cao, Thomas et al. 2012). Beta amyloid precursor protein (β−APP) is a common 
marker for traumatic axonal injury following trauma as it accumulates in axonal 
bulbs or swellings within hours following injury, due to disruption of axonal 
transport (Roberts, Gentleman et al. 1994, Suehiro and Povlishock 2001, Smith, 
Uryu et al. 2003).  
To evaluate whether Rin loss diminishes axonal injury, we performed IHC 
for β−APP 9 hr following CHI. Both wild-type and Rin-/- sham-injured controls 
displayed minimal accumulation of β−APP in axonal swellings (wild-type, 0.07 
punta/mm2; Rin-/-, 0.41 punta/mm2, Figure 5.4). As expected, there was an 
accumulation of aberrant β−APP localization to axonal swellings within the 
neocortex of wild-type mice following injury (3.78 punta/mm2). However, Rin loss 
resulted in significantly diminished axonal β−APP staining following CHI (0.90 
punta/mm2, Figure 5.4). These data suggest axonal protection following CHI in 
the absence of Rin. 
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Figure 5.4. Acute axonal injury blunted following CHI in the absence of Rin. 
A. Images of neocortical beta-amyloid precursor protein (β−APP) 9 hr following 
closed head injury in wild-type and Rin-/- animals. Arrows indicate examples of 
positive β−APP staining. Images were taken at the injury epicenter where β−APP 
accumulation was highest. B. Quantification of β−APP in the neocortex following 
injury indicates that Rin loss diminishes axonal swellings suggesting axonal 
protection. Data are expressed as mean ± SEM; n=9-11; one-way ANOVA 
followed by Turkey-Kramer post hoc test **p<0.01. 
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Analysis of the impact of Rin deficiency on post-CHI cognitive performance 
 Decreased pro-inflammatory cytokine production and axonal injury have 
been associated with improved behavioral outcomes in experimental models of 
TBI (Bachstetter, Rowe et al. 2013, Bachstetter, Webster et al. 2015). To 
determine whether Rin loss could improve behavioral outcomes following CHI, 
we performed radial arm water maze (RAWM), a spatial learning task (Alamed, 
Wilcock et al. 2006) with observable deficits up to 2 weeks following CHI  
(Webster, Van Eldik et al. 2015).  Overall, Rin loss had no significant effect on 
RAWM performance (Figure 5.5A, two-way repeated measure ANOVA); 
however, when teased apart, clear trends were noted. While wild-type mice 
displayed significant spatial learning deficits following CHI (Figure 5.5B), Rin-/- 
sham and Rin-/- injured mice performed equivalently (Figure 5.5C). Injured wild-
type and Rin-/- cohorts were found to perform equivalently (Figure 5.5D). 
Importantly, Rin-/- mice tended to have more errors than wild-type mice in the 
absence of injury (Figure 5.5E), suggesting that Rin loss results in a baseline 
defect in this assay (although this trend does not reach statistical significance). It 
is promising that Rin-/- sham and Rin-/- injured mice performed similarly in the 
task. However, the intrinsic performance differences at baseline between wild-
type and Rin-/- mice, combined with the modest increase in RAWM errors 
following CHI (~1 additional error following injury), do not permit definitive 
conclusions regarding cognitive sparing at this time. 
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Figure 5.5. Behavioral effects of Rin loss on CHI behavioral outcomes. 
Radial arm water maze assessed 14 d following CHI revealed (A) no significant 
alterations in performance based on genotype (B) a diminishment in cognitive 
performance of WT mice (C) no alteration between Rin-/- sham and Rin-/- CHI 
(D) no alteration between WT CHI and Rin-/- CHI (E) a clear trend towards 
decreased cognitive performance in Rin-/- sham animals. All data are expressed 
as mean ± SEM; n=9-11. Panel A was analyzed via a two-way repeated 
measures ANOVA whereas panels B-E were analyzed by one-way repeated 
measures ANOVAs. 
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Discussion 
 In the present study, we have identified a potential role for Rin GTPase in 
the initiation of neuroinflammation following diffuse brain injury. We demonstrated 
that Rin loss blunts acute production of pro-inflammatory IL-1β at 9 hr post-CHI, 
and, although it does not reach significance, a similar trend is observed in TNF-α 
production (Figure 5.1 A, C). Moreover, the absence of Rin increased the levels 
of anti-inflammatory IL-10 acutely following injury (Figure 5.1D). Interestingly, 
although acute IL-1β production was blunted in Rin null injured mice, there 
appeared to be prolonged pro-inflammatory response, as the levels of IL-1β had 
not returned to baseline by 7 d post-CHI (Figure 5.1A). Although glial 
populations respond to damage through secretion of cytokines (Morganti-
Kossmann, Satgunaseelan et al. 2007, Chen and Nunez 2010) we were unable 
to discern any considerable difference in the degree of astrocyte or microglial 
activation between wild-type and Rin-/- injured animals. However, we did find that 
Rin loss resulted in significantly diminished axonal accumulation of β-APP 
staining following CHI, suggesting that axonal injury was reduced, consistent with 
previous data following optic nerve injury (Chapter 4). Together these data 
suggest that Rin contributes to the regulation of post-CHI cytokine production, 
and axonal injury. However, due to the baseline differences in behavior between 
wild-type and Rin-/- sham-injured mice, it is currently unclear if this has any effect 
on behavioral outcomes following diffuse head injury. 
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 Although microglia are a major source of injury-related cytokine release 
(Hanisch 2002), other cell types, including astrocytes, have also been 
demonstrated to produce inflammatory mediators following stimulation (Kan, van 
der Hel et al. 2012, Choi, Lee et al. 2014).  Neurons, although generally thought 
of as a cytokine target, express Toll-like receptors and can both sense and 
mount inflammatory responses (Lafon, Megret et al. 2006) including the 
production of IL-1β, IL-10, TNF-α, in response to diverse stimuli (Freidin, Bennett 
et al. 1992, Yamamoto, Yamashita et al. 2011, Lim, Lu et al. 2016).  In our 
current study, Rin deficiency altered cytokine production; however, preliminary 
findings found no evidence that glial activation was altered. These data would 
suggest that cytokine release from these populations was equivalent in wild-type 
and Rin null mice. These results are in agreement with lack of endogenous 
expression of Rin in glial populations (Cahoy, Emery et al. 2008), however, 
isolation and stimulation of astrocyte and microglial cultures would be required to 
conclusively confirm that Rin function does not play a role in this cell types. 
Instead, differences in axonal injury following trauma may indicate that the 
altered cytokine profiles may result from decreased neuronal cytokine release. 
Given that these studies were conducted in a whole-body knock-out mouse, it is 
not possible to test this hypothesis in vivo. Regardless, the notion of cytokine 
differences post-injury being neuronally based are in line with previous studies 
indicating that Rin expression is limited to neurons and warrants further 
investigation (Shao, Kadono-Okuda et al. 1999, Lafon, Megret et al. 2006, 
Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015). While it is unlikely, due 
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to the nature of the injury, that the differences in cytokine profiles is the result of 
infiltrating immune cells of the PNS, we cannot completely rule out this 
possibility. 
 Previous studies from the lab have demonstrated that Rin lies upstream of 
p38 stress-kinase signaling (Shi, Han et al. 2005), a pathway that has been 
demonstrated to be upregulated following brain and ischemic injuries (Sugino, 
Nozaki et al. 2000, Nozaki, Nishimura et al. 2001, Mori, Wang et al. 2002, 
Donninger, Calvisi et al. 2015). Furthermore, microglial specific deletion of p38α 
leads to cognitive behavioral improvement following diffuse head injury 
(Bachstetter, Rowe et al. 2013). To date, our post-CHI behavioral data is 
inconclusive regarding the important issue of whether Rin loss provides spatial 
learning protection following diffuse brain injury, as our results indicate that there 
is a baseline behavioral deficit in Rin null animals that could be due to long-term 
Rin deletion or a difference in genetic background (Rin-/- mice were generated by 
pronuclear microinjection of 129SvEv ES cells into C57BL6/N blastocysts). 
Although we did not see a significant behavioral sparing, it is promising that Rin-/- 
sham and Rin-/- CHI mice displayed no behavioral differences using RAWM 
analysis, and it remains to be determined whether Rin loss provides functional 
sparing. Plans are underway to resolve this issue using two approaches. First, 
we have just completed ten generations of backcrossing the Rin null genetic 
deletion line into C57BL6 mice to generate a defined genetic background. In 
addition, we are engineering a Rin conditional knock-out mouse line that would 
permit cell-type specific Rin deletion. 
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 In summary, the data in this chapter suggests a role for Rin in the 
regulation of cytokine production following CHI. We postulate that the differences 
observed are the result of neuronal specific Rin actions, not only because all 
available evidence indicates that Rin is expressed solely in neurons, but also 
because of the significant reduction in axonal injury found in Rin-/- mice following 
diffuse head injury. However, more research is needed to define the role for Rin 
in the regulation of neuronal-specific inflammatory signaling. 
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CHAPTER SIX 
 
Discussion 
 
The studies in this dissertation were performed with the goal of identifying 
the physiological function of neuronally expressed Rin GTPase. To address this 
question, we used a mouse line bearing a genetic deletion of the endogenous 
Rin (RIT2) gene generated through gene trap insertion (Figure 3.1). Previous 
research in the lab indicated that Rin signaled downstream of growth factor 
stimulation (Shi and Andres 2005) and demonstrated that the closely related 
protein Rit functioned in post-trauma induction of neurogenesis (Cai, Carlson et 
al. 2012). Therefore, we implemented traumatic injury models to test the ability of 
Rin to improve neuronal survival and enhance cognitive outcomes following CNS 
injury. Using this novel knockout model, we have begun to characterize the 
genetic deletion of Rin and implicate a functional role for Rin in three major 
components of CNS trauma: neuronal death, axonal degeneration, and 
neuroinflammation. In doing so, we have not only demonstrated functionally 
divergent roles for Rin and Rit GTPases, but also established Rin deficiency as 
neuroprotective- clearly identifing roles for Rin in the regulation of neuronal cell 
loss and axonal degeneration following brain injury. The data presented within 
this dissertation suggests that Rin may be a viable therapeutic target following 
TBI. 
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Rin and Rit GTPase display functional specificity 
 Due to conservation of effector domain sequences and downstream 
effectors, it was believed that Rin would function similarly to the closely related 
GTPase, Rit, to regulate proliferation and survival (Reuther and Der 2000). 
However, early findings within our laboratory suggested that the two GTPases 
acted independently in vitro, with Rin expression resulting in decreased cell 
viability in cell culture models (data not shown). To further study Rit and Rin 
regulation, we moved our studies to in vivo mouse models. Studies conducted by 
Dr. Weiakng Cai, a previous graduate student in the lab, found that Rit deficiency 
increased neurodegeneration within the hippocampus following CCI (Cai, 
Carlson et al. 2012). Shown here, Rin loss revealed a strikingly distinct role 
following CCI injury model, increasing neuronal survival (Figure 3.3). Further, 
Rin loss had no effect on post-traumatic neurogenesis (Figures 3.4, 3.5, 3.6), 
although Rit has been demonstrated to be a key contributor in neurogenesis and 
proliferation of neural stem cells (Cai, Carlson et al. 2012, Mir, Cai et al. 2017, 
Mir, Cai et al. 2017). Together, these data support distinct physiological functions 
for these two closely related Ras family members.  
Although functional specificity had not been demonstrated in vivo prior to 
this work, there were several lines of evidence that indicated the divergence 
properties of Rin and Rit GTPase. First, unlike other members of the Ras family, 
Rin is unable to transform NIH-3T3 cells (Rusyn, Reynolds et al. 2000). Second, 
endogenous Rin expression was unable to complement Rit loss (Cai, Rudolph et 
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al. 2011). And finally, Rin and Rit have been associated with distinct pathological 
outcomes. Genetic GWAS studies have linked the loss of heterozygosity, or 
chromosomal events that result in RIT2 gene loss or silencing, to predominantly 
neuropsychological disorders, including autism, schizophrenia and Parkinson’s 
disease (Glessner, Reilly et al. 2010, Pankratz, Beecham et al. 2012, 
Emamalizadeh, Movafagh et al. 2014, Liu, Guo et al. 2015, Nie, Feng et al. 2015, 
Wang, Gong et al. 2015, Zhang, Niu et al. 2015, Liu, Shimada et al. 2016, Foo, 
Tan et al. 2017, Hamedani, Gharesouran et al. 2017, Li, Zhang et al. 2017). In 
contrast, mutations that lead to the activation of Rit has been connected to both 
the developmental disorder, Noonan Syndrome, in the case of germinal mutation, 
and lung cancer and leukemia if the mutation is somatic (Berger, Imielinski et al. 
2014, Chen, Yin et al. 2014, Xu, Sun et al. 2015, Cave, Caye et al. 2016, 
Koenighofer, Hung et al. 2016). Together these lines of evidence further 
suggested that Rin and Rit, despite their biochemical similarities, were 
functionally unique. 
An interesting question that remains to be answered is how the functional 
specificity between Rin and Rit GTPase is achieved. A similar conundrum was 
faced in regards to the three extremely well conserved founding members of the 
Ras family (H-Ras, K-Ras and N-Ras), which share approximately 80% primary 
sequence identity.  Several broad themes underlying their functional separation 
have been described (Castellano and Santos 2011). These include 1) differential 
patterns of tissue and developmental expression, 2)	  distinct specificities to 
different GAPs or GEFs, and 3) different intracellular pathways of processing and 
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membrane localization (Castellano and Santos 2011). It is conceivable that these 
characteristics also apply to the Rit subfamily and are discussed below.  
Expression differences between Rin and Rit have already been 
demonstrated broadly across tissues and development. Rit is expressed 
ubiquitously throughout the organism and throughout development, whereas Rin 
expression is limited to the CNS and is first detected late during mouse 
embryonic development (first appearing around e15 in the mouse brain) (Lee, 
Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et al. 2008, Sharma, 
Schmitt et al. 2015). The literature indicates that both Rin and Rit are expressed 
within neurons (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999), and our 
lab has demonstrated that the two proteins are activated by similar stimuli (Shi, 
Cai et al. 2013). So how is it determined which signal dominates? In K-Ras 
functionality can be determined through expression differences following 
stimulation. For example, it has been demonstrated that the levels of K-Ras4B 
are higher under physiological conditions, whereas K-Ras4A expression is 
induced during differentiation of pluripotent embryonic stem cells	  (Pells, Divjak et 
al. 1997). However, these forms of K-Ras are splice variants (Barbacid 1987) 
and alternatively spliced isoforms of Rit and Rin have not been described. It is 
more likely that differences in functionality are derived through distinct specificity 
of GEF and GAP proteins or subcellular localization.  
GEFs and GAPs regulate the activation states of small GTPases, 
therefore, controlling their intracellular signaling pathways and cellular roles	  (Bos, 
	   132	  
Rehmann et al. 2007). GEFs are direct activators of the Ras superfamily of 
GTPases; thereby, each stimulus that results in Ras activation requires GEF 
regulation	  (Quilliam, Khosravi-Far et al. 1995, Bernards and Settleman 2007). 
Furthermore, these proteins display substrate specificity in activating specific 
families of GTPases. For example, son of sevenless (SOS) preferentially 
activates Ras and Rac family members, but not Rap proteins	  (Nimnual and Bar-
Sagi 2002). Ras GAP proteins are required to stimulate GTP hydrolysis, ending 
signaling on a physiological time scale (Bernards and Settleman 2005). To date, 
few studies have accessed Rit subfamily regulatory proteins. However, 
association between Rin and SOS has been shown through co-
immunoprecipitation (Hoshino and Nakamura 2002). It has also been 
demonstrated that expression of the Ras specific GAP proteins, SynGAP and 
GAP1, can significantly decrease the concentration of GTP bound Rin; however, 
the Rap specific GAP, Rap1-GAP had no effect (Hoshino and Nakamura 2002). 
Similar to Rin, GTP bound Rit levels were elevated following expression of the 
Ras specific GEFs SOS and GRF (Spencer, Shao et al. 2002). With the data 
currently available it is impossible to determine the degree of regulatory overlap 
between Rin and Rit. However, given their apparent functional distinctions, this is 
a critical issue to generating greater understanding Rin and Rit signaling that 
requires further study. 
The subcellular distribution of small GTPases provides additional control 
of activation and function by allowing for association with and activation of local 
effectors in distinct cellular compartments (Castellano and Santos 2011). In this 
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way, despite identical effector and regulatory domains, Ras isoforms display 
functional specificity	  (Chiu, Bivona et al. 2002). For example, plasma membrane 
associated K-Ras enables transformation, whereas mitochondrial localized K-
Ras induces apoptosis (Bivona, Quatela et al. 2006). Unlike other Ras family 
members that undergo post-translational lipidation to ensure membrane tethering 
(Lowy and Willumsen 1993, Reuther and Der 2000), the Rit subfamily lacks 
canonical lipidation sequences (Shi, Cai et al. 2013). Indeed, currently there is no 
data available to indicate that they undergo lipid modification of any sort. Instead 
Rit subfamily proteins are localized through interactions between their extended 
polybasic C-terminus and charged PI(3,4,5)P3 and PI(4,5)P2 lipids on the plasma 
membrane (Heo, Inoue et al. 2006). To date the subcellular localization of Rin 
and Rit have not been extensively characterized. However, immunostaining for 
Rit in hippocampal neurons shows that Rit is localized not only in the cell body, 
but also the dendritic arbors and axonal shaft (Lein, Guo et al. 2007). Although 
subcellular localization has not been characterized for Rin, herein, we describe a 
novel role for Rin in the regulation of trauma-induced cell death (Figure 3.3, 3.7) 
and axonal injury (Chapter 4 and Figure 5.4), suggesting that Rin signaling 
affects processes in both the cell body and axon. Further characterization of the 
subcellular localization could provide valuable insight into the function and 
regulation of the Rit subfamily of GTPases. 
Does Rin signaling contribute to neuronal death? 
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 The studies presented in this dissertation indicate that Rin loss is 
neuroprotective, leading to the hypothesis that Rin signaling may contribute to 
neuronal loss following trauma.  If this hypothesis holds, expression of a 
constitutively active Rin mutation (RinQ78L) would diminish cell viability or initiate 
cell death in the absence of additional stimulation. Because Rin expression is 
limited to neurons, the best in vitro model system for these experiments would be 
primary neuronal cultures to ensure that Rin specific effectors are endogenously 
expressed. Furthermore, it might be important to use long-term neuronal 
cultures, to ensure they mature, as Rin loss does not appear to impact immature 
neuron survival in the hippocampus following contusive injury (Figure 3.4). Given 
our current data, it would be interesting to examine Rin expression in immature 
neurons and progenitor cell populations within the hippocampus. For the simplest 
explanation of why Rin loss has no apparent effect on these populations 
following trauma (Figures 3.4, 3.5, 3.6) is because Rin protein is not expressed 
in these early developmental cell types. Because Rin is not expressed at early 
developmental time points	  (Lee, Della et al. 1996), this remains a conceivable 
hypothesis. 
Although Rin is expressed in both cortical and hippocampal neuronal 
populations (Cahoy, Emery et al. 2008), our data suggest that Rin loss 
selectively protects hippocampal (Figure 3.3, 3.7), but not cortical neurons 
(Figure 3.2) following focal brain injury. Transferring studies into primary neurons 
would allow determination of whether selective protection is an effect of the 
hippocampal neuronal population itself or possibly due to differences in the 
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nature of stimuli needed to activate Rin (assuming that Rin activation initiates cell 
loss). Comparison of neuronal death and dendrite degeneration in cortical and 
hippocampal neurons generated from wild-type and Rin-/- mice would provide 
valuable insight in to the protective nature of Rin loss following stimulation with 
various experimental models of secondary injury. Neurons could be treated with 
L-glutamate to mimic excitotoxicity (Choi, Maulucci-Gedde et al. 1987), sodium 
nitroprusside, a nitric oxide donor, an experimental model for reactive oxygen 
species	  (Dawson, Dawson et al. 1993), and oxygen-glucose deprivation to 
induce hypoxia ischemia (Kaku, Goldberg et al. 1991). If Rin loss leads to 
selective protection of hippocampal neurons, then wild-type and Rin-/- cortical 
neurons should display the same degree of cell loss and viability while Rin-/- 
hippocampal neurons would display increased viability compared to wild-type 
hippocampal neurons. However, if the differences observed in the hippocampus 
and cortex following CCI were due to the type of stimulus, then we would expect 
differential protection in the two populations based on the experimental injury 
model.  
The role of Rin in axonal degeneration 
We have demonstrated in two separate injury models that Rin loss 
decreases axonal pathology. Following optic nerve stretch, axonal damage was 
equivalent acutely following injury (Figure 4.1); however, Rin loss significantly 
blunted the progression of degeneration 7 d following stretch injury (Figure 4.2). 
Furthermore, Rin loss was shown to diminish axonal damage in the cortex 
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acutely following diffuse closed head injury (Figure 5.4). Although these injury 
paradigms cannot be directly compared, axonal protection in both models, 
strongly implicates Rin signaling in the progression of axonal degeneration. 
Therefore, it will be interesting to assess the dependence of Rin signaling in the 
activation of known degenerative pathways. 
 Rin was shown to associate with DLK (Figure 4.3), a known regulator of 
axonal degeneration and cell death (Tedeschi and Bradke 2013). Levels of DLK 
have been determined to increase following injuries to the optic nerve and dorsal 
root ganglia (Watkins, Wang et al. 2013, Welsbie, Yang et al. 2013). Although 
DLK has been shown to lie upstream of both p38 and JNK MAPKs, the activation 
of JNK has been demonstrated as necessary to commit axons to a degenerative 
fate following injury, as its pharmacological inhibition is sufficient to blunt axonal 
fragmentation (Miller, Press et al. 2009). Furthermore, trauma-induced 
heightened DLK expression has been demonstrated to lead to subsequent 
increased phosphorylation and activation of JNK and c-Jun (Chen, Rzhetskaya et 
al. 2008, Ghosh, Wang et al. 2011, Watkins, Wang et al. 2013, Welsbie, Yang et 
al. 2013) (Figure 6.1). These studies from the literature, along with the DLK-Rin 
interaction, and the ability of Rin loss decrease degeneration provoked the 
hypothesis that Rin signals upstream of the DLK signaling cascades. If the 
hypothesis holds, Rin activation should increase the ability of DLK to activate 
JNK and c-Jun, as indicated by increased phosphorylation, and its loss diminish 
these effects. Strikingly, preliminary data generated by Binoy Joseph in the 
Saatman laboratory suggests that Rin loss blunts activation of c-Jun within the 
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retinal ganglion cells following optic stretch injury (data not shown). Further 
studies are needed to analyze the effects of Rin loss on JNK activation acutely 
following optic stretch; however, these data provide strong initial support of Rin 
regulating axonal degeneration upstream of the JNK MAPK cascade.  
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Figure 6.1. Does the trauma-induced DLK-JNK MAPK cascade include Rin 
GTPase activation? Axonal trauma induces activation of DLK. Once activated, 
DLK signals to JNK through MKK4/7. JNK has many substrates in the cell 
including c-Jun and SCG10. Activation of the transcription factor c-Jun has been 
associated with axonal degradation and cell death. JNK can also directly 
phosphorylate axonal SCG10 targeting it for degradation; loss of SCG10 
precedes axonal degradation. The ability of Rin to interact with DLK, diminish c-
Jun activation following stretch injury, and blunt axonal degradation suggests that 
Rin may regulate the DLK-JNK cascade following trauma. 
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Because Rin loss decreases activation of the JNK substrate, c-Jun, it 
would be interesting to look at other JNK substrates associated with axonal 
degeneration. SCG10 was identified as an important JNK substrate within the 
axon and its levels have been correlated with axonal fragmentation (Shin, Miller 
et al. 2012). Phosphorylation of SCG10 by JNK targets the protein for 
degradation (Figure 6.1). In a healthy neuron, SCG10 is rapidly replaced in the 
axon through anterograde transport; however, following trauma, transport is 
disrupted and SCG10 expression in the axon is lost (Shin, Miller et al. 2012). 
Diminished levels of axonal SCG10 have been correlated with axonal 
fragmentation of cultured neurons of both the PNS and CNS and, furthermore, 
silencing of SCG10 through short hairpin RNA was demonstrated to increase the 
rate of axonal fragmentation (Shin, Miller et al. 2012). Herein, we observed 
diminished axonal pathology following both optic nerve stretch (Figure 4.2) and 
diffuse head injury (Figure 5.4) in Rin null mice. Blunted axonal degradation 
would suggest lessened neurofilament fragmentation in which case, levels of 
SCG10 in the axon would be maintained. Rin loss could decrease JNK 
activation, thereby lessening SCG10 phosphorylation and turnover; either 
scenario would lead to maintained axonal SCG10 concentrations. Although 
further investigation is needed, the maintenance of axonal SCG10 concentrations 
could be another mechanism through which Rin loss blunts axonal pathology 
following axonal injury. 
A more in-depth analysis of Rin in Wallerian degeneration 
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The literature indicates that the absence of DLK protects distal axons from 
Wallerian degeneration (Miller, Press et al. 2009, Yang, Wu et al. 2015), which 
led us to examine the breakdown of distal axons following optic nerve transection 
in Rin null mice. Although preliminary, our initial studies do not suggest a role for 
Rin in Wallerian degeneration as the extent of axonal degeneration showed no 
discernable difference at 24 hr (Figure 4.7) or 7d (Figure 4.8) following 
transection. However, a more extensive analysis of more acute time points 
following injury is needed to confirm that Rin loss has no effect on Wallerian 
degeneration. Given the degree of axonal protection out to 7 d following optic 
nerve stretch, we decided to analyze Wallerian degeneration at the same 
endpoints hypothesizing that loss would be equally protective in both optic nerve 
stretch and transection. However, the pathway in which Rin signals through 
would ultimately determine the timeframe of axonal protection. For example, DLK 
deletion only delays axonal clearance for hours in mouse models and a couple 
days in Drosophila (Miller, Press et al. 2009). Simultaneous silencing of the three 
known JNK MAPKKK proteins (DLK, MKK2, and MEKK4) upstream of axonal 
degeneration only effectively diminished distal axon fragmentation for 6 d 
following a milder optic crush injury (Yang, Wu et al. 2015). If Rin loss results in 
delayed axonal degeneration at a shorter time period, for instance hours 
following transection as would be expected by inhibition of DLK, we could have 
missed the effect of Rin deficiency on Wallerian degeneration in our preliminary 
optic transection studies. 
	   141	  
It is also possible that the methods we used to analyze Wallerian 
degeneration did not give a clear depiction of axonal breakdown. Our current 
Wallerian data was generated through immunostaining of non-phosphorylated 
neurofilament (SMI-32) along the optic nerve following transection; however, this 
method has several limitations. Immunostaining did not allow us to track 
degeneration along a single severed axon, therefore we were unable to 
determine the percentage of axons undergoing Wallerian degeneration at a 
select time point and the percentage of axons that were spared. A more 
appropriate model would entail the use of Thy1-YFP mice, which express yellow 
fluorescent protein (YFP) at high levels within motor and sensory neurons 
including those of the retinal ganglion cell layer (Beirowski, Berek et al. 2004).  In 
this model, YFP expression is randomly distributed in approximately 3% of these 
neuronal populations, resulting in sparse YPF labeling throughout the cell bodies 
and axons of both the central and peripheral nervous systems (Beirowski, Berek 
et al. 2004). The restricted axonal labeling in Thy1-YFP mice permits quantitative 
and qualitative analysis of Wallerian degeneration because axonal collapse of a 
single cell can be visualized as fragmentation of the YPF labeled axons 
(Beirowski, Berek et al. 2004). Crossing Thy-1 YFP mice with our Rin knockout 
line would allow for a more thorough examination of the effects of Rin loss on 
axonal breakdown following optic transection. Generation of Thy1-YFP mice in 
our Rin-/- background have been generated in the lab (Figure 6.2) and will 
provide a new perspective to analyze axonal breakdown. 
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Figure 6.2. Thy-1 YFP mice will allow for tracing of axonal degeneration 
along a single axon. The neurons of Thy-1 YFP mice contain sparse labeling of 
YFP in neuronal cell bodies and axons. Axonal degeneration can thereby be 
observed and quantified along a single axon or population of axons. 
Representative confocal images of wild-type Thy1-YFP mouse brain hemisphere 
(2X), optic nerve whole mount (2X), CA1 (20X), and dentate gyrus (20X). 
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The combination of sparse labeling and more acute time intervals will give 
a more accurate depiction of the role of Rin in Wallerian degeneration. A milder 
optic crush injury may also be considered in order to slow axonal clearance and 
prolong the window that protection can be observed. However, it is also possible 
that Rin loss regulates neuronal cell death through DLK signaling, yet has no 
effect on Wallerian degeneration. 
Could Rin loss enhance axonal regeneration? 
Herein, we did not investigate the possibility that Rin loss enhances 
axonal regeneration following injury, although this would provide an alternative 
explanation to the observed decreases in SMI-32 (Figure 4.2) and APP (Figure 
5.4) immunostaining following stretch and CHI injury. The optic stretch model 
does not lend itself to regeneration studies due to the diffuse nature of the injury 
throughout the optic nerve. Previous literature, however, has demonstrated that 
the mild head injury (CHI) model utilized in Chapter 5 causes traumatic axonal 
injury that does not progress to cell death, instead axons show signs of 
reorganization and repair within a week of injury (Singleton, Zhu et al. 2002, 
Greer, McGinn et al. 2011, Greer, Povlishock et al. 2012). Although, electron 
microscopy could be used to determine the extent of axonal reorganization 
following CHI, it is not ideal due to the diffuse nature of the injury. Indeed, the 
question would be best examined using optic nerve crush (Watkins, Wang et al. 
2013) to provide a distinct point of injury and quantification of axonal sprouting 
beyond the injury site. 
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Rin expression in pheochromocytoma cells has previously been 
demonstrated to activate members of the Rho family of GTPases including 
RhoA, Cdc42, and Rac (Hoshino and Nakamura 2003) suggesting Rin may be 
capable of modulating cytoskeletal dynamics upstream of Rho family GTPases in 
neurons (Jaffe and Hall 2005). The RhoA/Rho kinase (ROCK) pathway is 
involved in several CNS processes including both physiological responses 
(dendrite development and axon extension) and pathological outcomes in CNS 
injury, stroke, neurodegenerative disease (Fujita and Yamashita 2014). Following 
injury activation of the RhoA/ROCK pathway has been associated with blunted 
regenerative responses. Indeed, inhibition of RhoA has been demonstrated to 
increase nerve regeneration following optic injury (Lehmann, Fournier et al. 1999, 
Fischer, Petkova et al. 2004, Bertrand, Winton et al. 2005) (Figure 6.3). The 
regenerative response associated with RhoA inhibition is believed to be 
dependent on blunting the activation of ROCK, as its inhibition also leads to 
improved regenerative responses in the CNS following trauma (Lingor, Teusch et 
al. 2007, Lingor, Tonges et al. 2008). If Rin lies upstream of RhoA, then it is 
possible that genetic deletion of Rin would also initiate improved nerve 
regeneration following optic tract injuries though reduced RhoA signaling, 
providing a novel molecular mechanism to explore the regenerative response in 
Rin null animals.  
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Figure 6.3. Does Rin activate RhoA following traumatic injury? Signaling 
through RhoA/ROCK has been demonstrated to inhibit axonal regeneration 
following injury. If Rin is capable of activating RhoA, then Rin deletion should 
have similar affects as RhoA or ROCK inhibition and increase axonal 
regeneration. 
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Role for Rin in inflammatory responses 
To assess the role of Rin in post-traumatic neuroinflammation, we utilized 
a mild concussive injury that leads to a robust inflammatory response in the 
absence of cell death (Kelley, Farkas et al. 2006, Kelley, Lifshitz et al. 2007, Cao, 
Thomas et al. 2012). Despite reports of Rin expression being limited to neuronal 
populations (Lee, Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et 
al. 2008, Sharma, Schmitt et al. 2015) we demonstrated that Rin null animals 
displayed blunted pro-inflammatory and enhanced anti-inflammatory cytokine 
production acutely following injury (Figure 5.1). This result is interesting given 
that cytokine production is prominently carried out by glial populations 
(Hernandez-Ontiveros, Tajiri et al. 2013, Karve, Taylor et al. 2016). However, in 
line with neuronal expression of Rin, Rin-/- mice displayed no significant reduction 
of astrogliosis or microgliosis following CHI (Figure 5.2, 5.3).  
Although neurons are often thought to respond to cytokine signaling, 
literature suggests that they can also produce cytokines in response to 
stimulation (Freidin, Bennett et al. 1992, Yamamoto, Yamashita et al. 2011, Lim, 
Lu et al. 2016). Because our previous work indicates decreased neuronal loss in 
Rin null animals (Chapter 3), we are lead to believe that the changes of cytokine 
profiles may result from diminished neuronal damage following injury. In order to 
confirm that changes in cytokine production are the result of neuronal 
populations we would need to culture primary neurons and measure cytokine 
levels following stimulation with neurotoxic agents. Stimulation of in vitro primary 
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neuronal cultures would allow us to monitor the effects of Rin loss without having 
to take into consideration other CNS cell populations. If Rin signals upstream of 
cytokine production in neurons, we should observe blunted production of IL-1β 
and TNF-α following with L-glutamate, sodium nitroprusside, and oxygen-glucose 
deprivation. 
To date, Rin expression has not been identified outside of the CNS. 
However, a more thorough examination of peripheral immune cells is needed to 
rule out the possibility of Rin expression in infiltrating cell types, such as 
macrophages of neutrophils. If Rin were expressed in non-resident immune cells, 
it would provide a possible explanation for the changes we observed in cytokine 
production acutely following CHI. To determine whether Rin is expressed in 
macrophages and/or neutrophils, these cell populations would need to be 
extracted and cultured from wild-type animals for qPCR analysis of Rin. 
Furthermore, if Rin signaling is necessary for cytokine production in these cells, 
then Rin-/- animals should display blunting of IL-1β and TNF-α levels following in 
vitro stimulation with the TLR4 agonist, lipopolysaccharide. 
Clarification of Rin Physiology using a conditional KO mouse model 
Herein, we have described how Rin loss alters cell death (Chapter 3), 
axonal degeneration (Chapter 4) and inflammatory responses (Chapter 5) 
following trauma; however, due to the complex interplay between cells of the 
CNS we are unable to determine a primary role for Rin. All the studies presented 
in this dissertation were carried out using a whole-body Rin null mouse model, 
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and although Rin is believed to be expressed solely in neurons, expression in 
other cell types remains a formal possibility. Furthermore, the use of a global 
knockout mouse does not allow us to determine whether the phenotypes 
observed following injury are due to Rin loss or compensatory effects acquired 
throughout the lifetime to counteract for Rin loss. In order to address these 
apparent issues, our lab has recently generated conditional KO Rin mice that can 
be combined with tamoxifen-induced Cre expression in specific tissues. When 
crossed to lines allowing inducible neuronal-selective Cre expression, these mice 
will allow neuron specific RIT2 loss (Betz, Vosshenrich et al. 1996). Using these 
mice, we can be certain that effects we have observed are specific to the neuron. 
 Using these mice, several outcomes of this body of work can be revisited 
to allow for more definitive answers regarding the protective properties of Rin 
loss. First, neuronal specific knockout of Rin would allow us to determine whether 
acute blunting of pro-inflammatory cytokine production following CHI (Figure 5.1) 
was indeed neuronally based without having to culture glia or immune cells. 
Furthermore, these mice will allow us to revisit RAWM testing following mild head 
injury (Figure 5.5) to determine whether Rin loss indeed leads to spatial learning 
deficits. 
Conclusions 
The data presented in this dissertation has demonstrated Rin loss to be 
neuroprotective in several models of traumatic injury: enhancing mature neuronal 
survival, diminishing cognitive decline, decreasing axonal injury, and blunting 
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acute pro-inflammatory cytokine production. These data suggest a novel and 
unexpected physiological role for Rin in the promotion of neuronal cell death and 
axonal degeneration following injury. Further studies are needed to investigate 
the contribution of Rin signaling to post-traumatic injury cascades; however, 
these initial studies provide evidence of a new avenue of therapeutic intervention 
through the inhibition of Rin GTPase.  
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Appendix 
 
List of Abbreviations 
 
AF6  ALL (acute lymphoblastic leukemia) fused gene on chromosome 6 
ANOVA Analysis of variance 
APP  Amyloid precursor protein 
Arf  ADP-ribosylation factor 
ASF  Area sampling fraction 
ATP  Adenosine triphosphate 
BBB  Blood brain barrier  
BDNF  Brain-derived neurotropic factor 
BrdU  5-bromo-2’-deoxyuridine 
CA-1  Cornu Ammonis area 1 
CA-3  Cornu Ammonis area 3 
CCI  Controlled cortical impact 
CD45  Cluster of Differentiation 45 
CD68  Cluster of Differentiation 68 
Cdc42  Cell division control protein 42 
CHI  Closed head injury 
CNS  Central nervous system 
DA  Dopamine 
DAMP  Damage associated molecular patterns 
Dcx  Doublecortin 
DG  Dentate gyrus 
DLK  Dual leucine zipper kinase 
DMEM Dulbecco’s modified Eagle’s medium 
EGF  Epithelial growth factor 
ELISA  Enzyme-linked immunosorbent assay 
ERK  Extracellular signal related protein kinase 
EtOH  Ethanol 
FBS  Fetal bovine serum 
FGF  Fibroblast growth factor 
FJC  Fluorojade-C 
GAP  GTPase-activating protein 
GCS  Glasgow Coma Score 
GDI  Guanine nucleotide dissociation inhibitor 
GDP  Guanosine diphosphate 
GEF  Guanine nucleotide exchange factor 
GFAP  Glial fibrillary acidic protein 
GTP  Guanosine triphosphate 
GTPase Guanosine triphosphatase 
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GRF  Growth hormone releasing factor 
GWAS Genome-wide Association Study 
IGF-1  Insulin-like growth factor- 1 
IGL  Inner granular layer 
IL-1b  Interleukin 1 beta  
IL-6  Interleukin 6 
IL-10  Interleukin 10 
JIP  JNK-interacting protein 
JNK   c-Jun N-terminal kinase 
Ki67  Antigen Ki-67 
KO  Knock-out 
MAPK  Mitogen-activated protein kinase 
MAPKK Mitogen-activated protein kinase kinase 
MAPKKK Mitogen-activated protein kinase kinase kinase 
MEKK4 Mitogen-activated protein kinase kinase kinase 4 
MKK2  Mitogen-activated protein kinase kinase kinase 2 
mTBI  Mild traumatic brain injury 
MONS Mono-ocular nerve stretch 
NAD+  Nicotinamide adenine dinucleotide 
NeuN  Neuronal Nuclei 
NF  Neurofilament 
NGF  Nerve growth factor 
NGS  Normal goat serum 
NDS  Normal donkey serum 
NMNAT Nicotinamide mononucleotide adenylyltransferase 1 
NOR  Novel Object Recognition 
NSS  Neurological Severity Score 
NT-3  Neurotrophin-3 
OGL  Outer granular layer 
PACAP38 Pituitary adenylate cyclase activated polypeptide 38 
PAGE  Polyscrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
PC6  Pheochromocytoma 6 cell line 
PD  Parkinson’s disease 
PFA  Paraformaldehyde 
PI3K  Phosphatidylinositol-3 kinase 
PI(3,4,5)P3 Phosphatidylinositol 3,4,5-triphosphate 
PI(4,5)P2  Phosphatidylinositol 4,5-bisphosphate 
PKC  Protein kinase C 
PTEN  Protein and tensin homolog 
Rab  Ras-related GTP-binding protein 
Rac  Ras-related C3 botulinum toxin substrate  
Ran  Ras related nuclear protein 
Ras  Rat sarcoma 
RAWM radial arm water maze 
Rho  Ras homolog gene family 
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RhoA  Ras homolog gene family, member A 
Ric  Ras-related protein which interacts with calmodulin 
Rin  Ras-related protein in neurons 
RIN1  Ras interaction protein-1 
Rit  Ras-related protein in tissues 
RNA  Ribonucleic acid 
RNAi  Ribonucleic acid interference 
ROCK  Rho-associated protein kinase 
ROS  Reactive oxygen species 
RT  Room temperature 
RTK  Receptor tyrosine kinase 
SAPK  Stress-activated protein kinase 
Sarm1 Sterile alpha and TIR containing 1 
SCG10 Superior cervical ganglion-10 
SDS  Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate poly-acrylamide gel electrophoresis 
SEM  Standard error mean 
SGZ  Sub-granular zone 
SH2  Src homology 2 domain 
SMI32  Nonphosphorylated neurofilament 
Sos1  Son of sevenless 1 
SSF  Selection sampling fraction 
TAI  Traumatic axonal injury 
TBI  Traumatic brain injury 
TBS  Tris buffered saline 
TNF-α Tumor necrosis factor alpha 
TSF  Thickness sampling fraction 
Ube4b ubiquitination factor e4b 
VEGF  Vascular endothelial rowth factor 
Wlds  Wallerian slow mutant 
WT  Wild-type 
YFP  Yellow Fluorescent Protein 
 
 
 
 
 
 
 
 
 
 
 
 
	   153	  
References 
 
Aberg, M. A., N. D. Aberg, H. Hedbacker, J. Oscarsson and P. S. Eriksson 
(2000). "Peripheral infusion of IGF-I selectively induces neurogenesis in the adult 
rat hippocampus." J Neurosci. 20(8): 2896-2903. 
Alamed, J., D. M. Wilcock, D. M. Diamond, M. N. Gordon and D. Morgan (2006). 
"Two-day radial-arm water maze learning and memory task; robust resolution of 
amyloid-related memory deficits in transgenic mice." Nat Protoc 1(4): 1671-1679. 
Araki, T., Y. Sasaki and J. Milbrandt (2004). "Increased nuclear NAD 
biosynthesis and SIRT1 activation prevent axonal degeneration." Science. 
305(5686): 1010-1013. 
Ariza, M., J. M. Serra-Grabulosa, C. Junque, B. Ramirez, M. Mataro, A. Poca, N. 
Bargallo and J. Sahuquillo (2006). "Hippocampal head atrophy after traumatic 
brain injury." Neuropsychologia 44(10): 1956-1961. Epub 2005 Dec 1913. 
Babetto, E., B. Beirowski, L. Janeckova, R. Brown, J. Gilley, D. Thomson, R. R. 
Ribchester and M. P. Coleman (2010). "Targeting NMNAT1 to axons and 
synapses transforms its neuroprotective potency in vivo." J Neurosci. 30(40): 
13291-13304. doi: 13210.11523/JNEUROSCI.11189-13210.12010. 
Bachstetter, A. D., R. K. Rowe, M. Kaneko, D. Goulding, J. Lifshitz and L. J. Van 
Eldik (2013). "The p38alpha MAPK regulates microglial responsiveness to diffuse 
traumatic brain injury." J Neurosci. 33(14): 6143-6153. doi: 
6110.1523/JNEUROSCI.5399-6112.2013. 
Bachstetter, A. D., S. J. Webster, D. S. Goulding, J. E. Morton, D. M. Watterson 
and L. J. Van Eldik (2015). "Attenuation of traumatic brain injury-induced 
cognitive impairment in mice by targeting increased cytokine levels with a small 
molecule experimental therapeutic." J Neuroinflammation. 12:69.(doi): 
10.1186/s12974-12015-10289-12975. 
Bachstetter, A. D., B. Xing, L. de Almeida, E. R. Dimayuga, D. M. Watterson and 
L. J. Van Eldik (2011). "Microglial p38alpha MAPK is a key regulator of 
proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands 
or beta-amyloid (Abeta)." J Neuroinflammation. 8:79.(doi): 10.1186/1742-2094-
1188-1179. 
Baker, A. J., R. J. Moulton, V. H. MacMillan and P. M. Shedden (1993). 
"Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in 
humans." J Neurosurg. 79(3): 369-372. 
	   154	  
Baldwin, S. A., I. Fugaccia, D. R. Brown, L. V. Brown and S. W. Scheff (1996). 
"Blood-brain barrier breach following cortical contusion in the rat." J Neurosurg. 
85(3): 476-481. 
Barbacid, M. (1987). "ras genes." Annu Rev Biochem 56: 779-827. 
Bardehle, S., M. Kruger, F. Buggenthin, J. Schwausch, J. Ninkovic, H. Clevers, 
H. J. Snippert, F. J. Theis, M. Meyer-Luehmann, I. Bechmann, L. Dimou and M. 
Gotz (2013). "Live imaging of astrocyte responses to acute injury reveals 
selective juxtavascular proliferation." Nat Neurosci. 16(5): 580-586. doi: 
510.1038/nn.3371. Epub 2013 Mar 1031. 
Beauchamp, K., H. Mutlak, W. R. Smith, E. Shohami and P. F. Stahel (2008). 
"Pharmacology of traumatic brain injury: where is the "golden bullet"?" Mol Med. 
14(11-12): 731-740. doi: 710.2119/2008-00050.Beauchamp. Epub 02008 Aug 
00018. 
Beirowski, B., L. Berek, R. Adalbert, D. Wagner, D. S. Grumme, K. Addicks, R. 
R. Ribchester and M. P. Coleman (2004). "Quantitative and qualitative analysis 
of Wallerian degeneration using restricted axonal labelling in YFP-H mice." J 
Neurosci Methods. 134(1): 23-35. 
Berger, A. H., M. Imielinski, F. Duke, J. Wala, N. Kaplan, G. X. Shi, D. A. Andres 
and M. Meyerson (2014). "Oncogenic RIT1 mutations in lung adenocarcinoma." 
Oncogene. 33(35): 4418-4423. doi: 4410.1038/onc.2013.4581. Epub 2014 Jan 
4427. 
Bernards, A. and J. Settleman (2005). "GAPs in growth factor signalling." Growth 
Factors. 23(2): 143-149. 
Bernards, A. and J. Settleman (2007). "GEFs in growth factor signaling." Growth 
Factors. 25(5): 355-361. doi: 310.1080/08977190701830375. 
Bertrand, J., M. J. Winton, N. Rodriguez-Hernandez, R. B. Campenot and L. 
McKerracher (2005). "Application of Rho antagonist to neuronal cell bodies 
promotes neurite growth in compartmented cultures and regeneration of retinal 
ganglion cell axons in the optic nerve of adult rats." J Neurosci. 25(5): 1113-
1121. 
Betz, U. A., C. A. Vosshenrich, K. Rajewsky and W. Muller (1996). "Bypass of 
lethality with mosaic mice generated by Cre-loxP-mediated recombination." Curr 
Biol. 6(10): 1307-1316. 
Bigler, E. D., D. D. Blatter, C. V. Anderson, S. C. Johnson, S. D. Gale, R. O. 
Hopkins and B. Burnett (1997). "Hippocampal volume in normal aging and 
traumatic brain injury." AJNR Am J Neuroradiol. 18(1): 11-23. 
	   155	  
Bivona, T. G., S. E. Quatela, B. O. Bodemann, I. M. Ahearn, M. J. Soskis, A. 
Mor, J. Miura, H. H. Wiener, L. Wright, S. G. Saba, D. Yim, A. Fein, I. Perez de 
Castro, C. Li, C. B. Thompson, A. D. Cox and M. R. Philips (2006). "PKC 
regulates a farnesyl-electrostatic switch on K-Ras that promotes its association 
with Bcl-XL on mitochondria and induces apoptosis." Mol Cell. 21(4): 481-493. 
Blaiss, C. A., T. S. Yu, G. Zhang, J. Chen, G. Dimchev, L. F. Parada, C. M. 
Powell and S. G. Kernie (2011). "Temporally specified genetic ablation of 
neurogenesis impairs cognitive recovery after traumatic brain injury." J Neurosci. 
31(13): 4906-4916. doi: 4910.1523/JNEUROSCI.5265-4910.2011. 
Borgens, R. B. and P. Liu-Snyder (2012). "Understanding secondary injury." Q 
Rev Biol. 87(2): 89-127. 
Bos, J. L., H. Rehmann and A. Wittinghofer (2007). "GEFs and GAPs: critical 
elements in the control of small G proteins." Cell. 129(5): 865-877. 
Buki, A. and J. T. Povlishock (2006). "All roads lead to disconnection?--Traumatic 
axonal injury revisited." Acta Neurochir (Wien). 148(2): 181-193; discussion 193-
184. Epub 2005 Dec 2020. 
Burda, J. E., A. M. Bernstein and M. V. Sofroniew (2016). "Astrocyte roles in 
traumatic brain injury." Exp Neurol. 275(Pt 3): 305-315. doi: 
310.1016/j.expneurol.2015.1003.1020. Epub 2015 Mar 1028. 
Cahoy, J. D., B. Emery, A. Kaushal, L. C. Foo, J. L. Zamanian, K. S. 
Christopherson, Y. Xing, J. L. Lubischer, P. A. Krieg, S. A. Krupenko, W. J. 
Thompson and B. A. Barres (2008). "A transcriptome database for astrocytes, 
neurons, and oligodendrocytes: a new resource for understanding brain 
development and function." J Neurosci. 28(1): 264-278. doi: 
210.1523/JNEUROSCI.4178-1507.2008. 
Cai, W., S. W. Carlson, J. M. Brelsfoard, C. E. Mannon, C. L. Moncman, K. E. 
Saatman and D. A. Andres (2012). "Rit GTPase signaling promotes immature 
hippocampal neuronal survival." J Neurosci. 32(29): 9887-9897. doi: 
9810.1523/JNEUROSCI.0375-9812.2012. 
Cai, W., J. L. Rudolph, S. M. Harrison, L. Jin, A. L. Frantz, D. A. Harrison and D. 
A. Andres (2011). "An evolutionarily conserved Rit GTPase-p38 MAPK signaling 
pathway mediates oxidative stress resistance." Mol Biol Cell. 22(17): 3231-3241. 
doi: 3210.1091/mbc.E3211-3205-0400. Epub 2011 Jul 3237. 
Cao, J., M. M. Semenova, V. T. Solovyan, J. Han, E. T. Coffey and M. J. 
Courtney (2004). "Distinct requirements for p38alpha and c-Jun N-terminal 
kinase stress-activated protein kinases in different forms of apoptotic neuronal 
death." J Biol Chem. 279(34): 35903-35913. Epub 32004 Jun 35910. 
	   156	  
Cao, T., T. C. Thomas, J. M. Ziebell, J. R. Pauly and J. Lifshitz (2012). 
"Morphological and genetic activation of microglia after diffuse traumatic brain 
injury in the rat." Neuroscience. 225:65-75.(doi): 
10.1016/j.neuroscience.2012.1008.1058. Epub 2012 Sep 1016. 
Carlson, S. W., S. K. Madathil, D. M. Sama, X. Gao, J. Chen and K. E. Saatman 
(2014). "Conditional overexpression of insulin-like growth factor-1 enhances 
hippocampal neurogenesis and restores immature neuron dendritic processes 
after traumatic brain injury." J Neuropathol Exp Neurol. 73(8): 734-746. doi: 
710.1097/NEN.0000000000000092. 
Carro, E., J. L. Trejo, S. Busiguina and I. Torres-Aleman (2001). "Circulating 
insulin-like growth factor I mediates the protective effects of physical exercise 
against brain insults of different etiology and anatomy." J Neurosci. 21(15): 5678-
5684. 
Casey, P. J. (1994). "Lipid modifications of G proteins." Curr Opin Cell Biol. 6(2): 
219-225. 
Castellano, E. and E. Santos (2011). "Functional specificity of ras isoforms: so 
similar but so different." Genes Cancer. 2(3): 216-231. doi: 
210.1177/1947601911408081. 
Cave, H., A. Caye, N. Ghedira, Y. Capri, N. Pouvreau, N. Fillot, A. Trimouille, C. 
Vignal, O. Fenneteau, Y. Alembik, J. L. Alessandri, P. Blanchet, O. Boute, P. 
Bouvagnet, A. David, A. Dieux Coeslier, B. Doray, O. Dulac, V. Drouin-Garraud, 
M. Gerard, D. Heron, B. Isidor, D. Lacombe, S. Lyonnet, L. Perrin, M. Rio, J. 
Roume, S. Sauvion, A. Toutain, C. Vincent-Delorme, M. Willems, C. Baumann 
and A. Verloes (2016). "Mutations in RIT1 cause Noonan syndrome with possible 
juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic 
leukemia." Eur J Hum Genet. 24(8): 1124-1131. doi: 1110.1038/ejhg.2015.1273. 
Epub 2016 Jan 1113. 
Chaparro-Huerta, V., M. E. Flores-Soto, G. Gudino-Cabrera, M. C. Rivera-
Cervantes, O. K. Bitzer-Quintero and C. Beas-Zarate (2008). "Role of p38 MAPK 
and pro-inflammatory cytokines expression in glutamate-induced neuronal death 
of neonatal rats." Int J Dev Neurosci. 26(5): 487-495. doi: 
410.1016/j.ijdevneu.2008.1002.1008. Epub 2008 Mar 1014. 
Chen, G. Y. and G. Nunez (2010). "Sterile inflammation: sensing and reacting to 
damage." Nat Rev Immunol. 10(12): 826-837. doi: 810.1038/nri2873. Epub 2010 
Nov 1019. 
Chen, P. C., J. Yin, H. W. Yu, T. Yuan, M. Fernandez, C. K. Yung, Q. M. Trinh, 
V. D. Peltekova, J. G. Reid, E. Tworog-Dube, M. B. Morgan, D. M. Muzny, L. 
Stein, J. D. McPherson, A. E. Roberts, R. A. Gibbs, B. G. Neel and R. 
Kucherlapati (2014). "Next-generation sequencing identifies rare variants 
	   157	  
associated with Noonan syndrome." Proc Natl Acad Sci U S A. 111(31): 11473-
11478. doi: 11410.11073/pnas.1324128111. Epub 1324122014 Jul 1324128121. 
Chen, R., L. Yang and T. M. McIntyre (2007). "Cytotoxic phospholipid oxidation 
products. Cell death from mitochondrial damage and the intrinsic caspase 
cascade." J Biol Chem. 282(34): 24842-24850. Epub 22007 Jun 24827. 
Chen, X., M. Rzhetskaya, T. Kareva, R. Bland, M. J. During, A. W. Tank, N. 
Kholodilov and R. E. Burke (2008). "Antiapoptotic and trophic effects of 
dominant-negative forms of dual leucine zipper kinase in dopamine neurons of 
the substantia nigra in vivo." J Neurosci. 28(3): 672-680. doi: 
610.1523/JNEUROSCI.2132-1507.2008. 
Cherfils, J. and M. Zeghouf (2011). "Chronicles of the GTPase switch." Nat 
Chem Biol. 7(8): 493-495. doi: 410.1038/nchembio.1608. 
Chiu, C. C., Y. E. Liao, L. Y. Yang, J. Y. Wang, D. Tweedie, H. K. Karnati, N. H. 
Greig and J. Y. Wang (2016). "Neuroinflammation in animal models of traumatic 
brain injury." J Neurosci Methods. 272:38-49.(doi): 
10.1016/j.jneumeth.2016.1006.1018. Epub 2016 Jul 1012. 
Chiu, V. K., T. Bivona, A. Hach, J. B. Sajous, J. Silletti, H. Wiener, R. L. Johnson, 
2nd, A. D. Cox and M. R. Philips (2002). "Ras signalling on the endoplasmic 
reticulum and the Golgi." Nat Cell Biol. 4(5): 343-350. 
Chodobski, A., B. J. Zink and J. Szmydynger-Chodobska (2011). "Blood-brain 
barrier pathophysiology in traumatic brain injury." Transl Stroke Res. 2(4): 492-
516. doi:410.1007/s12975-12011-10125-x. 
Choi, D. W., M. Maulucci-Gedde and A. R. Kriegstein (1987). "Glutamate 
neurotoxicity in cortical cell culture." J Neurosci. 7(2): 357-368. 
Choi, S. S., H. J. Lee, I. Lim, J. Satoh and S. U. Kim (2014). "Human astrocytes: 
secretome profiles of cytokines and chemokines." PLoS One. 9(4): e92325. doi: 
92310.91371/journal.pone.0092325. eCollection 0092014. 
Christman, C. W., M. S. Grady, S. A. Walker, K. L. Holloway and J. T. Povlishock 
(1994). "Ultrastructural studies of diffuse axonal injury in humans." J 
Neurotrauma. 11(2): 173-186. 
Colicelli, J. (2004). "Human RAS superfamily proteins and related GTPases." Sci 
STKE. 2004(250): RE13. 
Conti, A. C., R. Raghupathi, J. Q. Trojanowski and T. K. McIntosh (1998). 
"Experimental brain injury induces regionally distinct apoptosis during the acute 
and delayed post-traumatic period." J Neurosci. 18(15): 5663-5672. 
	   158	  
Cook, S. J., K. Stuart, R. Gilley and M. J. Sale (2017). "Control of cell death and 
mitochondrial fission by ERK1/2 MAP kinase signalling." Febs J: 14122. 
Coronado, V. G., L. Xu, S. V. Basavaraju, L. C. McGuire, M. M. Wald, M. D. Faul, 
B. R. Guzman and J. D. Hemphill (2011). "Surveillance for traumatic brain injury-
related deaths--United States, 1997-2007." MMWR Surveill Summ. 60(5): 1-32. 
Darcy, M. J., S. Trouche, S. X. Jin and L. A. Feig (2014). "Ras-GRF2 mediates 
long-term potentiation, survival, and response to an enriched environment of 
newborn neurons in the hippocampus." Hippocampus. 24(11): 1317-1329. doi: 
1310.1002/hipo.22313. Epub 22014 Jun 22317. 
Dash, P. K., S. A. Mach and A. N. Moore (2001). "Enhanced neurogenesis in the 
rodent hippocampus following traumatic brain injury." J Neurosci Res. 63(4): 313-
319. 
Dash, P. K., S. A. Mach and A. N. Moore (2002). "The role of extracellular signal-
regulated kinase in cognitive and motor deficits following experimental traumatic 
brain injury." Neuroscience 114(3): 755-767. 
Davalos, D., J. Grutzendler, G. Yang, J. V. Kim, Y. Zuo, S. Jung, D. R. Littman, 
M. L. Dustin and W. B. Gan (2005). "ATP mediates rapid microglial response to 
local brain injury in vivo." Nat Neurosci. 8(6): 752-758. Epub 2005 May 2015. 
Dawson, V. L., T. M. Dawson, D. A. Bartley, G. R. Uhl and S. H. Snyder (1993). 
"Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures." J 
Neurosci. 13(6): 2651-2661. 
Dixon, C. E., G. L. Clifton, J. W. Lighthall, A. A. Yaghmai and R. L. Hayes (1991). 
"A controlled cortical impact model of traumatic brain injury in the rat." J Neurosci 
Methods. 39(3): 253-262. 
Donninger, H., D. F. Calvisi, T. Barnoud, J. Clark, M. L. Schmidt, M. D. Vos and 
G. J. Clark (2015). "NORE1A is a Ras senescence effector that controls the 
apoptotic/senescent balance of p53 via HIPK2." J Cell Biol. 208(6): 777-789. doi: 
710.1083/jcb.201408087. 
Downward, J. (1998). "Ras signalling and apoptosis." Curr Opin Genet Dev. 8(1): 
49-54. 
Emamalizadeh, B., A. Movafagh, M. Akbari, S. Kazeminasab, A. Fazeli, M. 
Motallebi, G. A. Shahidi, P. Petramfar, R. Mirfakhraie and H. Darvish (2014). 
"RIT2, a susceptibility gene for Parkinson's disease in Iranian population." 
Neurobiol Aging. 35(12): e27-28. doi: 10.1016/j.neurobiolaging.2014.1007.1013. 
Epub 2014 Jul 1019. 
	   159	  
Fan, G., S. E. Merritt, M. Kortenjann, P. E. Shaw and L. B. Holzman (1996). 
"Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapk but 
not ERK2." J Biol Chem. 271(40): 24788-24793. 
Finkelstein, E., C.P., Miller, T. (2006). The Incidence and Economic Burden of 
Injuries in the United States. New York, NY, Oxford University Press. 
Fischer, D., V. Petkova, S. Thanos and L. I. Benowitz (2004). "Switching mature 
retinal ganglion cells to a robust growth state in vivo: gene expression and 
synergy with RhoA inactivation." J Neurosci. 24(40): 8726-8740. 
Foo, J. N., L. C. Tan, I. D. Irwan, W. L. Au, H. Q. Low, K. M. Prakash, A. Ahmad-
Annuar, J. Bei, A. Y. Chan, C. M. Chen, Y. C. Chen, S. J. Chung, H. Deng, S. Y. 
Lim, V. Mok, H. Pang, Z. Pei, R. Peng, H. F. Shang, K. Song, A. H. Tan, Y. R. 
Wu, T. Aung, C. Y. Cheng, F. T. Chew, S. H. Chew, S. A. Chong, R. P. Ebstein, 
J. Lee, S. M. Saw, A. Seow, M. Subramaniam, E. S. Tai, E. N. Vithana, T. Y. 
Wong, K. K. Heng, W. Y. Meah, C. C. Khor, H. Liu, F. Zhang, J. Liu and E. K. 
Tan (2017). "Genome-wide association study of Parkinson's disease in East 
Asians." Hum Mol Genet. 26(1): 226-232. doi: 210.1093/hmg/ddw1379. 
Fox, G. B. and A. I. Faden (1998). "Traumatic brain injury causes delayed motor 
and cognitive impairment in a mutant mouse strain known to exhibit delayed 
Wallerian degeneration." J Neurosci Res. 53(6): 718-727. 
Freidin, M., M. V. Bennett and J. A. Kessler (1992). "Cultured sympathetic 
neurons synthesize and release the cytokine interleukin 1 beta." Proc Natl Acad 
Sci U S A. 89(21): 10440-10443. 
Fujimoto, S. T., L. Longhi, K. E. Saatman, V. Conte, N. Stocchetti and T. K. 
McIntosh (2004). "Motor and cognitive function evaluation following experimental 
traumatic brain injury." Neurosci Biobehav Rev. 28(4): 365-378. 
Fujita, Y. and T. Yamashita (2014). "Axon growth inhibition by RhoA/ROCK in the 
central nervous system." Front Neurosci. 8:338.(doi): 10.3389/fnins.2014.00338. 
eCollection 02014. 
Gage, F. H. (2000). "Mammalian neural stem cells." Science. 287(5457): 1433-
1438. 
Gao, X., Y. Deng-Bryant, W. Cho, K. M. Carrico, E. D. Hall and J. Chen (2008). 
"Selective death of newborn neurons in hippocampal dentate gyrus following 
moderate experimental traumatic brain injury." J Neurosci Res. 86(10): 2258-
2270. doi: 2210.1002/jnr.21677. 
Gerdts, J., E. J. Brace, Y. Sasaki, A. DiAntonio and J. Milbrandt (2015). "SARM1 
activation triggers axon degeneration locally via NAD(+) destruction." Science. 
348(6233): 453-457. doi: 410.1126/science.1258366. Epub 1252015 Apr 
1258323. 
	   160	  
Gerdts, J., D. W. Summers, J. Milbrandt and A. DiAntonio (2016). "Axon Self-
Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism." 
Neuron. 89(3): 449-460. doi: 410.1016/j.neuron.2015.1012.1023. 
Gerdts, J., D. W. Summers, Y. Sasaki, A. DiAntonio and J. Milbrandt (2013). 
"Sarm1-mediated axon degeneration requires both SAM and TIR interactions." J 
Neurosci. 33(33): 13569-13580. doi: 13510.11523/JNEUROSCI.11197-
13513.12013. 
Geyer, M. and A. Wittinghofer (1997). "GEFs, GAPs, GDIs and effectors: taking a 
closer (3D) look at the regulation of Ras-related GTP-binding proteins." Curr Opin 
Struct Biol. 7(6): 786-792. 
Ghosh, A. S., B. Wang, C. D. Pozniak, M. Chen, R. J. Watts and J. W. Lewcock 
(2011). "DLK induces developmental neuronal degeneration via selective 
regulation of proapoptotic JNK activity." J Cell Biol. 194(5): 751-764. doi: 
710.1083/jcb.201103153. 
Gilley, J., G. Orsomando, I. Nascimento-Ferreira and M. P. Coleman (2015). 
"Absence of SARM1 rescues development and survival of NMNAT2-deficient 
axons." Cell Rep. 10(12): 1974-1981. doi: 1910.1016/j.celrep.2015.1902.1060. 
Epub 2015 Mar 1926. 
Gillingham, A. K. and S. Munro (2007). "The small G proteins of the Arf family 
and their regulators." Annu Rev Cell Dev Biol 23: 579-611. 
Glass, J. D., T. M. Brushart, E. B. George and J. W. Griffin (1993). "Prolonged 
survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic 
of the axon." J Neurocytol. 22(5): 311-321. 
Glessner, J. T., M. P. Reilly, C. E. Kim, N. Takahashi, A. Albano, C. Hou, J. P. 
Bradfield, H. Zhang, P. M. Sleiman, J. H. Flory, M. Imielinski, E. C. Frackelton, R. 
Chiavacci, K. A. Thomas, M. Garris, F. G. Otieno, M. Davidson, M. Weiser, A. 
Reichenberg, K. L. Davis, J. I. Friedman, T. P. Cappola, K. B. Margulies, D. J. 
Rader, S. F. Grant, J. D. Buxbaum, R. E. Gur and H. Hakonarson (2010). "Strong 
synaptic transmission impact by copy number variations in schizophrenia." Proc 
Natl Acad Sci U S A. 107(23): 10584-10589. doi: 
10510.11073/pnas.1000274107. Epub 1000272010 May 1000274120. 
Gould, E. and P. Tanapat (1997). "Lesion-induced proliferation of neuronal 
progenitors in the dentate gyrus of the adult rat." Neuroscience. 80(2): 427-436. 
Green, R. E., B. Colella, J. J. Maller, M. Bayley, J. Glazer and D. J. Mikulis 
(2014). "Scale and pattern of atrophy in the chronic stages of moderate-severe 
TBI." Front Hum Neurosci. 8:67.(doi): 10.3389/fnhum.2014.00067. eCollection 
02014. 
	   161	  
Greer, J. E., M. J. McGinn and J. T. Povlishock (2011). "Diffuse traumatic axonal 
injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in 
the axotomized neuronal population." J Neurosci. 31(13): 5089-5105. doi: 
5010.1523/JNEUROSCI.5103-5010.2011. 
Greer, J. E., J. T. Povlishock and K. M. Jacobs (2012). "Electrophysiological 
abnormalities in both axotomized and nonaxotomized pyramidal neurons 
following mild traumatic brain injury." J Neurosci. 32(19): 6682-6687. doi: 
6610.1523/JNEUROSCI.0881-6612.2012. 
Greve, M. W. and B. J. Zink (2009). "Pathophysiology of traumatic brain injury." 
Mt Sinai J Med. 76(2): 97-104. doi: 110.1002/msj.20104. 
Guo, G. and N. R. Bhat (2007). "p38alpha MAP kinase mediates hypoxia-
induced motor neuron cell death: a potential target of minocycline's 
neuroprotective action." Neurochem Res. 32(12): 2160-2166. Epub 2007 Jun 
2127. 
Gurtner, G. C., S. Werner, Y. Barrandon and M. T. Longaker (2008). "Wound 
repair and regeneration." Nature. 453(7193): 314-321. doi: 
310.1038/nature07039. 
Hall, E. D., P. G. Sullivan, T. R. Gibson, K. M. Pavel, B. M. Thompson and S. W. 
Scheff (2005). "Spatial and temporal characteristics of neurodegeneration after 
controlled cortical impact in mice: more than a focal brain injury." J Neurotrauma. 
22(2): 252-265. 
Hall, G. F. and V. M. Lee (1995). "Neurofilament sidearm proteolysis is a 
prominent early effect of axotomy in lamprey giant central neurons." J Comp 
Neurol. 353(1): 38-49. 
Hamedani, S. Y., J. Gharesouran, R. Noroozi, A. Sayad, M. D. Omrani, A. Mir, S. 
S. Afjeh, M. Toghi, S. Manoochehrabadi, S. Ghafouri-Fard and M. Taheri (2017). 
"Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum 
disorder." Metab Brain Dis: 9969-9964. 
Hanisch, U. K. (2002). "Microglia as a source and target of cytokines." Glia. 
40(2): 140-155. 
Harry, G. J. (2013). "Microglia during development and aging." Pharmacol Ther. 
139(3): 313-326. doi: 310.1016/j.pharmthera.2013.1004.1013. Epub 2013 Apr 
1030. 
Henninger, N., J. Bouley, E. M. Sikoglu, J. An, C. M. Moore, J. A. King, R. 
Bowser, M. R. Freeman and R. H. Brown, Jr. (2016). "Attenuated traumatic 
axonal injury and improved functional outcome after traumatic brain injury in mice 
lacking Sarm1." Brain. 139(Pt 4): 1094-1105. doi: 1010.1093/brain/aww1001. 
Epub 2016 Feb 1011. 
	   162	  
Heo, W. D., T. Inoue, W. S. Park, M. L. Kim, B. O. Park, T. J. Wandless and T. 
Meyer (2006). "PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic 
clusters to the plasma membrane." Science. 314(5804): 1458-1461. Epub 2006 
Nov 1459. 
Hernandez-Ontiveros, D. G., N. Tajiri, S. Acosta, B. Giunta, J. Tan and C. V. 
Borlongan (2013). "Microglia activation as a biomarker for traumatic brain injury." 
Front Neurol. 4:30.(doi): 10.3389/fneur.2013.00030. eCollection 02013. 
Hester, M. S. and S. C. Danzer (2014). "Hippocampal granule cell pathology in 
epilepsy - a possible structural basis for comorbidities of epilepsy?" Epilepsy 
Behav. 38:105-16.(doi): 10.1016/j.yebeh.2013.1012.1022. Epub 2014 Jan 1024. 
Hicks, R. R., D. H. Smith, D. H. Lowenstein, R. Saint Marie and T. K. McIntosh 
(1993). "Mild experimental brain injury in the rat induces cognitive deficits 
associated with regional neuronal loss in the hippocampus." J Neurotrauma. 
10(4): 405-414. 
Hill, C. S., M. P. Coleman and D. K. Menon (2016). "Traumatic Axonal Injury: 
Mechanisms and Translational Opportunities." Trends Neurosci. 39(5): 311-324. 
doi: 310.1016/j.tins.2016.1003.1002. Epub 2016 Mar 1031. 
Hoge, C. W., D. McGurk, J. L. Thomas, A. L. Cox, C. C. Engel and C. A. Castro 
(2008). "Mild traumatic brain injury in U.S. Soldiers returning from Iraq." N Engl J 
Med. 358(5): 453-463. doi: 410.1056/NEJMoa072972. Epub 072008 Jan 072930. 
Holsinger, T., D. C. Steffens, C. Phillips, M. J. Helms, R. J. Havlik, J. C. Breitner, 
J. M. Guralnik and B. L. Plassman (2002). "Head injury in early adulthood and 
the lifetime risk of depression." Arch Gen Psychiatry. 59(1): 17-22. 
Horner, M. D., P. L. Ferguson, A. W. Selassie, L. A. Labbate, K. Kniele and J. D. 
Corrigan (2005). "Patterns of alcohol use 1 year after traumatic brain injury: a 
population-based, epidemiological study." J Int Neuropsychol Soc. 11(3): 322-
330. 
Hoshino, M. and S. Nakamura (2002). "The Ras-like small GTP-binding protein 
Rin is activated by growth factor stimulation." Biochem Biophys Res Commun. 
295(3): 651-656. 
Hoshino, M. and S. Nakamura (2003). "Small GTPase Rin induces neurite 
outgrowth through Rac/Cdc42 and calmodulin in PC12 cells." J Cell Biol. 163(5): 
1067-1076. 
Hoshino, M., T. Yoshimori and S. Nakamura (2005). "Small GTPase proteins Rin 
and Rit Bind to PAR6 GTP-dependently and regulate cell transformation." J Biol 
Chem. 280(24): 22868-22874. Epub 22005 Apr 22814. 
	   163	  
Hu, B., C. Liu, H. Bramlett, T. J. Sick, O. F. Alonso, S. Chen and W. D. Dietrich 
(2004). "Changes in trkB-ERK1/2-CREB/Elk-1 pathways in hippocampal mossy 
fiber organization after traumatic brain injury." J Cereb Blood Flow Metab. 24(8): 
934-943. 
Hunsaker, M. R., B. Lee and R. P. Kesner (2008). "Evaluating the temporal 
context of episodic memory: the role of CA3 and CA1." Behav Brain Res. 188(2): 
310-315. doi: 310.1016/j.bbr.2007.1011.1015. Epub 2007 Nov 1029. 
Jaffe, A. B. and A. Hall (2005). "Rho GTPases: biochemistry and biology." Annu 
Rev Cell Dev Biol 21: 247-269. 
Jayaram, H. N., P. Kusumanchi and J. A. Yalowitz (2011). "NMNAT expression 
and its relation to NAD metabolism." Curr Med Chem 18(13): 1962-1972. 
Jessberger, S., R. E. Clark, N. J. Broadbent, G. D. Clemenson, Jr., A. Consiglio, 
D. C. Lie, L. R. Squire and F. H. Gage (2009). "Dentate gyrus-specific 
knockdown of adult neurogenesis impairs spatial and object recognition memory 
in adult rats." Learn Mem. 16(2): 147-154. doi: 110.1101/lm.1172609. Print 
1172009 Feb. 
Jin, K., M. Minami, J. Q. Lan, X. O. Mao, S. Batteur, R. P. Simon and D. A. 
Greenberg (2001). "Neurogenesis in dentate subgranular zone and rostral 
subventricular zone after focal cerebral ischemia in the rat." Proc Natl Acad Sci U 
S A. 98(8): 4710-4715. 
Johnson, V. E., J. E. Stewart, F. D. Begbie, J. Q. Trojanowski, D. H. Smith and 
W. Stewart (2013). "Inflammation and white matter degeneration persist for years 
after a single traumatic brain injury." Brain. 136(Pt 1): 28-42. doi: 
10.1093/brain/aws1322. 
Johnson, V. E., W. Stewart and D. H. Smith (2013). "Axonal pathology in 
traumatic brain injury." Exp Neurol. 246:35-43.(doi): 
10.1016/j.expneurol.2012.1001.1013. Epub 2012 Jan 1020. 
Kaku, D. A., M. P. Goldberg and D. W. Choi (1991). "Antagonism of non-NMDA 
receptors augments the neuroprotective effect of NMDA receptor blockade in 
cortical cultures subjected to prolonged deprivation of oxygen and glucose." 
Brain Res. 554(1-2): 344-347. 
Kan, A. A., W. S. van der Hel, S. M. Kolk, I. W. Bos, S. A. Verlinde, O. van 
Nieuwenhuizen and P. N. de Graan (2012). "Prolonged increase in rat 
hippocampal chemokine signalling after status epilepticus." J Neuroimmunol. 
245(1-2): 15-22. doi: 10.1016/j.jneuroim.2012.1001.1012. Epub 2012 Feb 1020. 
Karve, I. P., J. M. Taylor and P. J. Crack (2016). "The contribution of astrocytes 
and microglia to traumatic brain injury." Br J Pharmacol. 173(4): 692-702. doi: 
610.1111/bph.13125. Epub 12015 Apr 13124. 
	   164	  
Katz, M., I. Amit and Y. Yarden (2007). "Regulation of MAPKs by growth factors 
and receptor tyrosine kinases." Biochim Biophys Acta. 1773(8): 1161-1176. Epub 
2007 Jan 1110. 
Kelley, B. J., O. Farkas, J. Lifshitz and J. T. Povlishock (2006). "Traumatic axonal 
injury in the perisomatic domain triggers ultrarapid secondary axotomy and 
Wallerian degeneration." Exp Neurol. 198(2): 350-360. Epub 2006 Jan 2031. 
Kelley, B. J., J. Lifshitz and J. T. Povlishock (2007). "Neuroinflammatory 
responses after experimental diffuse traumatic brain injury." J Neuropathol Exp 
Neurol. 66(11): 989-1001. 
Kempermann, G., H. G. Kuhn and F. H. Gage (1997). "More hippocampal 
neurons in adult mice living in an enriched environment." Nature. 386(6624): 493-
495. 
Kernie, S. G., T. M. Erwin and L. F. Parada (2001). "Brain remodeling due to 
neuronal and astrocytic proliferation after controlled cortical injury in mice." J 
Neurosci Res. 66(3): 317-326. 
Kesner, R. P. (2007). "A behavioral analysis of dentate gyrus function." Prog 
Brain Res 163: 567-576. 
Koenighofer, M., C. Y. Hung, J. L. McCauley, J. Dallman, E. J. Back, I. Mihalek, 
K. W. Gripp, K. Sol-Church, P. Rusconi, Z. Zhang, G. X. Shi, D. A. Andres and O. 
A. Bodamer (2016). "Mutations in RIT1 cause Noonan syndrome - additional 
functional evidence and expanding the clinical phenotype." Clin Genet. 89(3): 
359-366. doi: 310.1111/cge.12608. Epub 12015 Jun 12604. 
Kolb, B. W., I.Q. (2008). Fundamentals of Human Neurophysiology, Worth 
Publishers. 
Krishnamurthy, K. and D. T. Laskowitz (2016). "Cellular and Molecular 
Mechanisms of Secondary Neuronal Injury following Traumatic Brain Injury." 
Kumar, A. and D. J. Loane (2012). "Neuroinflammation after traumatic brain 
injury: opportunities for therapeutic intervention." Brain Behav Immun. 26(8): 
1191-1201. doi: 1110.1016/j.bbi.2012.1106.1008. Epub 2012 Jun 1121. 
Lafon, M., F. Megret, M. Lafage and C. Prehaud (2006). "The innate immune 
facet of brain: human neurons express TLR-3 and sense viral dsRNA." J Mol 
Neurosci 29(3): 185-194. 
Langlois, J. A., W. Rutland-Brown and M. M. Wald (2006). "The epidemiology 
and impact of traumatic brain injury: a brief overview." J Head Trauma Rehabil. 
21(5): 375-378. 
	   165	  
Lee, C. H., N. G. Della, C. E. Chew and D. J. Zack (1996). "Rin, a neuron-
specific and calmodulin-binding small G-protein, and Rit define a novel subfamily 
of ras proteins." J Neurosci. 16(21): 6784-6794. 
Lee, E. and H. Son (2009). "Adult hippocampal neurogenesis and related 
neurotrophic factors." BMB Rep. 42(5): 239-244. 
Lehmann, M., A. Fournier, I. Selles-Navarro, P. Dergham, A. Sebok, N. Leclerc, 
G. Tigyi and L. McKerracher (1999). "Inactivation of Rho signaling pathway 
promotes CNS axon regeneration." J Neurosci. 19(17): 7537-7547. 
Lein, P. J., X. Guo, G. X. Shi, M. Moholt-Siebert, D. Bruun and D. A. Andres 
(2007). "The novel GTPase Rit differentially regulates axonal and dendritic 
growth." J Neurosci. 27(17): 4725-4736. 
Lesuisse, C. and L. J. Martin (2002). "Immature and mature cortical neurons 
engage different apoptotic mechanisms involving caspase-3 and the mitogen-
activated protein kinase pathway." J Cereb Blood Flow Metab. 22(8): 935-950. 
Levin, H. S. (1998). "Cognitive function outcomes after traumatic brain injury." 
Curr Opin Neurol. 11(6): 643-646. 
Li, J. Y., J. H. Zhang, N. N. Li, L. Wang, Z. J. Lu, L. Cheng, X. Y. Sun and R. 
Peng (2017). "Genetic association study between RIT2 and Parkinson's disease 
in a Han Chinese population." Neurol Sci. 38(2): 343-347. doi: 310.1007/s10072-
10016-12784-10076. Epub 12016 Nov 10026. 
Lim, J. C., W. Lu, J. M. Beckel and C. H. Mitchell (2016). "Neuronal Release of 
Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 
Receptor Is Neuroprotective." Front Cell Neurosci. 10: 270. eCollection 2016. 
Lingor, P., N. Teusch, K. Schwarz, R. Mueller, H. Mack, M. Bahr and B. K. 
Mueller (2007). "Inhibition of Rho kinase (ROCK) increases neurite outgrowth on 
chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult 
optic nerve in vivo." J Neurochem. 103(1): 181-189. Epub 2007 Jul 2002. 
Lingor, P., L. Tonges, N. Pieper, C. Bermel, E. Barski, V. Planchamp and M. 
Bahr (2008). "ROCK inhibition and CNTF interact on intrinsic signalling pathways 
and differentially regulate survival and regeneration in retinal ganglion cells." 
Brain. 131(Pt 1): 250-263. Epub 2007 Dec 2005. 
Liu, X., T. Shimada, T. Otowa, Y. Y. Wu, Y. Kawamura, M. Tochigi, Y. Iwata, T. 
Umekage, T. Toyota, M. Maekawa, Y. Iwayama, K. Suzuki, C. Kakiuchi, H. 
Kuwabara, Y. Kano, H. Nishida, T. Sugiyama, N. Kato, C. H. Chen, N. Mori, K. 
Yamada, T. Yoshikawa, K. Kasai, K. Tokunaga, T. Sasaki and S. S. Gau (2016). 
"Genome-wide Association Study of Autism Spectrum Disorder in the East Asian 
Populations." Autism Res. 9(3): 340-349. doi: 310.1002/aur.1536. Epub 2015 
Aug 1028. 
	   166	  
Liu, Z. H., J. F. Guo, Y. Q. Wang, K. Li, Q. Y. Sun, Q. Xu, X. X. Yan, C. S. Xu 
and B. S. Tang (2015). "Assessment of RIT2 rs12456492 association with 
Parkinson's disease in Mainland China." Neurobiol Aging. 36(3): 1600.e1609-
1611. doi: 1610.1016/j.neurobiolaging.2014.1612.1012. Epub 2014 Dec 1613. 
Lloyd, E., K. Somera-Molina, L. J. Van Eldik, D. M. Watterson and M. S. 
Wainwright (2008). "Suppression of acute proinflammatory cytokine and 
chemokine upregulation by post-injury administration of a novel small molecule 
improves long-term neurologic outcome in a mouse model of traumatic brain 
injury." J Neuroinflammation. 5:28.(doi): 10.1186/1742-2094-1185-1128. 
Lowy, D. R. and B. M. Willumsen (1993). "Function and regulation of ras." Annu 
Rev Biochem 62: 851-891. 
Lundin, A., C. de Boussard, G. Edman and J. Borg (2006). "Symptoms and 
disability until 3 months after mild TBI." Brain Inj. 20(8): 799-806. 
Lunn, E. R., V. H. Perry, M. C. Brown, H. Rosen and S. Gordon (1989). "Absence 
of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve." 
Eur J Neurosci 1(1): 27-33. 
Maas, A. I., B. Roozenbeek and G. T. Manley (2010). "Clinical trials in traumatic 
brain injury: past experience and current developments." Neurotherapeutics. 
7(1): 115-126. doi: 110.1016/j.nurt.2009.1010.1022. 
Maas, A. I., E. W. Steyerberg, I. Butcher, R. Dammers, J. Lu, A. Marmarou, N. A. 
Mushkudiani, G. S. McHugh and G. D. Murray (2007). "Prognostic value of 
computerized tomography scan characteristics in traumatic brain injury: results 
from the IMPACT study." J Neurotrauma. 24(2): 303-314. 
Mac Donald, C. L., K. Dikranian, S. K. Song, P. V. Bayly, D. M. Holtzman and D. 
L. Brody (2007). "Detection of traumatic axonal injury with diffusion tensor 
imaging in a mouse model of traumatic brain injury." Exp Neurol. 205(1): 116-
131. Epub 2007 Feb 2012. 
Madathil, S. K., S. W. Carlson, J. M. Brelsfoard, P. Ye, A. J. D'Ercole and K. E. 
Saatman (2013). "Astrocyte-Specific Overexpression of Insulin-Like Growth 
Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits 
following Traumatic Brain Injury in Mice." PLoS One. 8(6): e67204. doi: 
67210.61371/journal.pone.0067204. Print 0062013. 
Madsen, T. M., P. E. Kristjansen, T. G. Bolwig and G. Wortwein (2003). "Arrested 
neuronal proliferation and impaired hippocampal function following fractionated 
brain irradiation in the adult rat." Neuroscience 119(3): 635-642. 
Magavi, S. S., B. R. Leavitt and J. D. Macklis (2000). "Induction of neurogenesis 
in the neocortex of adult mice." Nature. 405(6789): 951-955. 
	   167	  
Maisonpierre, P. C., L. Belluscio, B. Friedman, R. F. Alderson, S. J. Wiegand, M. 
E. Furth, R. M. Lindsay and G. D. Yancopoulos (1990). "NT-3, BDNF, and NGF 
in the developing rat nervous system: parallel as well as reciprocal patterns of 
expression." Neuron. 5(4): 501-509. 
Mao, H., B. S. Elkin, V. V. Genthikatti, B. Morrison, 3rd and K. H. Yang (2013). 
"Why is CA3 more vulnerable than CA1 in experimental models of controlled 
cortical impact-induced brain injury?" J Neurotrauma. 30(17): 1521-1530. doi: 
1510.1089/neu.2012.2520. Epub 2013 Aug 1523. 
Marshall, L. F., S. B. Marshall, M. R. Klauber, M. Van Berkum Clark, H. 
Eisenberg, J. A. Jane, T. G. Luerssen, A. Marmarou and M. A. Foulkes (1992). 
"The diagnosis of head injury requires a classification based on computed axial 
tomography." J Neurotrauma. 9(Suppl 1): S287-292. 
Martin-Blanco, E. (2000). "p38 MAPK signalling cascades: ancient roles and new 
functions." Bioessays. 22(7): 637-645. 
McIntosh, T. K., K. E. Saatman, R. Raghupathi, D. I. Graham, D. H. Smith, V. M. 
Lee and J. Q. Trojanowski (1998). "The Dorothy Russell Memorial Lecture. The 
molecular and cellular sequelae of experimental traumatic brain injury: 
pathogenetic mechanisms." Neuropathol Appl Neurobiol. 24(4): 251-267. 
McKeon, R. J., R. C. Schreiber, J. S. Rudge and J. Silver (1991). "Reduction of 
neurite outgrowth in a model of glial scarring following CNS injury is correlated 
with the expression of inhibitory molecules on reactive astrocytes." J Neurosci. 
11(11): 3398-3411. 
Meaney, D. F., S. S. Margulies and D. H. Smith (2001). "Diffuse axonal injury." J 
Neurosurg. 95(6): 1108-1110. 
Menon, D. K., K. Schwab, D. W. Wright and A. I. Maas (2010). "Position 
statement: definition of traumatic brain injury." Arch Phys Med Rehabil. 91(11): 
1637-1640. doi: 1610.1016/j.apmr.2010.1605.1017. 
Miller, B. R., C. Press, R. W. Daniels, Y. Sasaki, J. Milbrandt and A. DiAntonio 
(2009). "A dual leucine kinase-dependent axon self-destruction program 
promotes Wallerian degeneration." Nat Neurosci. 12(4): 387-389. doi: 
310.1038/nn.2290. Epub 2009 Mar 1015. 
Ming, G. L. and H. Song (2005). "Adult neurogenesis in the mammalian central 
nervous system." Annu Rev Neurosci 28: 223-250. 
Ming, G. L. and H. Song (2011). "Adult neurogenesis in the mammalian brain: 
significant answers and significant questions." Neuron. 70(4): 687-702. doi: 
610.1016/j.neuron.2011.1005.1001. 
	   168	  
Mir, S., W. Cai and D. A. Andres (2017). "RIT1 GTPase Regulates Sox2 
Transcriptional Activity and Hippocampal Neurogenesis." J Biol Chem. 292(6): 
2054-2064. doi: 2010.1074/jbc.M2116.749770. Epub 742016 Dec 749722. 
Mir, S., W. Cai, S. W. Carlson, K. E. Saatman and D. A. Andres (2017). "IGF-1 
mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade." Sci Rep. 
7(1): 3283. doi: 3210.1038/s41598-41017-03641-41599. 
Morganti-Kossmann, M. C., L. Satgunaseelan, N. Bye and T. Kossmann (2007). 
"Modulation of immune response by head injury." Injury. 38(12): 1392-1400. 
Epub 2007 Nov 1328. 
Mori, T., X. Wang, J. C. Jung, T. Sumii, A. B. Singhal, M. E. Fini, C. E. Dixon, A. 
Alessandrini and E. H. Lo (2002). "Mitogen-activated protein kinase inhibition in 
traumatic brain injury: in vitro and in vivo effects." J Cereb Blood Flow Metab. 
22(4): 444-452. 
Mudo, G., A. Bonomo, V. Di Liberto, M. Frinchi, K. Fuxe and N. Belluardo (2009). 
"The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult 
brain." J Neural Transm (Vienna). 116(8): 995-1005. doi: 1010.1007/s00702-
00009-00207-z. Epub 02009 Mar 00717. 
Muizelaar, J. P., E. P. Wei, H. A. Kontos and D. P. Becker (1983). "Mannitol 
causes compensatory cerebral vasoconstriction and vasodilation in response to 
blood viscosity changes." J Neurosurg. 59(5): 822-828. 
Munch, E., P. Horn, L. Schurer, A. Piepgras, T. Paul and P. Schmiedek (2000). 
"Management of severe traumatic brain injury by decompressive craniectomy." 
Neurosurgery. 47(2): 315-322; discussion 322-313. 
Murray, J. L. L., A.D. (1996). Global Health Statistics, Harvard School of Public 
Health on behalf of the World Health Organization and the World Bank. 
Neary, J. T. (2005). "Protein kinase signaling cascades in CNS trauma." IUBMB 
Life. 57(11): 711-718. 
Nebreda, A. R. and A. Porras (2000). "p38 MAP kinases: beyond the stress 
response." Trends Biochem Sci. 25(6): 257-260. 
Nie, K., S. J. Feng, H. M. Tang, G. X. Ma, R. Gan, X. Zhao, J. H. Zhao, L. M. 
Wang, Z. H. Huang, J. Huang, L. Gao, Y. W. Zhang, R. M. Zhu, Z. P. Duan, Y. H. 
Zhang and L. J. Wang (2015). "RIT2 polymorphism is associated with 
Parkinson's disease in a Han Chinese population." Neurobiol Aging. 36(3): 
1603.e1615-1607. doi: 1610.1016/j.neurobiolaging.2014.1610.1013. Epub 2014 
Oct 1616. 
	   169	  
Nimmerjahn, A., F. Kirchhoff and F. Helmchen (2005). "Resting microglial cells 
are highly dynamic surveillants of brain parenchyma in vivo." Science. 308(5726): 
1314-1318. Epub 2005 Apr 1314. 
Nimnual, A. and D. Bar-Sagi (2002). "The two hats of SOS." Sci STKE. 
2002(145): pe36. 
Nozaki, K., M. Nishimura and N. Hashimoto (2001). "Mitogen-activated protein 
kinases and cerebral ischemia." Mol Neurobiol. 23(1): 1-19. 
Okonkwo, D. O., E. H. Pettus, J. Moroi and J. T. Povlishock (1998). "Alteration of 
the neurofilament sidearm and its relation to neurofilament compaction occurring 
with traumatic axonal injury." Brain Res. 784(1-2): 1-6. 
Osman, A. M., M. J. Porritt, M. Nilsson and H. G. Kuhn (2011). "Long-term 
stimulation of neural progenitor cell migration after cortical ischemia in mice." 
Stroke. 42(12): 3559-3565. doi: 3510.1161/STROKEAHA.3111.627802. Epub 
622011 Oct 627806. 
Osterloh, J. M., J. Yang, T. M. Rooney, A. N. Fox, R. Adalbert, E. H. Powell, A. 
E. Sheehan, M. A. Avery, R. Hackett, M. A. Logan, J. M. MacDonald, J. S. 
Ziegenfuss, S. Milde, Y. J. Hou, C. Nathan, A. Ding, R. H. Brown, Jr., L. Conforti, 
M. Coleman, M. Tessier-Lavigne, S. Zuchner and M. R. Freeman (2012). 
"dSarm/Sarm1 is required for activation of an injury-induced axon death 
pathway." Science. 337(6093): 481-484. doi: 410.1126/science.1223899. Epub 
1222012 Jun 1223897. 
Pankratz, N., G. W. Beecham, A. L. DeStefano, T. M. Dawson, K. F. Doheny, S. 
A. Factor, T. H. Hamza, A. Y. Hung, B. T. Hyman, A. J. Ivinson, D. Krainc, J. C. 
Latourelle, L. N. Clark, K. Marder, E. R. Martin, R. Mayeux, O. A. Ross, C. R. 
Scherzer, D. K. Simon, C. Tanner, J. M. Vance, Z. K. Wszolek, C. P. Zabetian, R. 
H. Myers, H. Payami, W. K. Scott and T. Foroud (2012). "Meta-analysis of 
Parkinson's disease: identification of a novel locus, RIT2." Ann Neurol. 71(3): 
370-384. doi: 310.1002/ana.22687. 
Parent, J. M. and D. H. Lowenstein (2002). "Seizure-induced neurogenesis: are 
more new neurons good for an adult brain?" Prog Brain Res 135: 121-131. 
Pells, S., M. Divjak, P. Romanowski, H. Impey, N. J. Hawkins, A. R. Clarke, M. L. 
Hooper and D. J. Williamson (1997). "Developmentally-regulated expression of 
murine K-ras isoforms." Oncogene. 15(15): 1781-1786. 
Pemberton, L. F. and B. M. Paschal (2005). "Mechanisms of receptor-mediated 
nuclear import and nuclear export." Traffic. 6(3): 187-198. 
Plassman, B. L., R. J. Havlik, D. C. Steffens, M. J. Helms, T. N. Newman, D. 
Drosdick, C. Phillips, B. A. Gau, K. A. Welsh-Bohmer, J. R. Burke, J. M. Guralnik 
	   170	  
and J. C. Breitner (2000). "Documented head injury in early adulthood and risk of 
Alzheimer's disease and other dementias." Neurology. 55(8): 1158-1166. 
Pleasant, J. M., S. W. Carlson, H. Mao, S. W. Scheff, K. H. Yang and K. E. 
Saatman (2011). "Rate of neurodegeneration in the mouse controlled cortical 
impact model is influenced by impactor tip shape: implications for mechanistic 
and therapeutic studies." J Neurotrauma. 28(11): 2245-2262. doi: 
2210.1089/neu.2010.1499. Epub 2011 Apr 2221. 
Povlishock, J. T. and D. I. Katz (2005). "Update of neuropathology and 
neurological recovery after traumatic brain injury." J Head Trauma Rehabil. 20(1): 
76-94. 
Povlishock, J. T., A. Marmarou, T. McIntosh, J. Q. Trojanowski and J. Moroi 
(1997). "Impact acceleration injury in the rat: evidence for focal axolemmal 
change and related neurofilament sidearm alteration." J Neuropathol Exp Neurol. 
56(4): 347-359. 
Price, L., C. Wilson and G. Grant (2016). "Blood-Brain Barrier Pathophysiology 
following Traumatic Brain Injury." 
Quadrato, G., M. Y. Elnaggar and S. Di Giovanni (2014). "Adult neurogenesis in 
brain repair: cellular plasticity vs. cellular replacement." Front Neurosci. 
8:17.(doi): 10.3389/fnins.2014.00017. eCollection 02014. 
Quilliam, L. A., R. Khosravi-Far, S. Y. Huff and C. J. Der (1995). "Guanine 
nucleotide exchange factors: activators of the Ras superfamily of proteins." 
Bioessays. 17(5): 395-404. 
Raman, M., W. Chen and M. H. Cobb (2007). "Differential regulation and 
properties of MAPKs." Oncogene. 26(22): 3100-3112. 
Reuther, G. W. and C. J. Der (2000). "The Ras branch of small GTPases: Ras 
family members don't fall far from the tree." Curr Opin Cell Biol. 12(2): 157-165. 
Rhoads, A. R. and F. Friedberg (1997). "Sequence motifs for calmodulin 
recognition." FASEB J. 11(5): 331-340. 
Roberts, G. W., S. M. Gentleman, A. Lynch and D. I. Graham (1991). "beta A4 
amyloid protein deposition in brain after head trauma." Lancet. 338(8780): 1422-
1423. 
Roberts, G. W., S. M. Gentleman, A. Lynch, L. Murray, M. Landon and D. I. 
Graham (1994). "Beta amyloid protein deposition in the brain after severe head 
injury: implications for the pathogenesis of Alzheimer's disease." J Neurol 
Neurosurg Psychiatry. 57(4): 419-425. 
	   171	  
Robinson, M. J. and M. H. Cobb (1997). "Mitogen-activated protein kinase 
pathways." Curr Opin Cell Biol. 9(2): 180-186. 
Rola, R., S. Mizumatsu, S. Otsuka, D. R. Morhardt, L. J. Noble-Haeusslein, K. 
Fishman, M. B. Potts and J. R. Fike (2006). "Alterations in hippocampal 
neurogenesis following traumatic brain injury in mice." Exp Neurol. 202(1): 189-
199. Epub 2006 Jul 2028. 
Rusyn, E. V., E. R. Reynolds, H. Shao, T. M. Grana, T. O. Chan, D. A. Andres 
and A. D. Cox (2000). "Rit, a non-lipid-modified Ras-related protein, transforms 
NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways." 
Oncogene. 19(41): 4685-4694. 
Rutland-Brown, W., J. A. Langlois, K. E. Thomas and Y. L. Xi (2006). "Incidence 
of traumatic brain injury in the United States, 2003." J Head Trauma Rehabil. 
21(6): 544-548. 
Saatman, K. E., B. Abai, A. Grosvenor, C. K. Vorwerk, D. H. Smith and D. F. 
Meaney (2003). "Traumatic axonal injury results in biphasic calpain activation 
and retrograde transport impairment in mice." J Cereb Blood Flow Metab. 23(1): 
34-42. 
Saatman, K. E., D. Bozyczko-Coyne, V. Marcy, R. Siman and T. K. McIntosh 
(1996). "Prolonged calpain-mediated spectrin breakdown occurs regionally 
following experimental brain injury in the rat." J Neuropathol Exp Neurol. 55(7): 
850-860. 
Saatman, K. E., K. J. Feeko, R. L. Pape and R. Raghupathi (2006). "Differential 
behavioral and histopathological responses to graded cortical impact injury in 
mice." J Neurotrauma. 23(8): 1241-1253. 
Sabirzhanova, I., C. Liu, J. Zhao, H. Bramlett, W. D. Dietrich and B. Hu (2013). 
"Changes in the GEF-H1 pathways after traumatic brain injury." J Neurotrauma. 
30(16): 1449-1456. doi: 1410.1089/neu.2012.2673. Epub 2013 Jul 1430. 
Sasaki, Y. and J. Milbrandt (2010). "Axonal degeneration is blocked by 
nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction 
into transected axons." J Biol Chem. 285(53): 41211-41215. doi: 
41210.41074/jbc.C41110.193904. Epub 192010 Nov 193911. 
Sasaki, Y., T. Nakagawa, X. Mao, A. DiAntonio and J. Milbrandt (2016). 
"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ 
depletion." Elife. 5.(pii): e19749. doi: 19710.17554/eLife.19749. 
Sasaki, Y., B. P. Vohra, R. H. Baloh and J. Milbrandt (2009). "Transgenic mice 
expressing the Nmnat1 protein manifest robust delay in axonal degeneration in 
vivo." J Neurosci. 29(20): 6526-6534. doi: 6510.1523/JNEUROSCI.1429-
6509.2009. 
	   172	  
Satoh, T., M. Nakafuku and Y. Kaziro (1992). "Function of Ras as a molecular 
switch in signal transduction." J Biol Chem. 267(34): 24149-24152. 
Satz, P., D. L. Forney, K. Zaucha, R. R. Asarnow, R. Light, C. McCleary, H. 
Levin, D. Kelly, M. Bergsneider, D. Hovda, N. Martin, N. Namerow and D. Becker 
(1998). "Depression, cognition, and functional correlates of recovery outcome 
after traumatic brain injury." Brain Inj. 12(7): 537-553. 
Scheff, S. W., D. A. Price, R. R. Hicks, S. A. Baldwin, S. Robinson and C. 
Brackney (2005). "Synaptogenesis in the hippocampal CA1 field following 
traumatic brain injury." J Neurotrauma. 22(7): 719-732. 
Schoch, K. M., H. N. Evans, J. M. Brelsfoard, S. K. Madathil, J. Takano, T. C. 
Saido and K. E. Saatman (2012). "Calpastatin overexpression limits calpain-
mediated proteolysis and behavioral deficits following traumatic brain injury." Exp 
Neurol. 236(2): 371-382. doi: 310.1016/j.expneurol.2012.1004.1022. Epub 2012 
May 1011. 
Sedgwick, J. D., S. Schwender, H. Imrich, R. Dorries, G. W. Butcher and V. ter 
Meulen (1991). "Isolation and direct characterization of resident microglial cells 
from the normal and inflamed central nervous system." Proc Natl Acad Sci U S A. 
88(16): 7438-7442. 
Selassie, A. W., M. L. McCarthy, P. L. Ferguson, J. Tian and J. A. Langlois 
(2005). "Risk of posthospitalization mortality among persons with traumatic brain 
injury, South Carolina 1999-2001." J Head Trauma Rehabil. 20(3): 257-269. 
Semenova, M. M., A. M. Maki-Hokkonen, J. Cao, V. Komarovski, K. M. Forsberg, 
M. Koistinaho, E. T. Coffey and M. J. Courtney (2007). "Rho mediates calcium-
dependent activation of p38alpha and subsequent excitotoxic cell death." Nat 
Neurosci. 10(4): 436-443. Epub 2007 Mar 2018. 
Serbest, G., M. F. Burkhardt, R. Siman, R. Raghupathi and K. E. Saatman 
(2007). "Temporal profiles of cytoskeletal protein loss following traumatic axonal 
injury in mice." Neurochem Res. 32(12): 2006-2014. Epub 2007 Mar 2031. 
Shao, H. and D. A. Andres (2000). "A novel RalGEF-like protein, RGL3, as a 
candidate effector for rit and Ras." J Biol Chem. 275(35): 26914-26924. 
Shao, H., K. Kadono-Okuda, B. S. Finlin and D. A. Andres (1999). "Biochemical 
characterization of the Ras-related GTPases Rit and Rin." Arch Biochem 
Biophys. 371(2): 207-219. 
Shapiro, L. A. (2017). "Altered Hippocampal Neurogenesis during the First 7 
Days after a Fluid Percussion Traumatic Brain Injury." Cell Transplant. 26(7): 
1314-1318. doi: 1310.1177/0963689717714099. 
	   173	  
Sharma, K., S. Schmitt, C. G. Bergner, S. Tyanova, N. Kannaiyan, N. Manrique-
Hoyos, K. Kongi, L. Cantuti, U. K. Hanisch, M. A. Philips, M. J. Rossner, M. Mann 
and M. Simons (2015). "Cell type- and brain region-resolved mouse brain 
proteome." Nat Neurosci. 18(12): 1819-1831. doi: 1810.1038/nn.4160. Epub 
2015 Nov 1812. 
Shi, G. X. and D. A. Andres (2005). "Rit contributes to nerve growth factor-
induced neuronal differentiation via activation of B-Raf-extracellular signal-
regulated kinase and p38 mitogen-activated protein kinase cascades." Mol Cell 
Biol. 25(2): 830-846. 
Shi, G. X., W. Cai and D. A. Andres (2013). "Rit subfamily small GTPases: 
regulators in neuronal differentiation and survival." Cell Signal. 25(10): 2060-
2068. doi: 2010.1016/j.cellsig.2013.2006.2002. Epub 2013 Jun 2011. 
Shi, G. X., J. Han and D. A. Andres (2005). "Rin GTPase couples nerve growth 
factor signaling to p38 and b-Raf/ERK pathways to promote neuronal 
differentiation." J Biol Chem. 280(45): 37599-37609. Epub 32005 Sep 37512. 
Shi, G. X., L. Jin and D. A. Andres (2010). "Src-dependent TrkA transactivation is 
required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit 
activation and neuronal differentiation." Mol Biol Cell. 21(9): 1597-1608. doi: 
1510.1091/mbc.E1509-1512-1033. Epub 2010 Mar 1510. 
Shi, G. X., L. Jin and D. A. Andres (2011). "A rit GTPase-p38 mitogen-activated 
protein kinase survival pathway confers resistance to cellular stress." Mol Cell 
Biol. 31(10): 1938-1948. doi: 1910.1128/MCB.01380-01310. Epub 02011 Mar 
01328. 
Shi, G. X., H. Rehmann and D. A. Andres (2006). "A novel cyclic AMP-dependent 
Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal 
differentiation." Mol Cell Biol. 26(23): 9136-9147. Epub 2006 Sep 9125. 
Shin, J. E., B. R. Miller, E. Babetto, Y. Cho, Y. Sasaki, S. Qayum, E. V. Russler, 
V. Cavalli, J. Milbrandt and A. DiAntonio (2012). "SCG10 is a JNK target in the 
axonal degeneration pathway." Proc Natl Acad Sci U S A. 109(52): E3696-3705. 
doi: 3610.1073/pnas.1216204109. Epub 1216202012 Nov 1216204127. 
Shohami, E., I. Yatsiv, A. Alexandrovich, R. Haklai, G. Elad-Sfadia, R. 
Grossman, A. Biegon and Y. Kloog (2003). "The Ras inhibitor S-trans, trans-
farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed 
head injury model." J Cereb Blood Flow Metab. 23(6): 728-738. 
Singh, I. N., P. G. Sullivan, Y. Deng, L. H. Mbye and E. D. Hall (2006). "Time 
course of post-traumatic mitochondrial oxidative damage and dysfunction in a 
mouse model of focal traumatic brain injury: implications for neuroprotective 
therapy." J Cereb Blood Flow Metab. 26(11): 1407-1418. Epub 2006 Mar 1415. 
	   174	  
Singleton, R. H., J. Zhu, J. R. Stone and J. T. Povlishock (2002). "Traumatically 
induced axotomy adjacent to the soma does not result in acute neuronal death." 
J Neurosci. 22(3): 791-802. 
Smith, D. H., H. D. Soares, J. S. Pierce, K. G. Perlman, K. E. Saatman, D. F. 
Meaney, C. E. Dixon and T. K. McIntosh (1995). "A model of parasagittal 
controlled cortical impact in the mouse: cognitive and histopathologic effects." J 
Neurotrauma. 12(2): 169-178. 
Smith, D. H., K. Uryu, K. E. Saatman, J. Q. Trojanowski and T. K. McIntosh 
(2003). "Protein accumulation in traumatic brain injury." Neuromolecular Med 
4(1-2): 59-72. 
Smith, D. H., J. A. Wolf, T. A. Lusardi, V. M. Lee and D. F. Meaney (1999). "High 
tolerance and delayed elastic response of cultured axons to dynamic stretch 
injury." J Neurosci. 19(11): 4263-4269. 
Smith, D. H. M., D.F. (2000). "Axonal damage in traumatic brain injury." Progress 
in Clinical Neuroscience 6: 483-495. 
Smith, G. M., R. H. Miller and J. Silver (1986). "Changing role of forebrain 
astrocytes during development, regenerative failure, and induced regeneration 
upon transplantation." J Comp Neurol. 251(1): 23-43. 
Smith, P. D., K. J. McLean, M. A. Murphy, A. M. Turnley and M. J. Cook (2005). 
"Seizures, not hippocampal neuronal death, provoke neurogenesis in a mouse 
rapid electrical amygdala kindling model of seizures." Neuroscience 136(2): 405-
415. Epub 2005 Oct 2013. 
Snow, D. M., D. A. Steindler and J. Silver (1990). "Molecular and cellular 
characterization of the glial roof plate of the spinal cord and optic tectum: a 
possible role for a proteoglycan in the development of an axon barrier." Dev Biol. 
138(2): 359-376. 
Spencer, M. L., H. Shao and D. A. Andres (2002). "Induction of neurite extension 
and survival in pheochromocytoma cells by the Rit GTPase." J Biol Chem. 
277(23): 20160-20168. Epub 22002 Mar 20125. 
Spencer, M. L., H. Shao, H. M. Tucker and D. A. Andres (2002). "Nerve growth 
factor-dependent activation of the small GTPase Rin." J Biol Chem. 277(20): 
17605-17615. Epub 12002 Mar 17604. 
Stankiewicz, T. R. and D. A. Linseman (2014). "Rho family GTPases: key players 
in neuronal development, neuronal survival, and neurodegeneration." Front Cell 
Neurosci. 8:314.(doi): 10.3389/fncel.2014.00314. eCollection 02014. 
Stenmark, H. and V. M. Olkkonen (2001). "The Rab GTPase family." Genome 
Biol 2(5): REVIEWS3007. Epub 2001 Apr 3027. 
	   175	  
Streit, W. J., R. E. Mrak and W. S. Griffin (2004). "Microglia and 
neuroinflammation: a pathological perspective." J Neuroinflammation. 1(1): 14. 
Suehiro, E. and J. T. Povlishock (2001). "Exacerbation of traumatically induced 
axonal injury by rapid posthypothermic rewarming and attenuation of axonal 
change by cyclosporin A." J Neurosurg. 94(3): 493-498. 
Sugino, T., K. Nozaki, Y. Takagi, I. Hattori, N. Hashimoto, T. Moriguchi and E. 
Nishida (2000). "Activation of mitogen-activated protein kinases after transient 
forebrain ischemia in gerbil hippocampus." J Neurosci. 20(12): 4506-4514. 
Sullivan, P. G., M. B. Thompson and S. W. Scheff (1999). "Cyclosporin A 
attenuates acute mitochondrial dysfunction following traumatic brain injury." Exp 
Neurol. 160(1): 226-234. 
Summers, C. R., B. Ivins and K. A. Schwab (2009). "Traumatic brain injury in the 
United States: an epidemiologic overview." Mt Sinai J Med. 76(2): 105-110. doi: 
110.1002/msj.20100. 
Tang-Schomer, M. D., V. E. Johnson, P. W. Baas, W. Stewart and D. H. Smith 
(2012). "Partial interruption of axonal transport due to microtubule breakage 
accounts for the formation of periodic varicosities after traumatic axonal injury." 
Exp Neurol. 233(1): 364-372. doi: 310.1016/j.expneurol.2011.1010.1030. Epub 
2011 Nov 1014. 
Teasdale, G. and B. Jennett (1974). "Assessment of coma and impaired 
consciousness. A practical scale." Lancet. 2(7872): 81-84. 
Tedeschi, A. and F. Bradke (2013). "The DLK signalling pathway--a double-
edged sword in neural development and regeneration." EMBO Rep. 14(7): 605-
614. doi: 610.1038/embor.2013.1064. Epub 2013 May 1017. 
Templeton, J. P. and E. E. Geisert (2012). "A practical approach to optic nerve 
crush in the mouse." Mol Vis 18: 2147-2152. Epub 2012 Jul 2127. 
Thurman, D. J. A., C.; Browne, D.; Dunn, K.A. (1999). "Traumatic Brain Injury in 
the United States: A Public Health Perspective." Journal of Trauma Rehabilitation 
14(6): 602-615. 
Tibbles, L. A. and J. R. Woodgett (1999). "The stress-activated protein kinase 
pathways." Cell Mol Life Sci. 55(10): 1230-1254. 
Tsenter, J., L. Beni-Adani, Y. Assaf, A. G. Alexandrovich, V. Trembovler and E. 
Shohami (2008). "Dynamic changes in the recovery after traumatic brain injury in 
mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and 
cognitive functions." J Neurotrauma. 25(4): 324-333. doi: 
310.1089/neu.2007.0452. 
	   176	  
van Praag, H., B. R. Christie, T. J. Sejnowski and F. H. Gage (1999). "Running 
enhances neurogenesis, learning, and long-term potentiation in mice." Proc Natl 
Acad Sci U S A. 96(23): 13427-13431. 
van Praag, H., T. Shubert, C. Zhao and F. H. Gage (2005). "Exercise enhances 
learning and hippocampal neurogenesis in aged mice." J Neurosci. 25(38): 8680-
8685. 
Villapol, S., K. R. Byrnes and A. J. Symes (2014). "Temporal dynamics of 
cerebral blood flow, cortical damage, apoptosis, astrocyte-vasculature interaction 
and astrogliosis in the pericontusional region after traumatic brain injury." Front 
Neurol. 5:82.(doi): 10.3389/fneur.2014.00082. eCollection 02014. 
Walker, L. J., D. W. Summers, Y. Sasaki, E. J. Brace, J. Milbrandt and A. 
DiAntonio (2017). "MAPK signaling promotes axonal degeneration by speeding 
the turnover of the axonal maintenance factor NMNAT2." Elife. 6.(pii): e22540. 
doi: 22510.27554/eLife.22540. 
Wang, J., M. A. Fox and J. T. Povlishock (2013). "Diffuse traumatic axonal injury 
in the optic nerve does not elicit retinal ganglion cell loss." J Neuropathol Exp 
Neurol. 72(8): 768-781. doi: 710.1097/NEN.1090b1013e31829d31828d31829d. 
Wang, J. T., Z. A. Medress and B. A. Barres (2012). "Axon degeneration: 
molecular mechanisms of a self-destruction pathway." J Cell Biol. 196(1): 7-18. 
doi: 10.1083/jcb.201108111. 
Wang, J. Y., M. Y. Gong, Y. L. Ye, J. M. Ye, G. L. Lin, Q. Q. Zhuang, X. Zhang 
and J. H. Zhu (2015). "The RIT2 and STX1B polymorphisms are associated with 
Parkinson's disease." Parkinsonism Relat Disord. 21(3): 300-302. doi: 
310.1016/j.parkreldis.2014.1012.1006. Epub 2014 Dec 1016. 
Wang, X., L. Xu, H. Wang, P. R. Young, M. Gaestel and G. Z. Feuerstein (2002). 
"Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 
deficiency protects brain from ischemic injury in mice." J Biol Chem. 277(46): 
43968-43972. Epub 42002 Sep 43964. 
Watkins, T. A., B. Wang, S. Huntwork-Rodriguez, J. Yang, Z. Jiang, J. Eastham-
Anderson, Z. Modrusan, J. S. Kaminker, M. Tessier-Lavigne and J. W. Lewcock 
(2013). "DLK initiates a transcriptional program that couples apoptotic and 
regenerative responses to axonal injury." Proc Natl Acad Sci U S A. 110(10): 
4039-4044. doi: 4010.1073/pnas.1211074110. Epub 1211072013 Feb 
1211074119. 
Webster, S. J., L. J. Van Eldik, D. M. Watterson and A. D. Bachstetter (2015). 
"Closed head injury in an age-related Alzheimer mouse model leads to an altered 
neuroinflammatory response and persistent cognitive impairment." J Neurosci. 
35(16): 6554-6569. doi: 6510.1523/JNEUROSCI.0291-6515.2015. 
	   177	  
Weinstein, D. E., P. Burrola and T. J. Kilpatrick (1996). "Increased proliferation of 
precursor cells in the adult rat brain after targeted lesioning." Brain Res. 743(1-2): 
11-16. 
Welsbie, D. S., Z. Yang, Y. Ge, K. L. Mitchell, X. Zhou, S. E. Martin, C. A. 
Berlinicke, L. Hackler, Jr., J. Fuller, J. Fu, L. H. Cao, B. Han, D. Auld, T. Xue, S. 
Hirai, L. Germain, C. Simard-Bisson, R. Blouin, J. V. Nguyen, C. H. Davis, R. A. 
Enke, S. L. Boye, S. L. Merbs, N. Marsh-Armstrong, W. W. Hauswirth, A. 
DiAntonio, R. W. Nickells, J. Inglese, J. Hanes, K. W. Yau, H. A. Quigley and D. 
J. Zack (2013). "Functional genomic screening identifies dual leucine zipper 
kinase as a key mediator of retinal ganglion cell death." Proc Natl Acad Sci U S 
A. 110(10): 4045-4050. doi: 4010.1073/pnas.1211284110. Epub 1211282013 
Feb 1211284119. 
Wennerberg, K., K. L. Rossman and C. J. Der (2005). "The Ras superfamily at a 
glance." J Cell Sci. 118(Pt 5): 843-846. 
Wes, P. D., M. Yu and C. Montell (1996). "RIC, a calmodulin-binding Ras-like 
GTPase." EMBO J. 15(21): 5839-5848. 
Wittmack, E. K., A. M. Rush, A. Hudmon, S. G. Waxman and S. D. Dib-Hajj 
(2005). "Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-
activated protein kinase." J Neurosci. 25(28): 6621-6630. 
Woodcock, T. and M. C. Morganti-Kossmann (2013). "The role of markers of 
inflammation in traumatic brain injury." Front Neurol. 4:18.(doi): 
10.3389/fneur.2013.00018. eCollection 02013. 
Xing, B., A. D. Bachstetter and L. J. Van Eldik (2011). "Microglial p38alpha 
MAPK is critical for LPS-induced neuron degeneration, through a mechanism 
involving TNFalpha." Mol Neurodegener. 6:84.(doi): 10.1186/1750-1326-1186-
1184. 
Xiong, Y., A. Mahmood and M. Chopp (2010). "Angiogenesis, neurogenesis and 
brain recovery of function following injury." Curr Opin Investig Drugs. 11(3): 298-
308. 
Xiong, Y., A. Mahmood and M. Chopp (2013). "Animal models of traumatic brain 
injury." Nat Rev Neurosci. 14(2): 128-142. doi: 110.1038/nrn3407. 
Xu, F., S. Sun, S. Yan, H. Guo, M. Dai and Y. Teng (2015). "Elevated expression 
of RIT1 correlates with poor prognosis in endometrial cancer." Int J Clin Exp 
Pathol. 8(9): 10315-10324. eCollection 12015. 
Yamamoto, T., A. Yamashita, K. Yamada and R. Hata (2011). 
"Immunohistochemical localization of chemokine CXCL14 in rat hypothalamic 
neurons." Neurosci Lett. 487(3): 335-340. doi: 310.1016/j.neulet.2010.1010.1051. 
Epub 2010 Oct 1023. 
	   178	  
Yang, H., Z. T. Gu, L. Li, M. Maegele, B. Y. Zhou, F. Li, M. Zhao and K. S. Zhao 
(2017). "SIRT1 plays a neuroprotective role in traumatic brain injury in rats via 
inhibiting the p38 MAPK pathway." Acta Pharmacol Sin. 38(2): 168-181. doi: 
110.1038/aps.2016.1130. Epub 2016 Dec 1026. 
Yang, J., Z. Wu, N. Renier, D. J. Simon, K. Uryu, D. S. Park, P. A. Greer, C. 
Tournier, R. J. Davis and M. Tessier-Lavigne (2015). "Pathological axonal death 
through a MAPK cascade that triggers a local energy deficit." Cell. 160(1-2): 161-
176. doi: 110.1016/j.cell.2014.1011.1053. 
Yu, T. S., G. Zhang, D. J. Liebl and S. G. Kernie (2008). "Traumatic brain injury-
induced hippocampal neurogenesis requires activation of early nestin-expressing 
progenitors." J Neurosci. 28(48): 12901-12912. doi: 
12910.11523/JNEUROSCI.14629-12908.12008. 
Zhang, P., Z. Zheng, L. Ling, X. Yang, N. Zhang, X. Wang, M. Hu, Y. Xia, Y. Ma, 
H. Yang, Y. Wang and H. Liu (2017). "w09, a novel autophagy enhancer, induces 
autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-
RAF1-MAP2K-MAPK1/3 pathway." Autophagy 17: 1-20. 
Zhang, X., M. Niu, H. Li and A. Xie (2015). "RIT2 rs12456492 polymorphism and 
the risk of Parkinson's disease: A meta-analysis." Neurosci Lett. 602:167-
71.(doi): 10.1016/j.neulet.2015.1007.1004. Epub 2015 Jul 1015. 
Ziebell, J. M. and M. C. Morganti-Kossmann (2010). "Involvement of pro- and 
anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic 
brain injury." Neurotherapeutics. 7(1): 22-30. doi: 10.1016/j.nurt.2009.1010.1016. 
Zink, B. J., J. Szmydynger-Chodobska and A. Chodobski (2010). "Emerging 
concepts in the pathophysiology of traumatic brain injury." Psychiatr Clin North 
Am. 33(4): 741-756. doi: 710.1016/j.psc.2010.1008.1005. 
 
 
 
 
 
 
 
 
	   179	  
VITA 
Megan Pannell 
Education 
University of Kentucky: Doctor of Philosophy in Biochemistry 
Indiana University: Master of Science in Biotechnology, highest 
distinction, 2012 
Transylvania University: Bachelor of Arts in Biology and Psychology, 
cum laude, 2011 
Publications 
Pannell MD, Cai W, Carlson S, Brelsfoard J, Littlejohn EL, Stewart T, 
Saatman K and Andres D. Rin GTPase signaling contributes to mature 
neuronal cell death and cognitive decline following traumatic brain injury. 
Submitted.  
Bush K. Pannell M, Lock JL, Queenan AM, Jorgensen JH, Lee RM, Lewis 
JS and Jarrett D. Detection systems for carbapenemase gene 
identification should include SME serine carbapenemase. Int J Antimicrob 
Agents. 2013 41 (1):1-4. 
Abstracts 
Pannell MD, Cia W, Carlson S, Brelsfoard J, Littlejohn EL, Steward T, 
Saatman KE, Andres DA. Deficiency of Rin GTPase mediates 
neuroprotection following traumatic brain injury. American Society for 
Biochemistry and Molecular Biology, Boston, MA 2015  
Cai W, Pannell MD, Carlson S, Saatman KE, Andres DA. Small GTPase 
Rit increases neurogenesis by coupling insulin-like growth factor to 
survival signaling. Kentucky Spinal Cord and Head Injury Research 
Symposium. Louisville, KY, May 2015 
Pannell MD, Cia W, Carlson S, Brelsfoard J, Littlejohn EL, Steward T, 
Saatman KE, Andres DA. Rin GTPase deficiency mediated 
neuroprotection following traumatic brain injury. Appalachian Regional Cell 
Conference, Huntington, WV, Nov 2014  
Cia W, Pannell MD, Carlson S, Brelsfoard J, Saatman K and Andres D. 
Divergent roles for the Rit and Rin GTPases in neuronal survival following 
	   180	  
traumatic brain injury. National Neurotrauma Society, Nashville, TN, Aug. 
2013 
Pannell M., King A, Davies T, Lee R, and Bush K. Characteristics of the 
novel Group 2b b-lactamase SHV-141. Annual Meeting of the American 
Society for Microbiology, San Francisco, CA, Jun. 2012 
Poster Presentations 
Pannell MD, Cia W, Carlson S, Brelsfoard J, Littlejohn EL, Steward T, 
Saatman KE, Andres DA. Deficiency of Rin GTPase mediates 
neuroprotection following traumatic brain injury. University of Kentucky 
Biochemistry Summer Research Conference. May 2015 
Cia W, Pannell MD, Carlson S, Saatman K and Andres D. Rit-mediated 
signaling promotes survival of immature hippocampal neurons. University 
of Kentucky Biochemistry Summer Research Conference. June 2012. 
Pannell MD, McClain JA, Hayes DM and Nixon K. Phosphorylated histone 
H3 detection in adolescent and adult hippocampus after binge ethanol 
exposure. University of Kentucky College of Pharmacy REU 
Presentations. July 2010. 
Oral Presentations, Seminars, and Journal Clubs 
“RINdering protection against traumatic brain injury” University of 
Kentucky Biochemistry Research Conference. May 2016 
“Rin GTPase deficiency provides neuronal protection following head 
injury” University of Kentucky Biochemistry Student Seminar Series. Oct 
2015 
“Rin loss mediates neuroprotection following traumatic brain injury” 
University of Kentucky Biochemistry Graduate Student Data Club. May 
2015 
“Identifying the link between LRRK2 kinase activity and Parkinsons’ 
disease toxicity” University of Kentucky Biochemistry Student Seminar 
Series. Jan 2015 
“Dual leucine zipper kinase mediates retinal ganglion cell death” University 
of Kentucky Biochemistry Seminar. Jan 2014 
 
“Characterization of the novel β-lactamase, SHV-141” Indiana University 
Biotechnology Seminar Series. Apr 2012 
	   181	  
 
“Virus derived small RNAs regulate transition from transcription to 
replication in Influenza A.” Indiana University Biochemistry. Apr 2012 
 
“Graduate school admissions advice for undergraduates: focus on 
biotechnology” Indiana University Undergraduate Biotechnology Seminar 
Series. Nov. 2011 
 
“Clinical methods of resistance detection and future options: emphasis on 
SHV-type b β-lactamases” Indiana University Biotechnology Seminar. 
Aug. 2011 
 
Honors and Awards  
NIH Training Grant 5T32 NS077889, Neurobiology of CNS Injury and Repair, 
2015-2017 
American Society for Biochemistry and Molecular Biology Travel Award, 
2015 
 University of Kentucky Graduate School Travel Award, 2015 
 First Year Graduate Fellowship, University of Kentucky, 2012-2013 
Pharmaceutical Science Summer Research Fellowship, University of 
Kentucky College of Pharmacy, 2010 
John B. Brownie Young Scholar, 2007-2012 
American Commercial Lines National Merit Scholarship Recipient, 2007-
2011  
Morrison Scholar, Transylvania University 2007-2011 
Jenny V. Watson Scholar, 2007-2011 
 
